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Protein quality control is important for the disposal of toxic misfolded proteins.  Ion channels 
represent a class of proteins that are suited for the study of protein quality control within the 
secretory pathway.  The inward rectifying potassium channel, Kir2.1, functions at the plasma 
membrane in several tissues to maintain membrane potential and osmotic homeostasis, and not 
surprisingly defects in Kir2.1 lead to a host of diseases.     To identify Kir2.1 regulators, a yeast 
Kir2.1 expression system was established.  Although a small population appeared to localize to 
the plasma membrane, Kir2.1 primarily localized to the ER and a significant fraction was 
targeted for ER associated-degradation (ERAD).   To identify the spectrum of factors that 
maintain Kir2.1 plasma membrane residence, the expression plasmid was introduced into a 
potassium transporter deficient strain in which Kir2.1 restores growth on low potassium, and the 
strain was crossed to the deletion collection to obtain haploid progeny.  Among the mutated 
genes that significantly increased cell growth on low potassium were those encoding members of 
the Endosomal Sorting Complex Required for Transport (ESCRT). ESCRT also regulated Kir2.1 
stability in HeLa cells.  These data indicate that Kir2.1 function is controlled by later steps in 
 iii 
secretory pathway quality control, but not ERAD.  The screen described represents a model that 
can be used for other ion channels. 
 
 iv 
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1.0  INTRODUCTION 
(Sections of this introduction were previously published in Kolb, A.R., T.M. Buck, and J.L. 
Brodsky. 2011. Saccharomyces cerivisiae as a model system for kidney disease: what can yeast 
tell us about renal function? Am J Physiol Renal Physiol. 301:F1-11.) 
 
Protein synthesis is a fundamental process required of all living organisms, from bacteria to 
humans.  However, protein synthesis can be inefficient and requires the constant monitoring and 
turnover of misfolded or over-expressed proteins.  A misfolded protein may abnormally present 
patches that make aberrant contacts with itself or with other proteins.  At its worst, misfolded 
proteins can form aggregates and/or alter protein function or localization, leading to cell toxicity 
(Dobson, 2003).   In order to prevent the toxicity that arises from aggregates and unregulated 
proteins, the cell possesses multiple forms of protein quality control that act at various points 
within the cell.  Protien quality control prevents misfolded or misregulated proteins from 
reaching or continuing to function by targeting them for degradation.   For example, one way of 
clearing aggregates is through protein quality control systems like autophagy.  During 
autophagy, portions of the cell are enclosed by a double membrane and targeted to the 
lysosome/vacuole for degradation (Arias and Cuervo, 2011; Mizushima, 2011).  To prevent 
aggregation, the cell possesses additional protein quality control pathways in the cytosol and 
secretory pathway (Arvan et al., 2002; Chen et al., 2011; Chhangani et al., 2012).  Protein quality 
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control represents an important step to maintain cell viability as illustrated by the numerous 
diseases associated with protein quality control disruption or misregulation of proteins 
(Guerriero and Brodsky, 2012).   
In the secretory pathway, protein quality control is essential because approximately one-
third of all translated proteins are secretory proteins (Ghaemmaghami et al., 2003) and because 
many of these proteins are glycosylated, possess disulfide bonds, and/or contain segments that 
traverse the membrane, which must fold properly so as not to disrupt the membrane (Araki and 
Nagata, 2011).  Failure to properly integrate any of these steps may produce a misfolded protein. 
Within the ER, aberrant proteins may be targeted to the proteasome for degradation through 
endoplasmic reticulum associated degradation (ERAD) (Araki and Nagata, 2011; Hebert et al., 
2010; Smith et al., 2011; Vembar and Brodsky, 2008).  Proteins that pass this initial step of 
protein quality control are further monitored by protein quality control mechanisms within the 
Golgi and at the plasma membrane, both of which can target misfolded proteins to the 
vacuole/lysosome (Apaja et al., 2010; Arvan et al., 2002; Jenness et al., 1997).  However, the full 
complement of protein quality factors that monitor misfolded proteins and how systems at 
different points within the cell interact with each other is unknown. 
 A large scale genetic screen to identify quality control factors is lacking. The model 
system, yeast, are exceptionally suited for large scale genomic studies, and yeast have been used 
to characterize protein quality control mechanisms within the secretory pathway (Carvalho et al., 
2006; Chang and Fink, 1995; McCracken and Brodsky, 1996; Vashist and Ng, 2004; Wang and 
Ng, 2010).  However, using yeast to identify the factors involved in protein quality control 
pathways has been difficult because disruption of protein quality control pathways does not 
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necessarily produce easily observable phenotypes.  Thus, a protein quality control substrate that 
is required for cell viability is required. 
Ion channels and transporters represent ideal proteins for such a screen.  Yeast must 
maintain proper osmotic and cation homeostasis in a variety of extracellular environments, and 
they possess multiple ion transporters to perform this function (Cyert and Philpott, 2013).  Ion 
channels are important in human physiology as well, and the loss of ion channel regulation 
results in many channelopathies due to loss of ionic and osmotic homeostasis (Hubner and 
Jentsch, 2002; Hubner and Jentsch, 2008; Webster and Berul, 2013).  Further, these channels are 
highly subject to protein quality control since they are transmembrane proteins that often must 
assemble into multimolecular complexes and they undergo open and closed conformational state 
changes.  Therefore, ion channels and transporters are protein classes that are required for cell 
viability and subject to protein quality control within the secretory pathway, and an examination 
of the quality control of two ion channels in yeast is a central focus of this thesis.   
In the remainder of the introduction, I focus on the benefits and disadvantages of using 
yeast as a model system.  I then present examples of how yeast has been used to examine renal 
and cardiac protein function and regulation, with specific emphasis on the Kir2.1 potassium 
channel.  Next, I describe various protein quality control mechanisms that may act on Kir2.1.  
Finally, I discuss the function of ESCRT, a protein complex utilized by both Golgi and plasma 
membrane quality control. 
 3 
1.1 YEAST AS A MODEL SYSTEM  
1.1.1 Advantages of the yeast system 
Protein quality control in eukaryotes is conserved between yeast and man, and the molecular 
underpinnings of many protein quality control events were first described in yeast.  As a model 
organism, yeast possess critical advantages.  First, the growth of large quantities of cells is rapid 
and inexpensive, thus aiding the development of biochemical assays.  Second, glycosylation and 
processing, which are important for protein function, occur similarly in yeast and mammalian 
cells (Lehle et al., 2006).  Third, yeast are easy to transform and can be engineered to express 
heterologous proteins.  Fourth, yeast exist in a haploid form or diploid state and recombine genes 
through homologous recombination.  This makes genetic ablation a simple undertaking and 
allows for genome-wide screens for genetic modifiers of essential processes.   Fifth, in 
comparison to other model organisms, abundant tools are available, either commercially or 
through the yeast community.  These tools include the yeast gene knock-out collection, which 
includes deletions in every non-essential gene (~85% of all genes) (Winzeler et al., 1999); a 
hypomorphic allele collection, in which essential yeast genes are placed under the control of a 
repressible promoter or contain destabilizing sequences in their messages (Breslow et al., 2008); 
a temperature sensitive mutant collection that includes about half of the ~1000 essential genes 
(Li et al., 2010); and strains in which each open reading frame is either GFP- or TAP-tagged for 
localization or purification, respectively (Howson et al., 2005).  There is also a wealth of yeast-
related resources available online, including the Saccharomyces Genome Database, BioGRID 
(General Repository of Interaction datasets), the Yeast GFP Fusion Localization Database, and 
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DIP (Database of Interacting Proteins), to name a few.   Together, it is relatively simple to 
design, perform and interpret experiments, and to plan subsequent confirmatory studies. 
1.1.2 Yeast to study human disease 
Heterologous expression in yeast has been used to study the protein quality control of many 
human proteins whose function must be tightly regulated.  This is particularly true of the many 
ion channels and transporters which function to maintain proper ion homeostasis within the cell. 
A reason for this is that yeast, like humans, require ion channels and transporters to maintain 
osmotic and ion homeostasis required for cell viability (Figure 1).  Since yeast are equipped to 
produce and monitor the biogenesis of protein channels, they also can be used to examine human 
channels that are heterologously expressed in this organism.   
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 Figure 1: The major plasma membrane and intracellular cation transporters in the yeast S. cerevisiae 
(Arino et al., 2010) 
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Misregulation of transporters and channels in humans leads to many channelopathies 
(Hubner and Jentsch, 2002; Hubner and Jentsch, 2008; Webster and Berul, 2013) and thus 
represents an important area of study. The kidney is a particularly important site of ion channel 
function, as it maintains physiological ion and osmotic homeostasis within the blood (Webster 
and Berul, 2013).  In the next section (1.2), I describe how yeast have contributed to a better 
understanding of channels and transporters in renal physiology.  I then shift focus to ion channel 
function important for heart function.  For example, the coordinated action of depolarizing 
sodium and calcium and repolarizing potassium channels regulate heart contractions (Giudicessi 
and Ackerman, 2012).  One focus of my research is Kir2.1, a potassium channel that participates 
in the repolarization of the ventricle.  Together, regardless of where they function, the 
mechanisms governing channel biogenesis and regulation are important to understand in order to 
treat the multiple channelopathies that exist. 
1.1.3 Limitations of the yeast system 
A discussion of any system is incomplete without mentioning its limitations.  Two of the major 
limitations to studying human physiology in the yeast system are that lab strains of yeast are 
single cell organisms and that yeast cells are not polarized, except during bud emergence 
(Johnson et al., 2011).   Therefore, yeast cannot be used to model the complicated cell-to-cell 
interactions that occur within organs.  Moreover, studies to examine the residence of proteins to 
distinct polarized areas in the cell cannot be interpreted in yeast. Nevertheless, this simple system 
has facilitated studies that have led to the isolation of factors required for the degradation, 
folding, and transport of critical human proteins.  The yeast system has also permitted a robust 
means to perform structure-function analyses of these proteins, and it has uncovered new 
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functions and the effects of disease-causing mutants in specific proteins of human physiological 
relevance.  This simplified system can also be utilized to more completely view the essential 
cellular pathways that impact metabolic and cellular processes.   
1.2 YEAST AS A MODEL SYSTEM TO STUDY RENAL PHYSIOLOGY 
Approximately 11% of adults age 20 and older (~20 million people in the United States) suffer 
from some form of chronic kidney-related disease (Levey et al., 2009), and in recent years more 
than a half-a-million patients in the US were under treatment for end-stage renal disease.  Some 
of these diseases, which specifically affect glomerular and tubular function, are the direct result 
of defective protein function or the misrouting, misprocessing, and/or degradation of a specific 
protein.  In most cases, however, the molecular basis of disease is unknown or poorly 
understood.    
A number of systems have been employed to study cellular aspects of kidney disease, 
including mouse models, primary and immortalized tissue culture cell lines, and Xenopus 
oocytes.  Mouse or other rodent models for disease are most desirable, but these systems are 
costly and the generation of mutations is an uncertain and long-term undertaking.  Tissue culture 
systems have been used to successfully model renal epithelia, but genetic manipulation of 
mammalian cells may not be trivial and there is often debate on which cell type represents the 
best model.  To study ion and water channel physiology and gating, functional assays may be 
performed in Xenopus oocyte expression systems, but biochemical techniques using this system 
are laborious and limited by the amount of material that can be obtained.  While critical 
discoveries have certainly been made using these systems, there is always a need for faster, 
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easier, cheaper, and more genetically amenable systems.  One such system, and the focus of my 
thesis, is the baker’s yeast, Saccharomyces cerevisiae.   
In the next section, the techniques, expressions systems, and scientific advances in kidney 
biology that have been made to date using this system are described as an example that the 
humble Baker’s yeast can indeed tell us a lot about human physiology and disease. I have 
attempted to highlight the diversity of not only the renal proteins (Fig. 1) that have already been 
investigated in yeast, but the diversity of techniques this model system offers for studying these 
proteins (Table I) and the possibility of extending these studies to proteins that reside in other 
tissues. 
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Figure 2: A topological and cellular model of the diverse kidney proteins that have been 
characterized in the yeast system.   
The proteins modeled above are expressed in renal epithelial cells and are localized, as 
depicted, to the cytosol, apical or basolateral membranes.  Please note that these proteins may not 
be located to the same type of kidney epithelia or region of the kidney nephron. 
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Table 1: Yeast studies of renal proteins 
Protein  Type of Study  Method used Reference 
Ion Channels   
ENaC 
Function 
Localization 
 
ERAD  
 
Characterization 
 
Sodium sensitive growth
Membrane preparations 
Immunofluorescence 
Cycloheximide chase 
 
Immunoblotting 
in vitro assay 
(Gupta and Canessa, 2000)
(Gupta and Canessa, 2000) 
(Buck et al., 2010) 
(Buck et al., 2010; Kashlan et al., 
2007) 
(Buck et al., 2010) 
(Buck et al., 2010) 
Kir 
Channel Function 
 
 
 
 
Structure 
Small molecule 
studies 
Rb+ flux assay
Low potassium rescue  
 
 
 
Low potassium rescue  
Low potassium rescue  
(D'Avanzo et al., 2010)
(Haass et al., 2007; Minor et al., 
1999; Nakamura and Gaber, 1998; 
Tang et al., 1995b; Zaks‐Makhina et 
al., 2009) 
(Minor et al., 1999) 
(Zaks‐Makhina et al., 2009) 
CFTR 
Structure/Function
 
Localization 
 
 
 
 
 
 
 
 
ERAD  
 
Characterization 
 
 
 
Yeast Response 
Screen: Rescue of mating 
phenotype 
Yeast two‐hybrid 
Immunofluorescence 
 
 
Membrane preparations 
 
Fractionation 
EM 
 
Cycloheximide chase 
 
Pulse chase 
 
 
Fluorescence microscopy 
Microarray 
(DeCarvalho et al., 2002; Teem et al., 
1993; Teem et al., 1996) 
(DeCarvalho et al., 2002) 
(Fu and Sztul, 2003; Fu and Sztul, 
2009; Kiser et al., 2001; Zhang et al., 
2001) 
(Fu and Sztul, 2003; Zhang et al., 
2001) 
(Kiser et al., 2001; Zhang et al., 2001) 
(Fu and Sztul, 2003; Sullivan et al., 
2003) 
(Ahner et al., 2007; Youker et al., 
2004; Zhang et al., 2001) 
(Fu and Sztul, 2003; Gnann et al., 
2004; Kiser et al., 2001; Lenk et al., 
2002) 
(Fu and Sztul, 2009) 
(Ahner et al., 2007) 
Transporters     
Na,K‐ATPase 
 
 
Function 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rb+ & Ti+ occlusion
 
Ouabain binding 
 
 
 
 
 
 
 
 
 
 
 
(Nielsen et al., 1998; Scheiner‐Bobis 
and Farley, 1994) 
(Horowitz et al., 1990; Jacobsen et 
al., 2002; Muller‐Ehmsen et al., 2001; 
Pedersen and Jorgensen, 1992; 
Pedersen et al., 2000; Pedersen et 
al., 1998; Pedersen et al., 1996a; 
Pedersen et al., 1996b; Pedersen et 
al., 1997a; Pedersen et al., 1997b; 
Scheiner‐Bobis, 2001; Scheiner‐Bobis 
and Farley, 1994; Scheiner‐Bobis et 
al., 1994; Scheiner‐Bobis and 
Schneider, 1997; Scheiner‐Bobis and 
Schreiber, 1999; Xu et al., 2003a) 
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Structure/Function 
 
 
Yeast Response 
 
Small Molecule 
Studies 
ATPase assays
 
 
 
 
 
 
 
 
 
 
 
 
β‐galactosidase chimera 
yeast two hybrid 
 
Transcription/Translational 
effects 
ATPase assays & ouabain 
binding 
(Horowitz et al., 1990; Jacobsen et 
al., 2002; Muller‐Ehmsen et al., 2001; 
Pedersen and Jorgensen, 1992; 
Pedersen et al., 2000; Pedersen et 
al., 1998; Pedersen et al., 1996a; 
Pedersen et al., 1996b; Pedersen et 
al., 1997a; Pedersen et al., 1997b; 
Scheiner‐Bobis, 2001; Scheiner‐Bobis 
and Farley, 1994; Scheiner‐Bobis et 
al., 1994; Scheiner‐Bobis and 
Schneider, 1997; Scheiner‐Bobis and 
Schreiber, 1999; Wang and Farley, 
1998; Xu et al., 2003a) 
(Yoon and Lee, 1998) 
(Colonna et al., 1997; Wang and 
Farley, 1998) 
(Steffensen and Pedersen, 2003; 
Steffensen and Pedersen, 2006) 
(Hauck et al., 2009; Scheiner‐Bobis, 
2001; Scheiner‐Bobis et al., 1994; 
Scheiner‐Bobis and Schneider, 1997) 
Na+/H+ 
antiporter/exchanger 
Function 
 
 
Localization 
Sodium sensitivity
Reconstitution 
 
Immunofluorescence 
(Xiang et al., 2007)
(Montero‐Lomeli and Okorokova 
Facanha, 1999) 
(Flegelova et al., 2006; Flegelova and 
Sychrova, 2005; Xiang et al., 2007) 
Na/Pi cotransporter 
Function 
Localization 
Low potassium rescue
Biotinylation 
(Bernhardt et al., 1999)
(Bernhardt et al., 1999) 
Aquaporins 
Function 
 
 
 
 
 
Structure/Folding 
 
Disease mutants 
Stop flow experiments
 
 
 
Protoplast bursting assays 
Complementation studies 
Stop flow experiments 
 
Stop flow experiments 
(Coury et al., 1998; Kuwahara et al., 
1999; Laize et al., 1997; Laize et al., 
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1.2.1 Ion channels 
Ion channel function in the kidney is vital to maintain osmotic and salt homeostasis, and as 
discussed above, a number of diseases are the direct result of mutations and/or misregulation of 
kidney-localized ion channels.  Ion channels including ENaC (Epithelial Sodium Channel), 
several members of the Kir (Inward rectifying Potassium Channel) family, and CFTR (the Cystic 
Fibrosis Transmembrane Conductance Regulator) have been successfully characterized in yeast, 
an organism that normally lacks these proteins (Figure 2; Table I).   
1.2.1.1 Epithelial Sodium Channel (ENaC) 
ENaC, a heterotrimeric sodium channel composed of α, β, and γ subunits, is expressed in 
the kidney, colon, and airway where it functions to maintain osmotic homeostasis (Snyder, 2002; 
Soundararajan et al., 2010).  ENaC is responsible for final sodium absorption in the distal 
nephron.  Thus, ENaC function and levels are tightly regulated, and either gain- or loss-of-
function mutations in ENaC alter sodium homeostasis in the kidney, resulting in hypertension 
(Liddle’s Syndrome), or hypotension (Pseudohypoaldosteronism Type I), respectively.  In 
addition, common polymorphisms in the genes encoding ENaC subunits may affect blood 
pressure variation in the population as a whole (Jin et al., 2010).   
To examine how ENaC is regulated during biosynthesis, the three ENaC subunits were 
expressed individually in yeast.  Immunofluorescence microscopy was used to determine that 
ENaC localized primarily to the ER (endoplasmic reticulum), although other immunostaining 
regions were observed that may represent secretory vesicles and/or the plasma membrane (Buck 
et al., 2010; Gupta and Canessa, 2000).  The primary ER residence of ENaC is consistent with 
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the fact that <20% of the channel resides at the plasma membrane in epithelial cells (Hanwell et 
al., 2002; Prince and Welsh, 1998; Staub et al., 1997; Valentijn et al., 1998; Weisz and Johnson, 
2003).  This makes yeast an ideal system to monitor early events during ENaC biogenesis, such 
as ER-associated degradation (ERAD) (see section 1.4.1) (Weisz and Johnson, 2003). 
ERAD is a quality control pathway exemplified by the chaperone-mediated recognition 
of misfolded proteins within the ER and the subsequent targeting of these aberrant proteins for 
ubiquitination and degradation by the cytosolic 26S proteasome; notably, ERAD was first 
discovered in yeast and the components and basic elements of this pathway are completely 
conserved (Goeckeler and Brodsky, 2010; Vembar and Brodsky, 2008).  Consistent with studies 
in vertebrate systems (Malik et al., 2006; Malik et al., 2001; Staub et al., 1997; Valentijn et al., 
1998), ENaC degradation was slowed in yeast strains with defects in the proteasome pathway 
when analyzed by a cycloheximide chase assay (Buck et al., 2010; Kashlan et al., 2007).  Using 
recently developed biochemical techniques, it was then determined that the ER resident E3 
ubiquitin ligases, Hrd1 and Doa10, append ubiquitin onto the ENaC subunits and facilitate their 
degradation (Buck et al., 2010).  Interestingly, the extent of ubiquitination and stabilization in the 
E3 mutant strains varied amongst the subunits.  This result supports data from other systems 
suggesting that the three subunits are differentially regulated (Canessa et al., 1994a; Hughey et 
al., 2003; Mueller et al., 2010; Staub et al., 1997). 
Because molecular chaperones aid in secretory protein folding and select misfolded 
proteins for ERAD, the chaperone requirements for ENaC degradation were also assessed in 
yeast.  Cycloheximide chase assays revealed that the small heat shock proteins, Hsp26 and 
Hsp42, facilitate the degradation of α-ENaC (Kashlan et al., 2007), and the ER lumenal Hsp40 
chaperones, Scj1 and Jem1, promote the degradation of each of the three ENaC subunits.  By 
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employing reagents obtained from wild type and mutant strains in defined cellular and in vitro 
assays, the Hsp40s were shown to function prior to substrate ubiquitination (Buck et al., 2010).  
The results obtained from the yeast studies were then validated in vertebrate cells.  Specifically, 
overexpression of the mammalian homologs of the small heat shock proteins or the Hsp40s in 
Xenopus oocytes accelerated ENaC degradation, and their expression decreased the amiloride-
sensitive ENaC current and ENaC residence at the plasma membrane (Buck et al., 2010; Kashlan 
et al., 2007). These studies indicate that yeast can provide a means to identify factors involved in 
ion channel biogenesis, and that results in this system can be translated into higher cell types.   
Earlier, another yeast expression system for ENaC, consisting of an inducible αβENaC 
concatamer, was established (Gupta and Canessa, 2000).  Immunoblotting of secretory vesicles 
and plasma membrane preparations confirmed that ENaC traffics to the plasma membrane, as it 
does in epithelial cells (see above).  Interestingly, ENaC expression led to defective cell growth 
when yeast were incubated on high (1M) sodium-containing media (Gupta and Canessa, 2000).  
These data suggested that ENaC is active in yeast, which sets-the-stage for genome-wide studies 
to identify and characterize additional regulators of ENaC function. 
1.2.1.2 Inward rectifying potassium channels 
A group of ion channels unrelated to those discussed have also been expressed in yeast.  
The Kir family is composed of seven subfamilies (Kir1-7) that share ~60% sequence homology 
and ~40% sequence identity within subfamilies (de Boer et al., 2010).  Several members of the 
Kir potassium channel family are expressed in the kidney, including Kir1.1, Kir4.1, Kir5.1 and 
Kir6.1 (de Boer et al., 2010; Hibino et al., 2010).   Kir1.1 (also known as ROMK) functions at 
the apical membrane and Kir4.1 and 5.1 function at the basolateral membrane of polarized 
epithelial cells. These channels maintain potassium homeostasis and provide potassium to the 
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Na+-K+-2Cl- co-transporter and to the Na+-K+-ATPase, thus contributing to the cellular flux of 
sodium and chloride.  Mutations in Kir1.1 result in Type 2 Bartter syndrome, which is 
characterized by potassium and sodium wasting (Hibino et al., 2010), and mutations of Kir4.1 
were recently shown to cause EAST/SeSAME syndrome, which also gives rise to a Bartter-like 
phenotype (Bockenhauer et al., 2009; Scholl et al., 2009).  Although Kir6.1’s role in the pancreas 
is better characterized, Kir6.1 is an ATP-sensitive potassium channel, and resides with Kir1.1 
and CFTR on the apical membrane of renal epithelial cells (Hibino et al., 2010; Ruknudin et al., 
1998).  Kir6.1 is also localized to the mitochondria in the kidney, where it may act as a 
mitochondrial potassium channel (Ng et al., 2010).   While there are insignificant levels of other 
Kir family members in the kidney, all family members are closely related.  Therefore, studies 
that involve Kir homologs that reside in other tissues may provide insights into the function of 
renal Kir family members.   
Multiple Kir proteins have been expressed in yeast.  In fact, ten of eleven Kir proteins, 
representing every Kir subfamily, have been expressed in this organism and traffic to the plasma 
membrane, as they do in mammalian cells.  Some of these channels were purified from yeast, 
reconstituted into proteoliposomes, and shown to have channel activity using a Rb+ flux assay 
(D'Avanzo et al., 2010).   
Another strategy to study channel function in yeast is to express Kir channels in a strain 
deleted for the genes encoding two endogenous plasma membrane-resident potassium 
transporters, Trk1 and Trk2.  This strain is inviable when grown on low potassium media, but 
cell growth is rescued upon the expression of a foreign, functional potassium channel that resides 
at the plasma membrane.  Kir2.1 was the first Kir channel expressed in this strain background 
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and restored cell growth on low potassium-containing media (Tang et al., 1995b).  This system 
was then optimized for genetic screens (Nakamura and Gaber, 1998). 
For example, a genome-wide SGA (synthetic gene array) screen was used to isolate 
factors that impact the trafficking of Kir3.2.  Seven genes that affected the protein’s residence at 
the plasma membrane were identified, including:  COPII cargo receptors, which mediate the 
transport of specific proteins from the ER to the Golgi (ERV25, EMP24, and TED1), a COPII 
vesicle packaging chaperone (ERV14), a fatty acid elongase (SUR4), a GPI inositol deacylase 
(BST1) and a regulatory subunit of mannosyl-transferases (CSG2)  (Haass et al., 2007).  Each of 
these factors plays a designated role in the secretory pathway.  Screens in Kir2.1-expressing 
yeast were also employed to uncover small molecule inhibitors of Kir and to define how the 
protein’s transmembrane domains are organized and contribute to channel function (Minor et al., 
1999; Zaks-Makhina et al., 2004; Zaks-Makhina et al., 2009).  As described below, I performed 
a screen for Kir2.1 plasma membrane regulators (see Chapter 2). 
In another example, an expression system for Kir6.1 was established, and like other Kir 
family members the channel rescued the growth of trk1Δtrk2Δ mutant yeast on low potassium-
containing media.   Mutated residues in Kir6.1 that ablated ATP sensitivity and trafficking in 
Xenopus oocytes were then scored as gain or loss-of-function mutations in this system (Graves 
and Tinker, 2000).  In principle, monitoring the growth of trk1Δ trk2Δ cells on low potassium-
containing media should facilitate continued studies on the function, trafficking, and regulation 
of any potassium channel that can be expressed in yeast.  
1.2.1.3 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 
The structure, function, biogenesis, and regulation of a third ion channel, CFTR, have 
also been extensively examined in the yeast system (Table 1).   Although its specific activity in 
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the kidney has not been well characterized, CFTR function in airway cells and in tissue culture 
has been extensively studied because mutations in CFTR destabilize the protein and result in 
cystic fibrosis.  The most common disease-causing mutation is a deletion of phenylalanine at 
position 508 (Belcher and Vij, 2010; Cheng et al., 1990; Pilewski and Frizzell, 1999).  Although 
kidney pathology is not associated with cystic fibrosis, it has been proposed that as patient 
survival increases due to improved treatment of the airway pathology, a renal pathology may 
become apparent (Soulsby et al., 2009).   
CFTR is a chloride channel of the ATP-binding cassette (ABC) transporter family, 
consisting of 12 transmembrane domains and containing two prominent cytoplasmic loops.  The 
first loop harbors a nucleotide binding domain (NBD1) and a regulatory domain, and the second 
loop contains a second NBD (NBD2).  In the active form CFTR’s regulatory domain is 
phosphorylated and the NBDs are in the ATP bound state (Csanady et al., 2010; Gadsby, 2009).  
The most common cystic fibrosis-causing mutation, ΔF508, is located near the end of NBD1, 
and is thought to affect the docking of this domain onto the transmembrane domains (Serohijos 
et al., 2008).  Consequently, the mutation severely affects CFTR folding in the ER, such that the 
protein is targeted for ERAD (Jensen et al., 1995; Ward et al., 1995).  In some cell types, a 
significant fraction of the wild type protein is trapped in the ER and degraded by the ERAD 
pathway.  However, improvements in the folding environment—by altering chaperone levels or 
by reduced temperature (Denning et al., 1992)—rescue the folding defect such that the protein 
can escape ERAD and function at the plasma membrane.  Thus, there is a profound need to 
better define the factors that play a role in the folding and degradation of CFTR, which might 
then become therapeutic targets.  
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One approach that was successfully used to explore the protein-folding pathway of CFTR 
was to use a chimera in which the NBD1 of the yeast ABC transporter, Ste6, was replaced with 
the NBD1 from CFTR.  Ste6 is required for the successful mating between haploid strains in 
yeast, and the expression of the Ste6-CFTR-NBD1 chimera supported this event.  However, 
mating efficiency was reduced when the cystic fibrosis causing mutation, ΔF508, was introduced 
into NBD1.  The system was then used to identify suppressor mutations that restored function.  
Strikingly, the mutations also corrected the folding and trafficking defect of full-length ΔF508 
CFTR when expressed in mammalian cells (DeCarvalho et al., 2002; Teem et al., 1993; Teem et 
al., 1996).  Even though the nature of the defect in the Ste6-CFTR-NBD1(ΔF508) chimera was 
subsequently reinterpreted (Paddon et al., 1996), these studies exemplified how yeast could be 
used to uncover  determinants within a domain that permit the proper folding and trafficking of a 
disease-causing mutant protein.  
A yeast expression system for full length CFTR has also been used to define how the 
protein is targeted for ERAD.  A variety of biochemical and cellular assays showed that CFTR 
resides primarily in the ER (Kiser et al., 2001; Sullivan et al., 2003; Zhang et al., 2001).  
Cycloheximide and pulse-chase experiments in yeast strains with mutations or deletions in ER-
associated factors demonstrated that CFTR degradation is dependent on the proteasome, the ER 
localized E2 ubiquitin-conjugating enzymes, Ubc6 and Ubc7, and E3 ubiquitin ligases, Hrd1 and 
Doa10 (see above), and the Cdc48 complex, which is required to extract ubiquitinated proteins 
from the ER and present them to the proteasome (Gnann et al., 2004; Kiser et al., 2001; Lenk et 
al., 2002; Nakatsukasa et al., 2008; Zhang et al., 2001).  The mammalian homolog of Cdc48, p97 
or VCP, is also important for degrading CFTR in higher cells (Vij et al., 2006).  Yeast 
chaperones that contribute to the degradation of immature forms of CFTR include the cytosolic 
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Hsp40s (Ydj1 and Hlj1) and an associated Hsp70 (Ssa1), which together help present misfolded 
ER membrane proteins to the ubiquitination machinery.  Interestingly, yeast Hsp90 prevented the 
aggregation of purified NBD1 and aided the folding of CFTR (Youker et al., 2004).  The ability 
of Hsp90 to fold CFTR has been confirmed in higher cell types (Loo et al., 1998; Wang et al., 
2006). 
To more globally identify factors involved in CFTR biogenesis, a microarray screen 
analyzed the yeast transcriptome in CFTR expressing cells, with the underlying assumption that 
factors required for CFTR degradation would be upregulated.  From this effort, the small heat 
shock proteins, Hsp26 and Hsp42, were found to be upregulated and their deletion had a 
profound effect on CFTR degradation in yeast.  In HEK293 cells, a mammalian Hsp26/Hsp42 
homolog preferentially selected ΔF508 over wild-type CFTR for degradation (Ahner et al., 
2007).  This result indicated that the yeast system could be used to uncover a component that can 
be specifically modulated to rescue the biogenesis of the disease-causing protein in higher cells.   
Of note, CFTR degradation in yeast may occur in discrete ER microdomains, termed ER-
associated complexes (ERACs) (Huyer et al., 2004a), which are maintained by the COPII/SAR1 
vesicle transport machinery (Fu and Sztul, 2003). Real-time fluorescence microscopy of an 
inducible EGFP-CFTR construct indicated a diffuse ER localization for the protein that was 
either degraded immediately or accumulated in distinct foci.  Using fluorescence recovery after 
photobleaching technology, the authors determined that the CFTR population in the foci was not 
as mobile as the CFTR in the diffuse ER pool, and the former pool appeared to be degraded via 
autophagy (Fu and Sztul, 2009).  Links between autophagy and defects in CFTR function, at 
least under some conditions, were recently reported (Luciani et al., 2010). 
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1.2.2 Transporters 
Osmotic homeostasis in kidney epithelia depends upon the coordinated efforts of ion channels 
and a diverse group of transporters.  For example, the ubiquitously expressed Na+-K+-ATPase 
imports two K+ ions for every three Na+ ions exported, and is composed of an α, β, and γ subunit 
(Kaplan, 2002).  The α and β subunits are sufficient to form an active channel while the γ subunit 
regulates activity.  There are three α subunit isoforms and four β-subunit isoforms, but the α1 and 
β1 subunit isoforms are the major isoforms expressed in the kidney.  In kidney epithelia, the Na+-
K+-ATPase functions at the basolateral membrane and provides the electrochemical gradient 
required for Na+ transport at the apical membrane, which is mediated by other ion channels, such 
as ENaC.  Na+-K+-ATPase function in the kidney has been linked to some forms of hypertension 
and has thus been targeted for therapeutics (Ferrari et al., 2003; Lingrel et al., 1994).   The Na+-
K+-ATPase also functions in the heart and has been targeted for the treatment of congestive heart 
failure through the use of cardiac glycosides, such as digoxin, which inhibit the transporter 
(Francis, 2008; May and Diaz, 2008).  Although not used clinically, another cardiac glycoside, 
ouabain, has been utilized extensively to characterize the function of the Na+-K+-ATPase 
because each ouabain molecule binds one holoenzyme and inhibits pump activity (Lingrel, 
2010).  
 Yeast, unlike animal cells, lack the Na+-K+-ATPase, and can therefore be used to 
characterize its activity.  Yeast compensate for the expression of an exogenous transporter by 
derepressing Gcn4, a transcription factor that mediates a response to nutrient starvation 
(Steffensen and Pedersen, 2003; Steffensen and Pedersen, 2006).  To establish a yeast expression 
system for the Na+-K+-ATPase, a sheep α subunit and a canine β subunit were individually 
expressed (Horowitz and Farley, 1988).  The resulting transporter exhibited potassium-sensitive 
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ouabain binding and ouabain-sensitive ATPase and p-nitrophenylphosphatase activities, as in 
mammalian cells (Horowitz et al., 1990).   This system was then adapted to study the activities of 
the many possible α - β isoform combinations.  This was accomplished by placing each subunit 
isoform on plasmids with different selectable markers (Pedersen and Jorgensen, 1992).  For 
example, each of the human α isoforms with the β1 isoform were expressed in yeast and each 
assembled enzyme exhibited similar potassium-sensitive ouabain binding affinities and activities, 
as observed in mammalian cells (Muller-Ehmsen et al., 2001). Since yeast lack endogenous Na+-
K+-ATPase activity, the data are more easily interpreted. 
The yeast system has also contributed to structure-function analyses of the Na+-K+-
ATPase.  In one study, truncated ATPase subunits were fused to a β-galactasidase reporter, 
which is only functional in the cytoplasm, and therefore allows one to determine transmembrane 
segment orientation.  It was found that the α subunit contains ten transmembrane segments while 
the β subunit contains one transmembrane segment, consistent with results from other studies 
(Fiedler and Scheiner-Bobis, 1996; Kaplan, 2002).  The yeast system also helped to establish that 
the α and β subunits constitute minimal transporter activity (Scheiner-Bobis and Farley, 1994).  
Further, the yeast system and yeast two-hybrid assays were used to identify regions within the α 
and β subunit that contribute to subunit-subunit association: A 63 amino acid tract (E63-D125) in 
the extracellular loop of the β subunit and the amino acid tract SYGQ along with V904, T890, 
and C908 in the extracellular loop between the 7th and 8th transmembrane segment of the α 
subunit were shown to be required to mediate intermolecular associations (Colonna et al., 1997; 
Wang and Farley, 1998).  Yeast two-hybrid assays were also employed to provide evidence that 
the α subunits may self-associate via the first cytoplasmic loop (Colonna et al., 1997; Yoon and 
Lee, 1998). 
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The Na+-K+-ATPase cycles through ATP-bound, ADP-bound, and nucleotide-free 
conformations, but the residues that mediate this cycle and the contributions of bound ions 
during the cycle were at first poorly understood.   To this end, mutated forms of the enzyme, 
such as one containing the phosphorylation site mutant, D369N, and cation binding site mutants 
in the α subunit were expressed, assembled, and assayed using ouabain binding and ATPase 
activity assays in yeast (Pedersen et al., 1996a). As a result of these efforts, phosphorylation at 
D369 was shown to be critical for a major conformational change of the K+-bound enzyme 
(Pedersen et al., 1996b; Pedersen et al., 1997a), and the D804, D808, E327, and E779 residues 
were found to coordinate sodium and potassium ions as the transporter changes conformation 
(Jorgensen et al., 1997; Nielsen et al., 1998; Pedersen et al., 1997b).  Multiple, other residues 
were isolated that affect the transporter’s ATPase activity (Jacobsen et al., 2002; Scheiner-Bobis 
and Schreiber, 1999; Xu et al., 2003a).  For example, mutations in residues 691 and 708-714 are 
important for Mg2+ binding and D369 phosphorylation (Jorgensen et al., 2001; Su and Scheiner-
Bobis, 2004).  In addition, mutations in this region (amino acids 708-720) induce the unfolded 
protein response (UPR) when expressed in yeast at higher temperatures, which indicates that the 
mutations likely affect protein stability (Jorgensen and Pedersen, 2001).  In fact, mis-assembly of 
the Na+-K+-ATPase is known to trigger its degradation through the ERAD pathway in 
mammalian cells (Beguin et al., 2000), which is consistent with the observed UPR induction 
upon the expression of the mis-assembled protein in yeast.   
As described above for the Kir proteins, drugs that target the Na+-K+-ATPase can be 
identified and characterized in yeast.  The yeast expression system was employed to show that 
the Na+-K+-ATPase is the target of palytoxin and sanguarine (Scheiner-Bobis, 2001; Scheiner-
Bobis et al., 1994), and that the activity of palytoxin does not depend on a catalytically active 
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enzyme (Scheiner-Bobis and Schneider, 1997).  In addition, cardiac glycosides, such as ouabain, 
were found to have different isoform specificities (Hauck et al., 2009).  Finally, the purified, 
detergent-solubilized enzyme from yeast membranes was used to validate the use of 
electrochemical dyes that can report on Na+-K+-ATPase activity in vitro (Habeck et al., 2009).  
A yeast expression system for another transporter, the Na+-H+ antiporter, has also been 
developed.  Na+-H+ antiporters are widely expressed and help maintain the intracellular pH, 
which is important for a variety of cellular functions, including cell division (Malo and Fliegel, 
2006).  There are two Na+-H+ antiporter families and alterations in the activities of these 
enzymes may also affect blood pressure (Malo and Fliegel, 2006; Xiang et al., 2007).  The 
Na+/H+ exchanger (NHE) is the first family and there are nine paralogs in humans (Malo and 
Fliegel, 2006).  The second group is the Na+/H+ antiporter NHA family, which is characterized 
by the presence of a shorter C-terminal tail and is encoded by two genes in mammals, NHA1 and 
NHA2, and one homolog in yeast (Xiang et al., 2007).  In the proximal tubule of the kidney, 
Na+-H+ antiporters contribute to sodium reabsorption (Bobulescu and Moe, 2009).   
When NHE1 was expressed in yeast, it localized primarily to the ER as opposed to the 
plasma membrane; however, the protein was active after its reconstitution into proteoliposomes 
(Montero-Lomeli and Okorokova Facanha, 1999). When NHE2 and NHE3 were expressed from 
a strong promoter, the salt tolerance of yeast lacking endogenous sodium transporters increased 
slightly in spite of the fact that most of the transporters remained in the ER (Flegelova et al., 
2006; Flegelova and Sychrova, 2005).  However, a decrease in the amount of the E3 ubiquitin 
ligase, Rsp5, increased the number of channels at the plasma membrane (Flegelova et al., 2006).  
Rsp5 is the yeast homolog of the mammalian ubiquitin ligase, Nedd4-2, which is required for the 
endocytosis and lysosomal degradation of ENaC (Kabra et al., 2008; Wiemuth et al., 2007; Zhou 
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et al., 2007) and possibly CFTR (Caohuy et al., 2009) after retrieval from the plasma membrane; 
therefore, these data suggest that later steps during the secretion, recycling, and quality control of 
renal proteins can be characterized in yeast.  Moreover, and consistent with these data, a related 
E3, Nedd4-1, was recently shown to play a role in mediating NHE1 endocytosis in mammalian 
cells (Simonin and Fuster, 2010).  
Two human NHA genes were also characterized in yeast.  NHA1 and 2 rescued growth 
on high sodium media when expressed in a strain deleted for endogenous sodium transporters, 
including yeast NHA1 (Xiang et al., 2007).  Rescue required plasma membrane residence.  These 
data further emphasize the possibility that yeast may prove to be a new model to identify factors 
that impact Na+-H+ antiporter stability and function. 
Another manner in which yeast can be leveraged to explore renal protein biogenesis and 
structure-function relationships is to express the protein in a yeast strain in which the homolog 
has been deleted, leaving only the mammalian protein to function in its place.  This is analogous 
to the ability of the human Kir proteins to support the growth of trk1Δtrk2Δ yeast on low 
potassium-containing media (see above).  The Na+-phosphate cotransporter is expressed in many 
epithelial cells where it functions to maintain phosphate homeostasis, and defects in transporter 
function lead to diseases such as X-linked hypophosphatemia and autosomal-dominant 
hypophosphatemic rickets (Biber et al., 2009; Virkki et al., 2007).  As anticipated, the wild-type 
cotransporter, but not an inactive mutant form of the protein trafficked to the plasma membrane 
and rescued the growth of yeast lacking the high affinity phosphate transport system (Bernhardt 
et al., 1999).  These data further support the ability of yeast to properly fold and secrete renal 
proteins.  
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1.2.3 Water channels 
The kidney plays a critical role in maintaining water homeostasis, and this role depends on the 
function of aquaporin (AQP) water channels.  AQPs are six transmembrane, ~30kDa proteins 
that tetramerize (Noda et al., 2010).  Humans express 13 AQPs that are divided into three 
families based on their channel selectivity for water and/or other solutes.  Seven of the AQPs are 
expressed in the kidney, AQP1, AQP2, AQP3, AQP4, AQP6, AQP7, and AQP11.  Mutations in 
two of these channels have been identified that lead to urine concentration defects (AQP1) and 
nephrogenic diabetes insipidus (AQP2).   Four of the renal aquaporins (AQP1-4) have been 
successfully expressed in yeast. 
   AQP1 was the first human aquaporin to be expressed in yeast (Laize et al., 1995).  The 
AQP1 expression system was used to assess channel function by isolating AQP1-containing 
vesicles and subjecting them to stop-flow experiments, which spectrophotometrically measure 
changes in vesicle size in response to hyperosmotic conditions.  In order to increase the signal-
to-noise, these experiments were carried out in a mutant yeast strain, sec6-4, which has an 
exocytosis defect that results in the accumulation of intracellular vesicles.  To further improve 
the sensitivity of this assay, some experiments were performed by first detergent solubilizing and 
purifying the AQPs from yeast, and then reconstituting the channels into synthetic 
proteoliposomes, in which the stop-flow experiments could be performed.  This approach 
permitted tighter control of the AQP:lipid ratio (Coury et al., 1998; Laize et al., 1997).  The 
effects of known channel inhibitors, such as CuSO4, AgNO3, TEA, and pCMBS, could then be 
assayed (Laize et al., 1995; Pettersson et al., 2006).  In fact, it was found that HgCl2 inhibits 
AQP4, contrary to previous studies in oocytes (Yukutake et al., 2008). 
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Yeast expression systems for AQPs have also been used to study channel selectivity as 
well as the structure-function relationship of channels that were subjected to site-directed 
mutagenesis.  To compare the properties between AQP family members, a protoplast-bursting 
assay was carried out. This study determined that AQP1 has a larger water conductance than 
AQP3, 5 or 9 (Pettersson et al., 2006). Similar to what was shown for AQP1 isolated from red 
blood cells, AQP2 appears to be water-selective as urea, glycerol, or formamide were not 
transported by the channel (Coury et al., 1998; Zeidel et al., 1995).  Additional studies of AQP 
pore selectivity focused on different AQP classes, which are defined by their selectivity for 
solutes and the NPA amino acid motif.  Class I aquaporins are primarily water selective, class II 
aquaporins are both water-permeable and are permeable to small neutral solutes, such as glycerol 
and urea, and class III aquaporins are the least selective.   It was found that class I aquaporins 
were impermeable to H2O2 whereas the class II aquaporin, AQP3, was H2O2 permeable (Bienert 
et al., 2007).  Studies investigating the properties of class III aquaporins found that AQP7 and 
AQP9 transport arsenite, providing a hint as to the route through which arsenic may enter cells 
(Liu et al., 2002).  The residues that mediated selectivity within the pore region, H180 and F56A, 
were defined for AQP1 (Beitz et al., 2006).   In another investigation, cysteine mutations within 
the pore-forming domains of AQP1 were examined.  These mutations abolished water channel 
function, and sucrose gradient analyses established that the absence of channel function was due 
to an inability of the mutant channel to tetramerize.  Thus, the residues that are critical for AQP 
assembly and selectivity could be defined (Mathai and Agre, 1999). 
Another important application of the yeast system was to characterize ten AQP2 
mutations that are known to cause nephrogenic diabetes insipidus.  These mutants fell into three 
categories: those that are functional, those that are partially functional, and those that are 
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completely inactive (Shinbo et al., 1999).  Together, these studies have contributed significantly 
to our overall understanding of several aspects of AQP biology, including differences between 
AQP family members, the structure-function relationships regarding the selectivity filter, the 
importance of intermolecular contacts required for tetramer formation, and a molecular 
characterization of disease-causing mutants. 
1.2.4 Signaling and other molecules 
The yeast expression system has also been used to characterize kidney-resident proteins that are 
involved in signaling and other activities (Table 1).  One of these proteins is SGK1, a cytosolic 
kinase of the AGC family (Loffing et al., 2006).  SGK1 is activated in response to a variety of 
stimuli, including aldosterone.  Aldosterone, among other stimuli, transcriptionally regulates 
SGK1, which then either directly or indirectly regulates various channels and transporters, 
including ENaC, the Na+,K+-ATPase, Kir1.1, and the Na+-K+-2Cl- co-transporter (Lang et al., 
2009; Loffing et al., 2006), each of which was discussed above. 
Yeast encode two kinases, Ypk1 and Ypk2, whose catalytic domains share 55% sequence 
identity with the catalytic domain of SGK1.   When expressed in yeast, SGK1 was able to restore 
the viability of yeast lacking the genes encoding both Ypk1 and Ypk2, making SGK-dependent 
functional assays possible in this mutant background.    Like the ion channels discussed in the 
preceding section (i.e., ENaC and CFTR), mutant yeast strains were then used to identify factors 
that modulated SGK1 levels.  It was discovered that SGK1 turn-over required the E2 ubiquitin-
conjugating enzymes, Ubc6 and Ubc7, the E3s Hrd1 and Doa10, and the proteasome (Arteaga et 
al., 2006).  Therefore, even though SGK1 is a cytosolic protein, it can interact with the 
cytoplasmic face of the ER and is degraded by the ERAD pathway.  By analogy, PDK1 is a 
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constitutively active kinase which regulates AGC kinases, including SGK1 (Bayascas, 2008).  
Yeast encode two PDK1 homologs, Pkh1 and Pkh2, and the expression of human PDK1 can 
rescue the growth of yeast strains in which the genes encoding Pkh1 and Pkh2 are deleted 
(Casamayor et al., 1999; Loffing et al., 2006).  This result indicates that the requirements for the 
functional expression of PDK1 can ultimately be defined in the yeast system.       
The characterization of two other renal proteins, RhGK and TREH, has benefited from 
the development of yeast expression systems.  RhGK (Rh glycoprotein kidney) is a poorly 
characterized protein, but by expressing RhGK in yeast it was demonstrated that it functions as 
an ammonium transporter (Marini et al., 2000).  TREH, a glycoprotein expressed in small 
intestines and renal brush borders, is responsible for metabolizing trehalose to glucose. The 
presence of TREH in the urine is a marker of kidney damage.  Yeast have three trehalases, 
ATH1, NTH1 and NTH2, each possessing a unique function in vivo.  Gene complementation 
studies in yeast deleted for the endogenous trehalases demonstrated that the human trehalase is 
not required for general metabolism (i.e., metabolizing trehalose to glucose), but may instead be 
a stress response protein that might be important for renal function (Ouyang et al., 2009). 
1.3 INWARD RECTIFYING POTASSIUM CHANNELS 
1.3.1 Introduction 
There are seven Kir channel subfamilies (Kir1-7) consisting of 15 proteins and these play critical 
roles in the function of several tissues including the kidney and heart (Hibino et al., 2010).  
These are named for their ability to conduct more potassium ions into a cell at potentials negative 
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to the equilibrium potential, but permit less flow at potentials positive to the equilibrium 
potential, which is contrary to that predicted by the Nernst equation (Hagiwara and Takahashi, 
1974; Noble, 1965).  This is accomplished by magnesium and polyamines blocking the 
intracellular side of the pore under potentials positive to the equilibrium potential and the release 
of the molecules under potentials negative to the membrane potential (Lopatin et al., 1994; 
Matsuda et al., 1987).  Kir channels are also activated by phosphatidylinositol 4,5-bisphosphate, 
which limits channel activity to the plasma membrane where phosphatidylinositol 4,5-
bisphosphate is most abundant (Huang et al., 1998; Lopes et al., 2002).  These combined 
characteristics allow Kir channels to serve a variety of functions including restoring resting 
membrane potentials in cardiac, neuronal or muscle cells and reabsorbing potassium in the 
kidney (see section 1.2.1.2). 
In order for the channels to perform their critical functions, they must assemble into 
tetramers.  Tetramerization can be either homomeric or heteromeric.  While heteromeric 
tetramerization is usually associated within members of the same subfamily, there are cases of 
heteromeric tetramers between families such as is seen between Kir4.1 and Kir5.1 (Konstas et 
al., 2003; Lourdel et al., 2002; Preisig-Muller et al., 2002).  As monomers, Kir channels are 
likely unstable and highly subject to protein quality control.  The transmembrane segments and 
termini in the monomers have been implicated in the formation of tetramers (Fink et al., 1996; 
Tinker et al., 1996), and as monomers these contact sites may be recognized as being misfolded 
by the protein quality control machinery.  In addition, the hydrophilic face of the pore (Minor et 
al., 1999) would be exposed to the membrane.  Thus, Kir channel assembly represents an 
additional challenge that may expose it to protein quality control.   
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  The Kir channel subunits share a common structure consisting of two transmembrane 
domains with an extracellular loop.  The extracellular loop of the channel forms a potassium 
selective pore, which is mediated by the sequence GYG (Figure 3).  Mutating this sequence 
decreases or eliminates potassium selectivity and permeability (Heginbotham et al., 1994).  For 
example, mutating the sequence to AAA completely eliminates channel activity even though 
expression levels remain similar (McLerie and Lopatin, 2003; Tinker et al., 1996). While the 
mutation is in the selectivity filter, the intracellular localization of this mutant has not been 
examined.  Finally, the two intracellular termini contain signaling information responsible for 
directing the intracellular localization of the channels as well as sites for other proteins to 
modulate channel activity (see section 1.3.2). 
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 Figure 3: Kir2.1 topology 
Kir2.1 contains two transmembrane domains that traverse the membrane (gray) as well as 
a segment that partially inserts into the membrane.  The diagram of Kir2.1 highlights residues 
that modulate its function/localization with black circles encoding the potassium selectivity filter 
within the extracellular loop, green circles encoding a Golgi export signal, blue circles encoding 
an ER export signal, yellow circles encoding a PDZ domain binding site, and the red circles 
representing a tyrosine endocytic motif (YXXΦ) (adapted from de Boer, et al., 2010) 
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1.3.2 Kir2.x subfamily 
While Kir1, Kir4, and Kir5 are expressed in the kidney, the Kir2 subfamily is primarily 
expressed in brain, cardiac, smooth, and skeletal muscles (de Boer et al., 2010; Hibino et al., 
2010).  This subfamily consists of five members: Kir2.1, 2.2, 2.3, 2.4 and 2.6.  Kir2.x channels 
are constitutively active and strong inward rectifiers, although their conductivity and rectification 
are not equal.  Kir2.1, 2.2, and 2.6 homotetramers conduct potassium 2-3 times better than Kir2.3 
and 2.4.  However Kir2.4 is the strongest inward rectifier while Kir2.1 is the weakest (de Boer et 
al., 2010).  Kir2.1 is the best studied protein in this subfamily and thus represents a strong 
candidate to explore protein quality control in the secretory pathway. 
1.3.2.1 Kir2.1 
Kir2.1 was one of the first Kir channels to be cloned and characterized (Kubo et al., 1993).  It is 
responsible for repolarization of the ventricle in cardiac cells.  Gain of function mutations in 
Kir2.1 lead to short QT syndrome, which can cause arrhythmia and sudden death (Priori et al., 
2005).  In contrast, loss of function mutations cause Andersen-Tawil syndrome in which the QT 
interval lengthens and causes arrhythmia, and due to its function in other tissues, patients with 
Andersen-Tawil syndrome also experience periodic paralysis and have developmental 
abnormalities (Hattori et al., 2012; Plaster et al., 2001).  These diseases illustrate the importance 
of Kir2.1 function in the heart, and as a result, Kir2.1 is being targeted as a biological pacemaker 
(Hu et al., 2012). 
Kir2.1 function in neurons is also medically relevant.  Kir2.1 loss of function in medium 
spiny neurons leads to increased hyperexcitabilty and decreased plasticity, symptoms associated 
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with Schizophrenia and Parkinson’s disease (Cazorla et al., 2012).  In support of a role for Kir2.1 
in Parkinson’s disease, peripheral blood lymphocytes from patients with Parkinson’s disease had 
decreased Kir2.x proteins compared to healthy individuals (Gui et al., 2011). Kir2.1 involvement 
in maintaining neuronal membrane potentials has led it to be targeted for gene-based 
neuromodulation (Boulis et al., 2013).  Thus, Kir2.1 plasma membrane residence must be tightly 
regulated. 
Kir channels are synthesized in the ER and likely assemble there. Thus, the ER represents 
the first point of protein quality control and regulation of Kir2.1.    If the channel folds and 
successfully avoids ERAD, ER exit signals in these channels such as FCYENE allow Kir2.1 to 
traffic to the Golgi, where it is potentially monitored by Golgi protein quality control (Figure 4) 
(Ma et al., 2001; Stockklausner et al., 2001).  Trafficking to the plasma membrane requires a 
Golgi export signal consisting of a bipartite signal in the N and C termini of Kir2.1 (Ma et al., 
2011; Stockklausner and Klocker, 2003).    Kir channels then traffic to the plasma membrane 
where they function and are exposed to a third protein quality control mechanism, plasma 
membrane protein quality control. Kir2.1 plasma membrane residence is maintained in part by 
association with proteins such as filamin-A (Pierri et al., 2003). 
Kir2.1 interacts with additional plasma membrane proteins including PDZ-domain 
containing proteins (Figure 3).  These interactions lead to the formation of macromolecular 
complexes that regulate its function (Leonoudakis et al., 2004; Leyland and Dart, 2004; Nehring 
et al., 2000).  For example, the PDZ-domain containing protein, SAP97, interacts with Kir2.1 
and forms a macromolecular complex with β-arrestin and protein kinase A (Vaidyanathan et al., 
2010).   Plasma membrane internalization of Kir2.1 is regulated by an AMP-activated protein 
kinase mechanism that leads to the phosphorylation of the E3 ubiquitin ligase Nedd4-2.  This in 
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turn activates the ligase, leading to the ubiquitination and subsequent internalization of the 
channel (Alesutan et al., 2011).   
Kir2.1 endocytosis requires a tyrosine based motif in the Kir2.1 C-terminus (Tong et al., 
2001).  Endocytosis ultimately leads to degradation in the lysosome.  For example, lysosomal 
inhibition with chloroquine, leupeptin, or NH4Cl increases Kir2.1 protein levels and increased 
current (Jansen et al., 2008; Nalos et al., 2011).  Kir channel regulation may occur at multiple 
places within the cell and while the determinants in the Kir2.1 sequence and some of the cellular 
components responsible for its localization have been identified, Kir2.1 protein quality control 
factors in both the early and late secretory pathway remain undefined.  
1.3.2.2 Kir2.1 in yeast 
As described above, Kir2.1 has been expressed in yeast, and yeast possess two 
transporters, Trk1 and Trk2, that are important for maintaining appropriate intracellular 
potassium levels when grown in low potassium environments.  Although both transporters have 
been shown to have high affinity for potassium, Trk1 is expressed to a greater degree than Trk2 
under normal conditions (Arino et al., 2010).  Growth on low potassium is rescued by the 
expression of this channel.  The initial system expressed Kir2.1 from either the constitutive PGK 
promoter or the inducible GAL promoter (Tang et al., 1995b).  The consequence of Kir2.1 
expression was further examined in a system that also lacked a potassium efflux system and it 
was found that these strains were more sensitive to high potassium when Kir2.1 was expressed 
(Kolacna et al., 2005).  This second system was then used to characterize functional elements 
within the transmembrane domains by examining a Kir2.1 mutant library for growth on low 
potassium in trk1Δ trk2Δ yeast (Minor et al., 1999).  Other screens for increased growth of the 
trk1Δ trk2Δ strain identified a Kir2.1 specific inhibitor as well as a mammalian cDNA encoding 
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the Kir2.1 trafficking factor, TRAK2 (Grishin et al., 2006; Zaks-Makhina et al., 2004).  
Together, thse data demonstrate yeast’s utility as an established model organism for examining 
Kir2.1 function, trafficking, and structure. 
1.4 PROTEIN QUALITY CONTROL 
As discussed briefly in the introduction to this chapter, approximately one-third of all translated 
proteins traverse the secretory pathway in eukaryotes.  Many of these proteins may be misfolded, 
which can lead to cell toxicity.  To prevent cell toxicity, there are numerous cellular mechanisms 
to detect and degrade aberrant proteins including ERAD, Golgi quality control, and plasma 
membrane quality control. 
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 Figure 4: Protein quality control in the secretory pathway 
In yeast, misfolded proteins in the ER are targeted by ERAD-C, ERAD-L, or ERAD-M 
depending on the site of the lesion (yellows star).  1) ERAD substrates are recognized by 
chaperones (green).  2) Chaperones facilitate delivery to E3 ubiquitin ligases (blue) where they 
are ubiquitinated. 3) Cdc48 aids in the extraction of substrates.  4) Cdc48 delivers substrates to 
the 26S proteasome.  Misfolded proteins at the Golgi and plasma membrane are targeted for 
degradation by Golgi quality control (GQC) and plasma membrane quality control (PMQC), 
respectively.  5) Misfolded substrates are ubiquitinated by E3 ubiquitin ligases. 6) Substrates are 
delivered into multivesicular bodies (MVBs) (see section 1.5). 7) In turn, MVBs are delivered to 
the vacuole so that enclosed proteins can be degraded. 
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1.4.1 Endoplasmic Reticulum Associated Degradation (ERAD) 
Protein quality control of secretory proteins begins in the ER with ERAD.  In ERAD, misfolded 
ER substrates are first recognized as substrates.  They are then ubiquitinated and 
retrotranslocated from the ER and eventually targeted to the proteasome for degradation (Araki 
and Nagata, 2011; Hebert et al., 2010; Smith et al., 2011; Vembar and Brodsky, 2008).  ERAD 
must be able to recognize a variety of substrates that contain misfolded lesions with the 
cytoplasm, lumen, and membrane (Figure 4). The ERAD-C (cytoplasm), ERAD-L (lumen), 
and/or ERAD-M (membrane) pathways are composed of specific components that recognize 
these substrates (Carvalho et al., 2006; Vashist and Ng, 2004). 
1.4.1.1 Recognition by chaperones 
ERAD substrates must first be recognized as being misfolded. For a non-glycosylated 
protein, like Kir2.1, this is accomplished primarily by molecular chaperones such as the heat 
shock proteins i.e., Hsp70s, Hsp40s (Dudek et al., 2009; Mayer and Bukau, 2005).  Members of 
the Hsp70 chaperones bind to hydrophobic patches of substrates via the substrate binding 
domain (Blond-Elguindi et al., 1993; Flynn et al., 1991; Wang et al., 1993).  They then prevent 
aggregation and can facilitate folding using energy from ATP hydrolysis via the ATPase domain; 
ATP rebinding and ADP displacement result in substrate release (McCarty et al., 1995).  Yeast 
Hsp70s have been shown to be involved in the ERAD of multiple substrates (Hill and Cooper, 
2000; Plemper et al., 1997; Zhang et al., 2001).  In yeast, the ER lumenal Hsp70 associated with 
ERAD substrates, such as CPY*, is Kar2, which is known as BiP in higher cells (Plemper et al., 
1997).  Membrane bound ERAD substrates with prominent cytoplasmic domains, such as mutant 
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forms of Pma1 and Ste6, are primarily recognized by the yeast cytosolic Hsp70, Ssa1 (Han et al., 
2007; Nakatsukasa et al., 2008). 
Hsp40s are Hsp70 cochaperones that are best characterized for their ability to stimulate 
ATP hydrolysis, although some bind substrates directly, which may allow Hsp40s to deliver 
substrates to Hsp70s (Laufen et al., 1999; McCarty et al., 1995; Szabo et al., 1994).  In yeast 
there are four Hsp40s associated with ERAD. Scj1 and Jem1 are the lumenal Hsp40s while Ydj1 
and Hlj1 are the cytosolic Hsp40s that are involved in the degradation of ERAD-C substrates 
(Nishikawa et al., 2001; Youker et al., 2004). If the chaperones are unable to facilitate the 
folding of the misfolded substrate, the protein is delivered to the ubiquitination machinery. 
1.4.1.2 Ubiquitination of ERAD substrates 
Substrates are ubiquitinated by specific ER-associated or in some cases cytoplasmic E3 
ubiquitin ligases (Claessen et al., 2012).  Ubiquitin is a small (76 amino acid) ubiquitously 
expressed peptide that acts as a signaling molecule and controls a variety of cellular functions 
including the cell cycle, transcription, internalization, and in the case of ERAD, degradation.  
Chains of ubiquitin are covalently attached to proteins through the coordination of three 
enzymes: an E1 activating enzyme, an E2 conjugating enzyme, and an E3 ubiquitin ligase. The 
E1 activating enzyme forms a thiol-ester bond with ubiquitin.  The E1 transfers the ubiquitin to 
the E2 conjugating enzyme.  The E2 conjugating enzyme partners with an E3 ubiquitin ligase to 
attach ubiquitin to the substrate (Claessen et al., 2012; Goder, 2012; Kostova et al., 2007; 
Spasser and Brik, 2012).  
 There are two E1s, approximately 40 E2s and over 1000 E3s in mammals (Claessen et 
al., 2012).  In yeast, there is less complexity with only one E1, approximately 12 E2s and around 
100 E3s (Kostova et al., 2007).  The large number of E3 ubiquitin ligases provides specificity for 
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the vast number of substrates that need to be ubiquitinated.  Hrd1 and Doa10 are the primary E3 
ubiquitin ligases that function in the ERAD of most substrates in yeast (Kostova et al., 2007).  
Hrd1 is associated primarily with the ubiquitination of ERAD-L and ERAD-M substrates such as 
HMG-CoA reductase, CPY*, Sec61-2, and Pdr5* (Bordallo et al., 1998; Hampton et al., 1996; 
Plemper et al., 1998).  Conversely, Doa10 is associated with ERAD-C substrates such as Ste6* 
and Pma1-D378N (Huyer et al., 2004b; Wang and Chang, 2003).  Although other E3 ubiquitin 
ligases such as Rsp5 have been implicated in ERAD under different conditions (Haynes et al., 
2002), their role as general modulators of substrate degradation is less clear. 
1.4.1.3 Retrotranslocation and degradation 
To be ubiquitinated, a substrate must access the enzymatic domain of the E3s, which are 
located in the cytosol.  Further, the proteasome, which is responsible for the degradation of 
ERAD substrates, resides in the cytosol.  Thus, all soluble, lumenal ERAD substrates must cross 
the ER membrane to the cytosol to be degraded.  Recognition and retrotranslocation of 
polyubiquitinated, misfolded, soluble and integral substrates occurs through a disputed channel 
and is primarily facilitated by the AAA-ATPase, Cdc48 and two cofactors, Npl4 and Ufd1 (Bays 
and Hampton, 2002; Meyer et al., 2002; Rabinovich et al., 2002; Stolz et al., 2011; Ye et al., 
2001).  Cdc48 with the aid of additional cofactors then presents the polyubiquitinated substrate 
to the 26S proteasome for degradation (Richly et al., 2005).  
The proteasome is a large proteolytic complex composed of a 20S core and a 19S 
regulatory particle (Matyskiela and Martin, 2013; Nickell et al., 2009).  The 20S core is 
composed of two sets of seven member protein rings that contain multiple catalytic activities to 
cleave proteins into short peptides (Groll et al., 1997; Heinemeyer et al., 1997; Lowe et al., 
1995).  The 19S regulatory particle is composed of multiple proteins that recognize ubiquitinated 
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substrates and an AAA+ “unfoldase” that denatures proteins and threads them into the 
proteolytic core (Aubin-Tam et al.; Martin et al., 2008; Thrower et al., 2000).  Given that so 
many proteins are degraded by the 26S proteasome it is not surprising that multiple diseases are 
due to proteasome dysfunction and proteasome inhibitors have been used therapeutically (Chitra 
et al., 2012). 
1.4.2 Golgi and plasma membrane quality control 
There is also a need for protein quality control at later secretory compartments, because not all 
misfolded proteins are targeted for ERAD.  For example, a mutant form of the plasma membrane 
ATPase, pma1-7, is not targeted to the plasma membrane but to the vacuole after passing 
through the Golgi (Chang and Fink, 1995).  A screen to identify genes that when mutated 
rescued mutant Pma1 localization identified members of retromer (VPS29, VPS35), members of 
phosphatidylinositol 3-kinase II complex (PI3KII) (VPS38, VPS36), endocytic targeting to the 
vacuole (MVP1, BSD2), vesicle tethering (VPS8, SRO77), a glucosyl transferase (ALG8), and an 
uncharacterized gene (VPS13), as involved in this process (Luo and Chang, 1997).  Studies of 
two more chimeric plasma membrane proteins demonstrated that these Golgi quality control 
substrates were dependent on Vps10, a receptor necessary for transport of CPY to the vacuole 
(Holkeri and Makarow, 1998; Hong et al., 1996).  Golgi quality control not only targets mutant 
plasma membrane proteins, but also proteins that escape ERAD because the pathway is saturated 
or because the substrate cannot be recognized by ERAD (Coughlan et al., 2004; Haynes et al., 
2002; Spear and Ng, 2003).  While it is unclear how these substrates are recognized, studies in 
yeast show they are ubiquitinated by either Rsp5 or Tul1 and targeted to the vacuole via the 
multivesicular body (MVB) pathway (Pizzirusso and Chang, 2004; Reggiori and Pelham, 2002; 
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Wang et al., 2011).  While not as well characterized, a Golgi quality control pathway also exists 
in mammalian cells (Armstrong et al., 1990; Ashok and Hegde, 2009). 
Quality control also exists at the plasma membrane.  For example, a mutation in the 
transmembrane domain of the α factor receptor, Ste2, leads to it being degraded by the vacuole 
faster than the wild-type protein (Jenness et al., 1997). Degradation is dependent on Vps23 (Li et 
al., 1999), which is a member of the endosomal sorting complex required for transport (ESCRT) 
(See section 1.5).  In mammalian cells, plasma membrane substrates can be ubiquitinated by a E3 
ubiquitin ligase known as CHIP and then transferred to the lysosome for degradation via the 
multivesicular body pathway (Apaja et al., 2010; Okiyoneda et al., 2010) (see 1.5).  Thus, it 
appears that alternative quality control mechanisms that function beyond the ER utilize similar 
pathways that are dependent on ESCRT mediated degradation by the vacuole/lysosome (Figure 
4). 
1.5 ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT (ESCRT) 
As discussed, quality control at the Golgi and the plasma membrane utilizes the MVB pathway, 
which requires ESCRT.  In addition to forming MVBs, ESCRT functions in exosome secretion 
(Baietti et al., 2012; Wehman et al., 2011), cell abscission (Guizetti et al., 2011; Samson et al., 
2008), and autophagy (Filimonenko et al., 2007; Rusten and Stenmark, 2009).  ESCRT is 
composed of five subcomplexes: ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III and the Vps4-
Vta1 complex (Henne et al., 2011).  Disruption of ESCRT leads to multiple diseases such as 
cancer (Li and Cohen, 1996; Xu et al., 2003b) and neurodegenration (Filimonenko et al., 2007; 
Skibinski et al., 2005).  In addition, enveloped viruses make use of the ESCRT machinery to bud 
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from cells (Garrus et al., 2001).  However, its role in the formation of MVBs is best 
characterized. 
MVB formation begins with the recruitment of ESCRT-0.  ESCRT-0 is composed of 
Vps27 and Hse1 (Hrs and STAM1/2 in mammals), which are recruited to endosomes through 
interactions with phosphatidylinositol 3-phosphate and clathrin (Bilodeau et al., 2002; Katzmann 
et al., 2003; Raiborg et al., 2001).  There, they bind ubiquitinated cargo and cluster at the future 
site of invagination (Bilodeau et al., 2002; Wollert and Hurley, 2010) (Figure 5A).  The ESCRT-
I complex, composed of Vps23 (Tsg101 in humans), Vps28, Vps37, and Mvb12, is recruited to 
this site via an interaction between Vps27 and Vps23 (Chu et al., 2006; Katzmann et al., 2001; 
Katzmann et al., 2003).  At this site, ESCRT-I components, Vps23 and Mvb12, assist in binding 
ubiquitinated cargo (Shields et al., 2009) (Figure 5B).  Next, an interaction between Vps28 and 
Vps36 recruits ESCRT-II, which also consists of Vps22 and Vps25 (Babst et al., 2002b; Teo et 
al., 2006).  ESCRT-I and ESCRT-II recruitment leads to deformation of the membrane (Wollert 
and Hurley, 2010) (Figure 5C).  ESCRT-II recruits and aids in the assembly of ESCRT-III, 
which consists of a Vps20-Snf7 subcomplex and a Vps24-Vps2 subcomplex (Babst et al., 
2002a).  Vps20 interacts with Vps25 of ESCRT-II and this leads to the oligomerization of Snf7 
that forms a ring around the cargo (Henne et al., 2012; Teo et al., 2004) (Figure 5D).  Snf7 
oligomerization is stabilized by Bro1 (Alix in humans), which recruits Doa4 to deubiquitinate the 
cargo so that ubiquitin can be recycled (Dupre and Haguenauer-Tsapis, 2001; Luhtala and 
Odorizzi, 2004) (Figure 5E).  Next, Vps24 and Vps2 drive invagination of the Snf7 oligomer and 
ultimately lead to termination of oligomer formation (Henne et al., 2012) (Figure 5F).  The 
AAA-ATPase Vps4 and the activating protein Vta1 are recruited by ESCRT-III to disassemble 
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the complex so that it can be recycled and scission can occur, thereby completing the formation 
of an MVB (Babst et al., 1997; Babst et al., 1998) (Figure 5G). 
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 Figure 5: ESCRT functions to produce MVBs 
Cargo (purple) marked with ubiquitin (blue circle) is sequestered into an internal vesicle 
through the actions of ESCRT-0 (red), ESCRT-I (green), ESCRT-II (orange), ESCRT-III 
(yellow), and the Vps4/Vta1 complex. A) ESCRT-0 sequesters cargo. B) ESCRT-I is recruited 
and aids in cargo sequestration. C) ESCRT-II is recruited and vesicle invagination is initiated. D) 
ESCRT-III begins to encircle the cargo and recruits Doa4. E) Vps2 and Vps24 are recruited and 
Doa4 deubiquitinates the cargo, releasing ESCRT-0, ESCRT-I and ESCRT-II. F) Vps2 and Vps4 
drive invagination of the Snf7 oligomer.  G) Vps4 and Vta1 aid in scission and disassembly of 
ESCRT-III. 
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 Overall the coordination of these ESCRT subcomplexes confers the ability to transfer a 
membrane bound protein to the lumen of the vacuole/lysosome.  Thus, this pathway is ideally 
suited for disposing of membrane proteins, such as Kir2.1, that have trafficked beyond the ER 
and that may still be partially misfolded. 
1.6 THESIS OUTLINE 
Protein quality control is an active area of investigation and protein quality control systems have 
been found in many cellular compartments (Arvan et al., 2002; Chen and Lamb, 2008; 
Chhangani et al., 2012).  The secretory pathway represents a unique area to study protein quality 
control as a protein may be synthesized in the ER, mature in the Golgi, and function at the 
plasma membrane. Thus, there is a need for protein quality control at all of these compartments, 
and not surprisingly such systems have been identified.  However, the complete set of factors 
involved in these systems remains unknown.  Moreover, how these systems coordinate with each 
other is unclear. 
In chapter 2, I present my work addressing how the secretory protein, Kir2.1, is 
monitored by protein quality control at multiple sites within the cell.  To accomplish this, I 
engineered a yeast strain deleted for the potassium transporters, Trk1 and Trk2, whose growth on 
low potassium depends on the potassium channel Kir2.1 functioning at the cell surface.   I then 
crossed this strain to the yeast deletion collection using synthetic gene array methodology and 
screened the resulting strains on low potassium media for effectors of Kir2.1 plasma membrane 
residence.  I identified 53 genes (Appendix A) including several members of the ESCRT 
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complex whose deletion leads to increased growth and thus increased plasma membrane 
residence of Kir2.1.  A collaboration with the Welling lab showed that ESCRT regulates the 
trafficking of Kir2.1 in HeLa cells demonstrating the utility of yeast to study mammalian protein 
trafficking and protein quality control.  In chapter 3 I discuss my findings with an emphasis on 
alternative approaches and areas of future study.  I also included an appendix that describes my 
work examining the protein quality control of ENaC. 
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2.0  A YEAST GENOMIC SCREEN REVEALS ESCRT REGULATES KIR2.1 
PLASMA MEMBRANE RESIDENCE 
2.1 INTRODUCTION 
Protein quality control systems exist throughout the eukaryotic secretory pathway to ensure that 
toxic misfolded proteins or protein complexes do not accumulate.  Quality control systems may 
also act as a means to regulate protein levels and thus their activities.  When protein quality 
control is defective or fails to recognize an aberrant protein, human diseases may result 
(Gestwicki and Garza, 2012; Guerriero and Brodsky, 2012).   
In the secretory pathway, protein quality control begins in the endoplasmic reticulum 
(ER).  Proteins that fail to pass quality control may be destroyed by a process termed 
endoplasmic reticulum-associated degradation (ERAD).  During ERAD, substrates are first 
recognized by molecular chaperones and chaperone-like lectins, which target them to the ER-
associated ubiquitination machinery (Aebi et al., 2010; Claessen et al.; Hebert and Molinari, 
2012). During or after ubiquitination, ERAD substrates are retrotranslocated to the cytoplasm 
and delivered to and degraded by the 26S proteasome (Mehnert et al., 2010; Smith et al., 2011).  
However, if the ERAD machinery is overwhelmed, or aberrant proteins are not recognized by the 
ERAD machinery, the unfolded protein response is induced and in some cases misfolded species 
may escape the ER and advance to the Golgi.  In these circumstances, ERAD substrates may be 
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returned to the ER and degraded (Haynes et al., 2002; Taxis et al., 2002; Vashist et al., 2001) or 
a Golgi-resident quality control system can recognize and deliver substrates to the vacuole/ 
lysosome for degradation via the multivesicular body (MVB) pathway (Chang and Fink, 1995; 
Coughlan et al., 2004; Hong et al., 1996; Spear and Ng, 2003; Wang and Ng, 2010).  Protein 
quality control mechanisms also exist at the plasma membrane, and in this case selected 
substrates are endocytosed and targeted to the lysosome (Huotari and Helenius, 2011).  For 
example, the disease-associated ΔF508 mutation of the cystic fibrosis transmembrane 
conductance regulator (CFTR) is normally an ERAD substrate but is less stable than wild type 
CFTR when artificially delivered to the plasma membrane (Okiyoneda et al., 2010).  A large 
scale screen indicated that a significant number of factors are required for the disposal of ΔF508 
CFTR (Trzcinska-Daneluti et al., 2009).  In general, plasma membrane quality control, like 
Golgi quality control (GQC), appears to use the MVB pathway to route substrates to the vacuole 
(Apaja et al., 2010; Arvan et al., 2002; Jenness et al., 1997).  Together, there are several protein 
quality control mechanisms in place to ensure that unwanted secreted proteins are destroyed, but 
it is unclear how these different mechanisms cooperate. 
 The functions of distinct protein quality control networks must be linked with the 
machineries that regulate protein localization. Multiple screens have been performed to identify 
the factors that regulate the localization and trafficking of proteins, and one of the critical 
trafficking complexes that delivers proteins from the plasma membrane and Golgi to the 
vacuole/lysosome is the endosomal sorting complex required for transport (ESCRT) (Bankaitis 
et al., 1986; Bonangelino et al., 2002; Robinson et al., 1988; Rothman et al., 1989).  ESCRT 
functions primarily in the formation of MVBs (MacGurn et al., 2012), which begins with the 
recognition and initial clustering of ubiquitinated cargo by ESCRT-0 (Bilodeau et al., 2002; 
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Mayers et al., 2011; Wollert and Hurley, 2010).  ESCRT-I and ESCRT-II are then recruited and 
confine cargo at the site of vesicle formation, which initiates vesicle invagination before ESCRT-
III is recruited (Gill et al., 2007; Kostelansky et al., 2007; Teo et al., 2006; Teo et al., 2004; 
Wollert and Hurley, 2010).  Association of ESCRT-III leads to cargo deubiquitination 
(McCullough et al., 2006) and vesicle maturation (Wollert and Hurley, 2010; Wollert et al., 
2009).  The Vps4-Vta1 complex then aids in disassembly of the ESCRT complex to complete 
vesicle formation (Azmi et al., 2008; Babst et al., 1998).  In addition to Golgi and plasma 
membrane quality control, ESCRT is also required for cell abscission and viral budding in 
metazoans (Carlton et al., 2008; Carlton and Martin-Serrano, 2009; Chen and Lamb, 2008; Xie et 
al., 1998) and autophagy (Rusten and Stenmark, 2009).  Defects in ESCRT function may lead to 
human diseases, including cancer and neurodegeneration (Filimonenko et al., 2007; Li and 
Cohen, 1996; Saksena and Emr, 2009; Skibinski et al., 2005; Xu et al., 2003b). 
In addition to serving as a tool to identify components that comprise the trafficking 
machinery, yeast systems have also been co-opted to examine the protein quality control and 
trafficking of specific mammalian proteins (Franssens et al., 2009; Kolb et al., 2011; Winderickx 
et al., 2008).  In some cases these analyses were facilitated by employing specific genomic tools 
such as synthetic gene array (SGA) methodology (Tong and Boone, 2006).  For example, a 
screen was performed in which the inward rectifying potassium channel 3.2 (Kir3.2) was 
mutated so that it was sodium-selective, and strains expressing the protein were crossed to a 
subset of the deletion collection (Haass et al., 2007).  The resulting haploids were screened on 
medium containing high sodium and seven genes associated with COPII-dependent transport and 
lipid biogenesis were identified that when mutated reduced sodium-mediated toxicity.  These hits 
were confirmed when a potassium-selective Kir3.2 construct was expressed that led to increased 
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growth  in a yeast strain lacking the Trk1 and Trk2 potassium transporters (Haass et al., 2007).  
Trk1 and Trk2 are the main route for potassium influx into yeast in low extracellular potassium, 
and when they are deleted yeast are only able to grow in the absence of high potassium if an 
exogenous potassium channel is expressed (Nakamura and Gaber, 1998). 
The Kir2 potassium channels form a tetramer and function primarily in heart, skeletal 
muscle, and neurons, and consists of five family members, Kir2.1-2.4, and 2.6 (de Boer et al., 
2010; Hibino et al., 2010).  Gain of function mutations in Kir2.1 lead to short QT syndrome, 
which can cause arrhythmia and sudden death (Priori et al., 2005).  In contrast, loss of function 
mutations in Kir2.1 result in Anderson-Tawil syndrome (Plaster et al., 2001).  Kir2.1 function in 
cardiac tissue has led to efforts to target its levels as a biological pacemaker (Hu et al., 2012).  
Kir2.1 loss of function in medium spiny neurons also leads to increased hyperexcitabilty and 
decreased plasticity, symptoms associated with schizophrenia and Parkinson’s disease (Cazorla 
et al., 2012).     These cases illustrate the importance of maintaining proper Kir2.1 levels at the 
plasma membrane.  However, the factors necessary for Kir2.1 biogenesis, trafficking, and 
stability have not been explored systematically. 
To this end, I utilized a new yeast Kir2.1 expression system. Like many complex 
membrane proteins (Jensen et al., 1995; Needham et al., 2011; Tamarappoo et al., 1999; 
Valentijn et al., 1998; VanSlyke et al., 2000; Ward et al., 1995), the Brodsky lab found that the 
majority of Kir2.1 is ER localized and targeted for ERAD.  Specifically, Kir2.1 degradation was 
dependent on the AAA-ATPase, Cdc48, the ER-associated E3 ubiquitin ligases, Hrd1 and 
Doa10, and the cytoplasmic Hsp70 chaperone, Ssa1.  Because Kir2.1 supports the growth of 
trk1Δ trk2Δ on low potassium (Nakamura and Gaber, 1998; Tang et al., 1995b; Zaks-Makhina et 
al., 2004), this system also provided us with the unique opportunity to identify the spectrum of 
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protein quality control and trafficking factors necessary for the maintenance of active Kir2.1 at 
the plasma membrane.   Interestingly, ERAD-requiring factors were absent from the yeast 
mutants that supported growth on low potassium medium, suggesting that the level of functional 
Kir2.1 is not primarily regulated by ERAD.  In contrast, most of the ESCRT complex 
components were isolated from our screen.  These data indicate that later steps during secretory 
protein quality control are required for the maintenance of Kir2.1 at the plasma membrane.  
Consistent with this hypothesis, ESCRT also regulated Kir2.1 residence at the plasma membrane 
in human cultured cells.  Together, these data provide the first genomic analysis of how a single 
protein can be subject to multiple quality control pathways, and demonstrate that only specific 
quality control pathways may need to be modulated to correct unique disease-associated 
membrane proteins. 
2.2 MATERIALS AND METHODS 
2.2.1 Yeast strains and growth conditions 
Yeast strains were propagated at 26°C, and standard methods for growth, media preparation, and 
transformation were used unless indicated otherwise (Adams, 1998).  Yeast with plasmids 
containing constitutive promoters (GPD or TEF) were grown in selective medium and harvested 
at the optical density (OD) indicated in each experiment. Yeast harboring plasmids containing 
the MET25 promoter were maintained on medium containing 0.5mM methionine to inhibit 
synthesis of the desired protein. To induce Kir2.1 expression, cells were grown to log phase in 
selective medium supplemented with methionine, collected by centrifugation and washed in 
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sterile water, and then resuspended in selective medium lacking methionine for 1-2 h. After 
protein induction, cells were used as described for each experiment.   For low potassium growth 
assays and the SGA screen, 20mM MES and the indicated concentration of potassium were 
added.  Medium was also prepared at the desired pH with Tris-HCl.  A complete list of the 
strains used in this study is presented in Table 2. 
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Table 2:  Yeast strains  
Strain Relevant Genotype Source 
BY4742 MATα his3, leu2, ura3 Invitrogen 
pdr5Δ MATα, his3, leu2, ura3, pdr5::KANMX Invitrogen 
HRD1/DOA10 MATα, ade2, his3, leu2, ura3, trp1 (Pagant et al., 
2007) 
hrd1Δ MATα, ade2, his3, leu2, ura3, trp1, hrd1::KANMX (Pagant et al., 
2007) 
doa10Δ MATα, ade2, his3, leu2, ura3, trp1, doa10::KANMX (Pagant et al., 
2007) 
hrd1Δ doa10Δ MATα, ade2, his3, leu2, ura3, trp1,hrd1, 
doa10::KANMX 
(Pagant et al., 
2007) 
pep4Δ MATα, his3, leu2, ura3, pep4::KANMX Invitrogen 
pep4Δ pdr5Δ MATα, his3, leu2, ura3, pep4::KANMX, pdr5::KANMX This Lab 
SSA1 MATα, his3-11,15, leu2-3,112, ura3-52, trp1-Δ1, lys2, 
ssa2-1(LEU), ssa3-1(TRP1), ssa4-2(LYS2), 
(Becker et al., 
1996) 
ssa1-45 MATα, his3-11,15, leu2-3,112, ura3-52, trp1-Δ1, lys2, 
ssa1-45, ssa2-1(LEU), ssa3-1(TRP1), ssa4-2(LYS2), 
(Becker et al., 
1996) 
CDC48 MATα his3, leu2, ura3 This Lab 
cdc48-2 MATα his3, leu2, ura, cdc48-2::KANMX This Lab 
R5421 ura3-52 his3Δ200 leu2Δ1 trp1Δ1 ade2 trk1::HIS3 
trk2::HIS3 
(Nakamura and 
Gaber, 1998) 
SGY1528 MATα ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 (Haass et al., 
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ura3-1 trk1::HIS3 trk2::TRP1 2007) 
Y7029 can1Δ::STE2pr-HIS3 lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 
met15Δ0 
(Tong and Boone, 
2007) 
Query Strain 
(YAK01) 
can1Δ::STE2pr-HIS3 lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 
met15Δ0 trk1Δ::URA trk2Δ::NAT 
This Lab 
vps23Δ (YAK02) can1Δ::STE2pr-HIS3 lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 
met15Δ0 trk1Δ::URA trk2Δ::NAT vps23Δ::KANMX 
This Lab 
doa10Δ (YAK03) can1Δ::STE2pr-HIS3 lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 
met15Δ0 trk1Δ::URA trk2Δ::NAT doa10Δ::KANMX 
This Lab 
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For growth assays, 5 mL cultures were grown to log phase in synthetic complete medium 
lacking leucine (SC-Leu) but containing 100mM KCl at 30°C, and 1 OD600 of cells was collected 
by centrifugation.  The yeast were resuspended in 500 µL sterile water.  Cells were serially 
diluted 10 fold and plated using a 32 pin manifold onto SC-Leu medium with 0, 10, 25, or 100 
mM KCl added (potassium levels in regaents is estimated to be 7-10 mM (Nakamura and Gaber, 
1998)) and were grown at 30° for 2d.  Plates were imaged using an EPSON Perfection 3490 
Photo Scanner.  To assay for protein expression, an equal number of cells was taken from the 
plates, and total protein was precipitated with 10% trichloroacetic acid and resolved by SDS-
PAGE before western blot analysis (Zhang et al., 2001).  Kir2.1 was detected using an anti-HA-
horseradish peroxidase (HRP)–conjugated antibody and blots were probed with anti-G6PD 
antiserum to provide a loading control. The G6PD primary antibody was decorated with donkey 
HRP-conjugated anti–rabbit immunoglobulin G (IgG) secondary antibody.  The Supersignal 
Chemiluminescent Substrate (Pierce, Rockford, IL) was used to develop the blots, and the 
signals were quantified using a Kodak 440CF Image Station and the associated Kodak 1D 
software (Eastman Kodak, Rochester, NY). 
Strain YAK01 (see Table 2) was constructed from Y7029 by homologous recombination 
(Brachmann et al., 1998).  The NAT cassette was PCR amplified using primers oAK01, oAK02 
(Table 3) that also contained homology to the TRK2 locus and the PCR product was used to 
delete TRK2 in Y7029.  The URA3 cassette from pRS426 (Mumberg et al., 1995) was PCR 
amplified using primers oAK05, oAK06 (Table 3) that contained homology to the TRK1 locus.  
The PCR product was used to delete TRK1 in Y7029.  YAK02 and YAK03 were constructed 
from AK01 by mating this strain with a vps23Δ and a doa10Δ mutant from the yeast deletion 
collection (Invitrogen), respectively.  All constructed strains were confirmed by growth on 
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selective medium and by PCR using specific confirmation primers (Table 3).  CDC48 and 
cdc48-2 were constructed by mating cdc48-2 (Li et al., 2011) to ybr074Δ (Invitrogen), and the 
identity of the desired genotype was confirmed by plating on medium containing G418 
(Research Products International) and sequencing following PCR amplification of the locus). 
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Table 3: Oligonucleotide primers 
Primer use Sequence 
oAK01 Deletion of Trk2 5’-tgtactattcaccgacgataagaggctgtaagaaccactccggatccccgggttaattaa-
3’ 
oAK02 Deletion of Trk2 5’-acgttggctcttatgtaggtaaagaggggtaaacttgattgaattcgagctcgtttaaac-
3’ 
oAK03 Confirm trk2Δ 5’-ctcctgtgaagaataggatgaga-3’ 
oAK04 Confirm trk2Δ 5’-gctgttgaatcgtagtggtac-3’ 
oAK05 Deletion of trk1 5’-
cattcctatccattttacttaaagttattacctttttttgataactaacaagattgtactgagagtgca
-3’ 
oAK06 Deletion of trk1 5’-
ttcttaaatattgagtacgaaaacctatttctaaagaatgagtatatatgctatgaccatgattacg
cca-3’ 
oAK07 Confirm trk1Δ 5’-cactgattccacacttgtattgcc-3’ 
oAK08 Confirm trk1Δ 5’-ggacatcagaaatgtacgtaggca-3’ 
oAK09 Confirm vps23Δ 5’-acatgaacaccatcagtagttcctt-3’ 
oAK10 Confirm vps23Δ 5’-gtctatctgtgcgtttagcgagt-3’ 
kanC Internal KanMx 
to confirm 
deletions 
5’-tgattttgatgacgagcgtaat-3’ 
oAK11 mutant 
construction pcr-a 
5’-tagtggatcccccgggctgcaggaatt-3’ 
oAK12 Kir2.1Δ314-315 
construction pcr-a 
5’-gaatttcattggccagactccggcattgagttg-3’ 
oAK13 Kir2.1Δ314-315 
construction pcr-b 
5’-caactcaatgccggagtctggccaatgaaattc-3’ 
oAK14 mutant 
construction pcr-b 
5’-gctatagttcgaatagctatggcagctgg-3’ 
oAK15 GYG-AAA 
construction pcr-a 
5’- 
tccatcgagacccagacaaccattgccgctgctttcaggtgtgtgacagacgagtgccc-3’ 
oAK16 GYG-AAA 
construction pcr-b 
5’-
gggcactcgtctgtcacacacctgaaagcagcggcaatggttgtctgggtctcgatgga-3’ 
Myc-
Fwd 
Amplification of 
Myc-Kir2.1-HA 
5’-gagcagaagctgatatctg-3’ 
 
Kir2-
REV 
Amplification of 
Myc-Kir2.1-HA 
5’-atctccgattctcgcc-3' 
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2.2.2 Plasmid construction 
Mouse Kir2.1 in pcDNA3.1 was modified with an internal HA tag that was positioned so that it 
faced the extracellular space (Ma et al., 2001).  To create a yeast Kir2.1-HA expression construct 
with a C-terminal myc tag (myc-Kir2.1-HA), the Kir2.1 coding sequence within the pcDNA3.1 
vector was PCR amplified using the PCR Master Mix reagent (Fermentas). The amplified Kir2.1 
sequence was purified using the Purelink PCR purification kit (Invitrogen) and ligated into the 
pGEM-T easy vector (Promega). The pGEM-T-Kir2.1 plasmids were sequenced to identify 
clones that contained the correct Kir2.1 insert. The insert was removed from pGEM-T using 
EcoRI, the fragment was gel purified using PureLinkTM Quick Gel Extraction Kit (Invitrogen) 
and the isolated species was ligated into the EcoRI site of yeast plasmids containing either 
constitutive (TEF, GPD) or regulated (MET25) promoters (Mumberg et al., 1994; Mumberg et 
al., 1995).  The myc- Kir2.1-HA insert was then cloned into digested pRS vectors containing 
different promoters and auxotrophic selections (Mumberg et al., 1994; Mumberg et al., 1995) 
using SmaI and XhoI.  The cut vector was treated with antarctic phosphatase (New England 
Bioloabs) and the digested vectors were run on a 1% agarose gel and purified with PureLinkTM 
Quick Gel Extraction Kit (Invitrogen).  The cut vectors and inserts were finally ligated using T4 
DNA Ligase (Fermentas).   Kir2.1-AAA and Kir2.1Δ314-315 were made by two stage PCR 
mutagenesis (Vallejo et al., 1994).  The Kir2.1 mutated cassettes were inserted into the 
PRS415TEF vectors as described above.  All isolated inserts were subject to DNA sequence 
analysis. 
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2.2.3 Genetic screening conditions 
The query strain (YAK01) was mated to the MATa strain deletion collection (Invitrogen) as 
described (Tong and Boone, 2006).  In brief, the query strain was plated onto SC-Leu plates 
using a 96 pin manifold (Aladin Enterprises Inc., Birsbane, CA).  Strains in the deletion 
collection were then plated over the query strain and plates were incubated at 30°C for 1 d.  The 
cells were then plated onto SC-Leu containing 200 mg/L G418 (Research Products 
International), 100 mg/L clonNAT (Werner Bioagents, Germany), and 100 mM KCl to select for 
diploids and to maintain a potassium-sensitive phenotype and were incubated at 30°C for 2 d.  
The manifold was sequentially washed with water, 10% bleach, 2 times in water, in ethanol and 
then flamed between each plate.  Next, the diploid cells were plated onto sporulation medium 
and kept at room temperature for 5 d.  Finally, the spores were plated on diploid selection media 
lacking histidine, arginine, and uracil and containing 50 mg/L canavanine (Sigma, St. Louis, 
MO) and then were incubated at 30°C for 2d.  This step was repeated 2 additional times with 1 d 
incubations to select against any remaining diploids.  The resulting haploid strains, each 
expressing Kir2.1, but deleted for TRK1, TRK2, and one of ~5000 genes in the collection, were 
screened on SC -Leu medium lacking potassium and were examined after 2 d at 30°C. 
Colonies that grew significantly better than the average colony size on the plate were 
verified by growth in liquid SC-Leu media containing 100 mM KCl at 30°C in a 96 well plate.  
A total of 5 µL of cells were then pipetted into 195 µL of SC-Leu medium lacking KCl and 
grown at 30°C with shaking.  The OD600 was measured every 1-2 h with a Thermo Scientific 
Multiskan Go plate reader to obtain the doubling times.  All experiments were performed in 
triplicate.   
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2.2.4 Indirect immunofluorescence in yeast 
Yeast cells expressing Kir2.1 were grown to an OD600 of 0.5 - 0.8 and fixed with 3.7% 
formaldehyde for 1 h at 30°C.  The cells were then collected by centrifugation and washed with 
solution A (2 M sorbitol, 0.5M KPO4 pH 7) and resuspended in 500 µl solution A supplemented 
with 60 ng/ml 100T zymolyase (MP Biomedicals, Solon, OH) and 25 mM 2-mercaptoethanol 
and were incubated at 37°C for 30 min. The spheroplasts were next pelleted at 3000 rpm for 3 
min, washed with solution A, and resuspended in 800 µl of solution A.  The cell suspension (30 
µl) was added to a microscope slide well (pretreated with 1 mg/ml polylysine) and incubated at 
room temperature for 30 min. The cell suspension was aspirated and the wells were washed once 
with PBS/0.1% bovine serum albumin (BSA) and twice with PBS/0.1% BSA/0.1% NP40, and 
then incubated with the following primary antibodies at 4°C: anti-HA at 1:250 dilution, and anti-
Kar2  at a 1:500 dilution. The slides were next washed once with PBS/0.1% BSA, once with 
PBS/0.1%BSA/0.1% NP40, and once with PBS/0.1% BSA, and were incubated with the 
appropriate secondary antibodies (Alexa Fluor 568 goat anti-rabbit and Alexa Fluor 488 goat 
anti-mouse) in PBS/0.1% BSA for 1 h at room temperature. The slides were then washed as 
above, and coverslips were mounted using ProLong Gold Antifade mounting media (Invitrogen). 
Images were captured on an Olympus BX60 microscope (Olympus, Tokyo, Japan) fitted with a 
Hamamatsu C4742–95 digital camera (Hamamatsu, Bridgewater, NJ), and using QED Imaging 
software (Media Cybernetics, Silver Spring, MD). 
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2.2.5 Biochemical assays 
Kir2.1 degradation was assayed by cycloheximide chase analysis as described (Buck et al., 
2010). In brief, cells were grown in liquid selective medium with shaking to log phase (OD600 
0.4-1.2), and 100 µM cycloheximide (Sigma, St. Louis, MO) was added to stop protein 
translation.   The yeast were incubated at 30° in a shaking water bath, and temperature sensitive 
mutants were incubated at 37°C for 10 min prior to performing the chase at 37°C.  The cdc48-2 
temperature sensitive strain and the isogenic wild-type were incubated at 39°C for 2 h prior to 
the start of the chase, and the incubation was continued at 39°C.  A 1 mL aliquot of the culture 
was collected at the indicated time points and pelleted cells were washed with ice cold water 
containing protease inhibitors, flash-frozen in liquid nitrogen and stored at -80°C.  Total protein 
was precipitated from samples as described (Zhang et al., 2001) and immediately resolved by 
SDS–PAGE before western blot analysis, as described above. 
To measure the relative amount of Kir2.1 ubiquitination, cells harboring the 
pRS426MET25-Kir2.1 plasmid were grown to an OD600 of 1.0 in 50 ml cultures of selective 
medium containing 0.5 mM methionine.  The yeast were collected by centrifugation, washed in 
sterile water, and resuspended in the same medium lacking methionine for 2 h.  After induction, 
the cells were collected by centrifugation and quick frozen in liquid nitrogen and stored at -80 C 
until use.  Immunoprecipitations were preformed essentially as described (Ahner et al., 2007).  In 
brief, cells were broken by glass bead lysis, and membranes were collected by centrifugation.  
The membranes were then treated with SDS buffer to liberate Kir2.1 and after dilution into a 
TritonX-100-containing buffer an anti-HA antibody conjugated to agarose beads (Pierce) was 
added, and the slurry was incubated overnight with rocking at 4 °C. The beads were washed, and 
then SDS sample buffer was used to liberate the bound proteins.  The released proteins were 
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subjected to SDS-PAGE and western blot analysis to detect total Kir2.1 and the ubiquitinated 
Kir2.1 fraction.  
The intercellular residence of Kir2.1 was determined by sedimentation in a sucrose 
gradient essentially as described (Sullivan et al., 2003). A 40 ml culture was grown to an OD600 
of 0.8 and the cells were harvested by centrifugation, resuspended in 10 mM Tris-HCl, pH 7.5, 1 
mM EDTA, 10% sucrose, and then disrupted by agitation with glass beads. The cell lysates were 
cleared of debris by low speed centrifugation and the resulting lysate (300 µl) was layered on the 
top of a 1mL 30-70% sucrose gradient and centrifuged at 100,000xg in a Beckman SW41 rotor 
for 14 h at 4oC. Fractions were collected by pippeting from the top of the tube and proteins were 
analyzed by SDS-PAGE and western blotting for Kir2.1 with anti-HA antibody or antisera 
against the ER (Kar2/BiP) and plasma membrane (Pma1) resident proteins. 
2.2.6 Analysis of Kir2.1 in HeLa cells 
HeLa cells were cultured in DMEM with 10% FBS, 100U/mL penicillin/streptomycin and 2 mM 
glutamine at 37°C, 5% CO2.  XtremeGENE9 transfection reagent (Roche) was used as per the 
manufacturer’s guidelines to transfect mouse Kir2.1 in pcDNA3.1 (pcDNA3.1-HA-Kir2.1).  To 
knock-down the expression of ESCRT members, HeLa cells plated in 6-well dishes were co-
transfected with 1µg pcDNA3.1-HA-Kir2.1 and 2 µg siRNA using XtremeGENE siRNA 
transfection reagent.  The siRNAs for human TSG101 (CCAAAUACUUCCUACAUGC), 
human HRS (HGS) (GAACCCACACGUCGCCUUG), and a scramble control- ON-
TARGETplus non-targeting siRNA #1 were obtained from Invitrogen.  After 54 h 100 µL 
leupeptin was added.   After another 18 h cells were washed with PBS and collected in 1% 
Triton in PBS with Protease Inhibitor Cocktail (Sigma, P8340).  Lysates were rotated for 1 h at 
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4°C, followed by centrifugation at 13,000RPM for 5 min at 4°C.  Supernatants were incubated 
with SDS loading buffer for 30 min at room temperature. 
To determine the extent to which Kir2.1 accumulates in MVBs in HeLa cells, Kir2.1-HA 
was co-localized with the MVB marker, CD63 (Escola et al., 1998), using a rabbit monoclonal 
HA- antibody and a mouse monoclonal CD63 antibody. For these studies, cells were grown on 
glass coverslips and then fixed (4% paraformaldehyde, 30 min, 5oC), permeabilized with 0.1% 
Triton X-100 (10 min, 5oC) and blocked in 5% FBS (30 min, 5oC).  The cells were then 
incubated with the primary antibodies (1:100, 2 h, 5oC), washed, and incubated with anti-mouse 
and anti-rabbit AlexaFluor conjugated secondary antibodies (1:250, 1 h at room temperature). 
After washing, the cells were mounted in VectaShield mounting media containing the nuclear 
marker, DAPI.  The signals corresponding to each protein were visualized with a Zeiss 510 
confocal microscope using 63X oil immersion lens (NA = 1.4), and images were processed using 
Volocity image analysis software (PerkinElmer).  
For immunoblot analysis, cells were washed with PBS and collected in 1%Triton X-100 
in PBS with Protease Inhibitor Cocktail (Sigma, P8340) and then incubated with rotation for 1 h 
at 4°C and then centrifuged at high speed (13,000RPM, 5 min 4°C) to pellet insoluble material. 
Supernatant protein concentration was determined by BCA Protein Assay Kit (Pierce) and 
proteins were resolved by SDS-PAGE, transferred to nitrocellulose membrane, and probed with 
the appropriate primary and HRP-conjugated secondary antibodies. SuperSignal West Pico 
Chemiluminescent Substrate was used to detect the signal from the HRP –conjugated antibody, 
and the chemiluminescent signal was visualized by fluorography. Densitometric measurements 
were made in the linear range using NIH software, ImageJ.  
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To monitor Kir2.1 stability, 50 µg/mL cycloheximide (Sigma, St. Louis, MO) in the 
presence or absence of 15 µg/mL MG132 (Peptides International) were added to cells expressing 
Kir2.1-HA to stop protein translation and inhibit the proteasome, respectively. The cells were 
incubated at 37°C and were harvested with 100 µL lysis buffer (50mM Tris pH7.2, 1% Triton X-
100, 150 mM NaCl, cOmplete Mini protease inhibitor cocktail (Roche Diagnostics)), and the  
protein concentration was measured by BCA (Thermo Scientific).  Equal amounts were resolved 
by SDS–PAGE before western blot analysis.  
2.2.7 Statistical Analysis 
To analyze experiments performed in HeLa Cells (Figure 15), Statistical analysis was performed 
using GraphPad Prism. Statistical significance was determined by one-way ANOVA and TuKeys 
post hoc test in G, and two-way ANOVA and Bonferroni post tests in H. 
2.2.8 Antibodies  
The following primary antibodies were used for studies in yeast: horseradish peroxidase (HRP)-
conjugated rat monoclonal anti-HA high affinity (3F10, Roche Applied Science), anti-HA mouse 
monoclonal (Roche, Indianapolis, IN), G6PD rabbit polyclonal antibody (Sigma-Aldrich, St. 
Louis, MO),  a ubiquitin (P4D1) mouse monoclonal antibody from Santa Cruz (sc-8017), a 
polyclonal rabbit anti-Kar2 (Brodsky and Schekman, 1993).  A polyclonal rabbit anti-Pma1 was 
a gift from Amy Chang (University of Michigan, Ann Arbor, MI).  The following secondary 
antibodies were used in yeast: HRP-conjugated goat anti-mouse and goat anti-rabbit antibodies 
(Jackson ImmunoResearch), Alexa Fluor 568 goat anti-rabbit and Alexa Fluor 488 goat anti-
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mouse (Invitrogen, Carlsbad, CA).  The following antibodies were used for studies in HeLa 
cells: HA mouse monoclonal antibody (Covance), HA rabbit monoclonal antibody (Cell 
Signaling), CD63 mouse monoclonal antibody (Invitrogen), TSG101 mouse monoclonal 
antibody (GeneTex), HRS (HGS) mouse monoclonal antibody (Abcam), and VPS35 goat 
polyclonal antibody (Abcam).  The following secondaries were used for immunofluorescence 
studies in HeLa cells: anti-mouse and anti-rabbit AlexaFluor conjugated secondary antibodies 
(Molecular Probes) 
2.3 RESULTS 
2.3.1 Kir2.1 is an ERAD substrate 
The Kir2.1 potassium channel must traverse the secretory pathway and most likely encounters 
multiple levels of protein quality control.  For example, a disease-causing mutation in the 
channel, Δ314-315, prevents the trafficking of the channel from the Golgi apparatus to the 
plasma membrane by virtue of its inability to associate with AP-1 (Ma et al., 2011).  To examine 
whether Kir2.1 is also subject to ER quality control, a new yeast expression system was 
established, which permits a rapid means to analyze the ERAD requirements for a given 
substrate.  To this end, a double tagged (HA-Kir2.1-Myc) version of Kir2.1 was expressed under 
the control of the constitutive GPD promoter.  Analysis of Kir2.1 localization by indirect 
immunofluorescence primarily showed a perinuclear staining that colocalized with the ER 
resident chaperone, Kar2 (BiP) (Figure 6A).  Sucrose gradient centrifugation analysis indicated 
that Kir2.1 was also mostly present in the same fractions as Kar2 (Fig. 5B lanes 1-6).  However, 
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a fraction (<5%) of Kir2.1 comigrated with the plasma membrane protein Pma1 (lanes 9-11).  
These data suggest that while the majority of Kir2.1 is localized in the ER, a small pool advances 
to the plasma membrane in yeast. This is in contrast to what is observed in mammalian cells 
in which the majority of Kir2.1 traffics beyond the ER (Stockklausner et al., 2001).  This may 
suggest that yeast lack Kir2.1 assembly or anterograde trafficking factors important for its 
biogenesis. 
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 Figure 6: Kir2.1 localization in yeast. 
A) Indirect immunofluorescence of yeast expressing Kir2.1.  Fixed cells were probed with 
antibodies against the ER marker Kar2/BiP and the HA tag to visualize Kir2.1.  The right panel 
is a merge showing extensive co-localization.  B) Lysates from cells expressing Kir2.1 were 
analyzed by centrifugation in a 30% - 70% sucrose gradient under conditions to  maximize ER 
and plasma membrane separation (Roberg et al., 1997). The gradient was fractionated from the 
top (fraction 1) to the bottom of the tubes (fraction 14). The migration of Kir2.1, the ER 
chaperone, Kar2/BiP, and the plasma membrane protein Pma1 were evaluated by western blot 
analysis.  
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Next, Kir2.1 protein stability in yeast was analyzed by cycloheximide chase by Patrick 
Needham, a post-doctoral research fellow in the Brodsky laboratory.  The channel was rapidly 
turned-over with nearly complete degradation occurring after 90 min (Figure 7A).  Kir2.1 was 
expressed in pdr5Δ yeast, which allows treatment with the proteasome inhibitor, MG132, and 
when this compound was added 20 min prior to the chase, Kir2.1 was partially stabilized (Figure 
7A).  Incomplete stabilization of Kir2.1 may be due to incomplete proteasome inhibition and/or 
may suggest that an alternative degradation pathway is being utilized.  Further, I found that the 
AAA-ATPase, Cdc48, which extracts ERAD substrates from the ER membrane and into the 
cytosol (Wolf and Stolz, 2012), was required for degradation since Kir2.1 was completely 
stabilized in a temperature sensitive mutant, cdc48-2, at a non-permissive temperature (Figure 
7B). 
To determine whether Hsp70 chaperones facilitate the ERAD of Kir2.1, the protein was 
expressed in the temperature sensitive Ssa1 mutant, ssa1-45.  The cytosolic Hsp70, Ssa1, is 
required for the degradation of ERAD substrates with misfolded cytosolic domains (Han et al., 
2007; Hill and Cooper, 2000; Nakatsukasa et al., 2008; Zhang et al., 2001).  Dr. Needham 
discovered that Kir2.1 degradation was attenuated at the non-permissive temperature in this 
mutant (Figure 7C).  In this case, incomplete stabilization of Kir2.1 may be due to incomplete 
inactivation of Ssa1 or may be due to other chaperones facilitating its degradation.    In contrast, 
Kir2.1 degradation was unaffected in a kar2-1 mutant, which is required for the ERAD of 
substrates with misfolded lumenal domains (Brodsky et al., 1999; Hill and Cooper, 2000; 
Plemper et al., 1997) (Figure 7D).  Together, these data suggest that Kir2.1 folds poorly in yeast 
and is recognized as an ERAD substrate by the cytosolic Hsp70, Ssa1.  As described below, 
Kir2.1 is also targeted for ERAD in mammalian cells. 
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 Figure 7: Kir2.1 degradation is proteasome- and cytosolic chaperone-dependent. 
Cycloheximide chase reactions were performed and lysates were blotted with anti-HA antibody 
to measure Kir2.1 stability over time.  (A) A pdr5Δ yeast strain was pretreated for 20 min with 
100 µM MG-132 () or DMSO (). Data represent the means +/- S.E. of 3 independent 
experiments.  The degradation of Kir2.1 was also measured in (B) CDC48 () or cdc48-2 () 
mutant yeast (C) SSA1 () or ssa1–45 () mutant yeast, and (D) KAR2 () or kar2–1 () 
mutant yeast.  Data represent the means +/- S.E. for 4–6 independent experiments. In each 
experiment, representative western blots are shown in the bottom panels. 
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Nearly all ERAD substrates in yeast are ubiquitinated by the E3 ligases, Hrd1 or Doa10 
(Claessen et al., 2012).  To investigate whether Kir2.1 was degraded in a Hrd1- and/or Doa10-
dependent manner, Dr. Needham expressed Kir2.1 in hrd1Δ, doa10Δ, hrd1Δ doa10Δ, and HRD1 
DOA10 strains.  He found that Kir2.1 was stabilized to a similar level when either HRD1 or 
DOA10 were deleted.  When the genes encoding both E3s were absent the protein was further 
stabilized (Figure 8A).  To verify that Doa10 and Hrd1 are directly required for Kir2.1 
ubiquitination, he asked if deletion of these E3 ubiquitin ligases led to a decrease in Kir2.1 
ubiquitination.  Kir2.1 was immunoprecipitated from wild-type or hrd1Δ doa10Δ yeast and 
ubiquitin levels were examined by immunoblotting.  Deletion of HRD1 and DOA10 led to a 40% 
reduction in Kir2.1 ubiquitination (Figure 8B-C).  Because Kir2.1 degradation is Ssa1 dependent 
(see above), we anticipated the requirement for Doa10.  However, the Hrd1 dependence suggests 
that Kir2.1 lesions may also be recognized within the membrane (Sato et al., 2009).  Thus, the 
folding lesions in Kir2.1 are complex and require a set of factors that are needed for both ERAD-
C and ERAD-M substrates (Carvalho et al., 2006; Denic et al., 2006; Vashist and Ng, 2004). 
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 Figure 8: Kir2.1 degradation and ubiquitination are E3 ubiquitin ligase dependent. 
A) Cycloheximide chase reactions were performed and lysates were blotted with anti-HA 
antibody to measure Kir2.1 stability over time; wild type (), hrd1Δ (z), doa10Δ ({), or hrd1Δ 
doa10Δ ().  Data represent the means +/- S.E. for 4–6 independent experiments.  A 
representative western blot from one experiment is shown below the graph.  B) Kir2.1 expressed 
in either wild type (lane 1) or hrd1Δ doa10Δ (lane 2) mutant yeast strains was 
immunoprecipitated from lysates with anti-HA-agarose beads and the amount of protein and 
conjugated ubiquitin were analyzed by western blot (WB) analysis. The result from an 
immunoprecipitation using cells containing a vector control is shown for comparison (lane 3). C) 
Relative ubiquitination of Kir2.1 immunoprecipitated from wild type and hrd1Δ doa10Δ yeast. 
The graph represents the means +/- S.E. from thirteen precipitated samples of each strain, each 
from a distinct clone. 
 72 
2.3.2 A yeast genomic screen identifies regulators of Kir2.1 biogenesis 
Kir2.1 has been shown to rescue the growth of yeast strain lacking the Trk1 and Trk2 potassium 
transporters on medium containing low potassium (Nakamura and Gaber, 1998; Tang et al., 
1995b).  Because Kir2.1 is significantly subjected to ER quality control but can also transit to the 
plasma membrane in yeast (see above), we decided to use a genetic approach to identify the 
spectrum of factors that affect Kir2.1 stability in the ER and trafficking from this organelle.  
Moreover, because Kir2.1 is subject to quality control beyond the ER (Ma et al., 2011), I 
reasoned that this screen might also uncover components required for this later event.  Therefore, 
an SGA query strain was engineered in which TRK1 and TRK2 were deleted.  Kir2.1, under the 
control of various promoters, was then introduced into this strain.  In principle, growth on low 
potassium should correlate with Kir2.1 plasma membrane residence.   I ultimately determined 
that expressing Kir2.1 from a TEF promoter on a centromeric plasmid (Figure 9A) and then 
screening on medium lacking potassium at pH 4 (Nakamura and Gaber, 1998) and 30°C (Figure 
9B) provided the optimal set of conditions to screen for genes that, when mutated, would 
augment growth on low potassium. 
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 Figure 9: Optimization of Kir2.1 screening conditions 
A) The trk1Δ trk2Δ strain expressing Kir2.1 from a GPD, TEF or MET25 promoter were 
serially plated onto selective medium with 10 or 25 mM KCl at pH 4.  Medium containing 100 
mM KCl at pH 6 served as a control for normal growth of the strains.  Where indicated, Kir2.1 
was either expressed from a plasmid or integrated into the TRK1 locus.  Plates were incubated at 
30°C for 5 d.  B) The query strain containing a Kir2.1 expression construct under the control of 
the TEF promoter or control vector were serially plated onto selective medium with 0, 10, 25 
mM KCl at pH 4 or 100 mM KCl at pH 6 at 23°C, 30°C, or 37°C and incubated for 2 d. 
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Preventing the ERAD of several proteins increases their folding and secretion efficiencies 
(Fisher et al., 2011; Grove et al., 2009; Halaban et al., 1997; Kincaid and Cooper, 2007; Mitchell 
et al., 1998; Qu et al., 1996; Schubert et al., 1998; Vij et al., 2006).  Consistent with Kir2.1 
possibly behaving in a similar manner, I found that deletion of DOA10 subtly increased growth 
of the trk1Δ trk2Δ strain on low potassium when Kir2.1 was expressed (Figure 10).  Therefore, 
the query strain was crossed to the yeast deletion collection using established SGA methodology 
(Tong and Boone, 2006).  The resulting haploid strains, which each lacked one of  4,848 non-
essential yeast genes were screened on selective medium at pH 4 in the absence of added 
potassium ([K+] < 10mM (Nakamura and Gaber, 1998)).   A total of 288 strains that led to 
increased growth on low potassium compared to the average colony size on the plate were 
identified (see Figure 11A for an example).  To focus my studies, strains with mutated genes that 
compromised select biosynthetic pathways or contained well characterized transcription and 
translation factors were eliminated.  In addition, strains containing dubious open reading frames 
were eliminated from further consideration. 
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 Figure 10: doa10Δ modestly increases Kir2.1 dependent rescue of trk1Δ trk2Δ on low K+ 
(A) The Kir2.1 expression construct and a vector control were introduced into trk1Δ trk2Δ and trk1Δ 
trk2Δ doa10Δ strains, and 10-fold serial dilutions were plated onto medium with 0, 10, 25, 50, or 100 mM 
KCl.  Three independent colonies of the trk1Δ trk2Δ doa10Δ strain expressing Kir2.1 are shown (#1--#3).  
(B) Cells were harvested from the plate, lysed, and analyzed by SDS-PAGE and western blots were 
probed with an anti-HA antibody to analyze Kir2.1.  G6PD served as a loading control. 
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Fresh isolates of the remaining 215 strains that lacked unique genes were rearrayed into 
three 96 well plates and were again crossed to the query strain containing either a vector control 
or the Kir2.1 expression vector.  Included in this analysis were strains lacking genes that encode 
for members of protein complexes that appeared to feature prominently in the preliminary 
screen.  The strongest hits from this second screen were selected for further study, and to rank 
the hits, the doubling times of these strains containing either the Kir2.1 expression vector or the 
vector control were measured in liquid culture.  The ratio of the doubling time of each strain 
containing the vector control to the same strain expressing Kir2.1 was then used to produce a 
growth score. This analysis also eliminated mutated genes that rescue growth on low potassium 
that were Kir2.1 independent.  This left 53 deletion strains with a significantly higher growth 
score than the query strain (Figure 11B, Table 4, Appendix A).  To my surprise, genes required 
for ERAD were completely absent from this list.  Instead, nearly all of the genes encoded 
proteins associated with secretory pathway compartments within or beyond the Golgi.  In fact, 
the corresponding proteins are primarily involved in the delivery of proteins to the vacuole, with 
a member of the phosphatidylinositol 3-kinase complex (Vps38) that regulates CPY sorting and 
interacts with retromer representing the strongest hit (Burda et al., 2002; Kihara et al., 2001). 
Also prominent amongst the hits were members of the ESCRT complex (Did2, Vps36, Vps22, 
Vps2, Vps23, Vps37, Mvb12, and Vta1). 
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 Figure 11: A genetic screen identifies ESCRT as a major effector of Kir2.1 
A) Representative section of a plate following the mating of a query strain expressing Kir2.1 to 
the yeast deletion collection.  Haploid progeny were plated on selective medium with either 0 
mM KCl or 100 mM KCl, as indicated.  Medium with100 mM KCl added serves as a control for 
equal growth amongst the different mutant strains.  Circles represent negative control strains in 
which a strain was absent and used as a plate identifier.  Boxes represent strains that showed 
increased growth compared to average colony growth.  B) The Kir2.1 growth scores of each hit 
was calculated based on the doubling times of the strains with an empty vector control divided 
by the doubling times of strains expressing the Kir2.1 expression vector.  These values were then 
normalized to vps38Δ, which was the strongest hit.  All strains are deleted for TRK1 and TRK2, 
as well as the gene indicated.  Error bars represent the SD of three independent measurements.
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Table 4: Genes that when deleted led to increased growth on low potassium in the trk1Δ trk2Δ strain 
Family Function Genes 
Protein trafficking complexes      
ESCRT & ESCRT 
partners 
Formation of MVBs Vps23 Vps37 Mvb12 Vps22 Vps36 
Vps2 Did2 Vta1 Opi8 
PI3K II PI3 kinase involved in vacuolar 
protein sorting 
Vps38 Vps30 
Retromer Retrieval of vacuolar targeted 
proteins 
Vps5 Vps17 Vps26 Vps29 Vps35 
GARP Retrieval of vacuolar targeted 
proteins 
Vps52 Vps54 
TRAPP Golgi trafficking Tca17 Trs85 
COG Golgi cytosolic tethering 
complex 
Cog5 Cog6 Cog7 Cog8 
RAVE Endosomal trafficking, Golgi 
localization, V-ATPase assembly 
Rav1 Rav2 
AP-1 
Clathrin adaptor protein complex 
associated with  protein sorting at 
the Golgi Aps1 
BLOC Endosomal sorting Vab2 
EGO & GSE Vacuolar invagination Gtr2 
GTPase and associated proteins    
GTPase Regulates trafficking through 
GTP hydrolysis 
Arl1 Ypt6 Arl3 
GAP Stimulates GTPase activity Gyp7 Rgd2 
Rsp5 adaptors Facilitate ubiquitination by the 
Rsp5 ubiquitin ligase 
Bsd2 Tre1 
   
Vacuole function    
Morphogenesis Vacuolar fusion Vam10 
Assembly Factors V-ATPase assembly Pkr1 
Phosphatase activators Stimulate dephosphorylation Sap155 Irs4 
Other    
v-SNARE Mediates vesicle fusion Gos1 
Prefoldin Complex Transfers proteins to chaperonin Gim4 
Glutamate 
dehydrogenase 
Synthesizes glutamate Gdh3 
Sphingolipid alpha-
hydroxylase Long chain fatty acid biogenesis Scs7 
NatC Protein acetylation Mak10 
CCR4-NOT Transcription regulation Ccr4 
Endo-beta-1,3-
glucanase Cell wall maintenance Bgl2 
Uncharacterized   Ldb16 Vps13 Ecm30 YJL132w 
    YJL118w YJL163c   
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 ESCRT is involved in Golgi and the plasma membrane quality control (Apaja et al., 
2010; Wang and Ng, 2010), so I directly examined the role of select ESCRT members in Kir2.1 
protein quality control.  First, a vps23Δ strain that also lacked TRK1 and TRK2 was remade by 
PCR mutagenesis and after introduction of the Kir2.1 expression vector the yeast were 
rescreened on low potassium medium.  Increased rescue of this strain by Kir2.1 was quite 
prominent compared to the trk1Δ trk2Δ VPS23 background (Fig 11A).    To confirm that rescue 
on low potassium medium was directly associated with Kir2.1 function, a new Kir2.1 expression 
plasmid was constructed.  In this case, Kir2.1 contained a dominant negative mutation in which 
the selectivity filter was mutated from 144GYG146 to 144AAA146 (Tinker et al., 1996).  After the 
plasmid was introduced into cells, the inactive channel was unable to rescue growth even though 
it was expressed to similar levels as wild type Kir2.1 (Figure 12A, B).  Further, to ensure that 
Kir2.1-mediated rescue was unaffected by the presence of the HA epitope, an untagged form of 
Kir2.1 was expressed in trk1Δ trk2Δ cells and growth was rescued on low potassium medium to 
a similar extent as that observed for the Myc-Kir2.1-HA construct (Figure 13). 
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 Figure 12: Deletion of VPS23 increases Kir2.1 dependent rescue of trk1Δ trk2Δ on low potassium 
medium. 
 A) The control or indicated plasmids were introduced into the query strain (trk1Δ trk2Δ) and into a trk1Δ 
trk2Δ vps23Δ strain.  10-fold serial dilutions were plated onto selective medium with 100mM, 25mM, 
10mM or 0mM KCl and growth was measured after 2 d at 30°C.  B) Equal number of cells were collected 
from the plates, lysed, and analyzed by SDS- PAGE and blotted with anti-HA antibody to assess the 
levels of Kir2.1. G6PD served as a loading control. 
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 Figure 13: Affinity tagged Kir2.1 behaves similar to wild type Kir2.1. 
A) Kir2.1 was expressed as either a double tagged (Myc-Kir2.1-HA) or untagged (Kir2.1) protein in 
trk1trk2 yeast; empty expression vector (sector 1), doubly tagged Myc-Kir2.1-HA (sector 2), or untagged 
Kir2.1 (sector 3) were inoculated onto high (100mM) or low (10 mM) potassium medium and incubated 
for 3 d at 26°C.  B) Cycloheximide chase assays were performed in wild type yeast expressing double 
tagged Myc-Kir2.1-HA () or untagged Kir2.1 (). Data represent the means +/- S.E. for 4 independent 
experiments.  A representative western blot from one experiment is shown below the graph. 
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I next wished to explore whether the yeast system could be used to assay disease linked 
mutations in Kir2.1  I therefore created a Kir2.1 expression vector in which a Golgi export signal 
was absent and that results in Andersen-Tawil syndrome in humans (Ma et al., 2011).  This 
mutant (Δ314-315) failed to rescue growth of trk1Δ trk2Δ yeast on low potassium; however, the 
protein was expressed to lower levels than wild type Kir2.1 (Figure 13A, B).  In an attempt to 
raise expression levels, an alternate promoter was used, but this led to increased toxicity (data 
not shown). To determine why Kir2.1Δ314-315 was less stable than the wild type protein, I 
analyzed the proteasome and vacuolar dependent degradation of Kir2.1Δ314-315 degradation. 
Kir2.1Δ314-315 was stabilized in the pdr5Δ strain when MG132 was added, but degradation was 
unaffected when vacuolar proteases were inactivated (Figure 14).  These results suggest either 
that defects in the progression of the Andersen-Tawil mutant protein beyond the Golgi result in 
the retrieval of the protein to the ER and proteasomal degradation.  Retrograde trafficking to the 
ER would require that the misfolded protein first bypass the ERAD machinery before it is 
recognized by Golgi associated factors.  Alternativey, I favor a model in which the protein 
exhibits an ER folding defect as well as a defect in AP1-mediated trafficking (see below) 
resulting in recognition by ERAD components. 
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 Figure 14: Kir2.1Δ314-315 is degraded by the 26S proteasome 
Cycloheximide chases were performed in the pep4Δ strain ({) or in the pdr5Δ strain that 
was pretreated with 100 µM MG132 () or DMSO () for 30 min.  Data represent the means of 
5-6 independent experiments ±SD. Representative western blots from one experiment are shown. 
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2.3.3 Proteasome and ESCRT-dependent degradation of Kir2.1 in human cells 
The results presented in the preceding sections indicate that Kir2.1 is an ERAD substrate in yeast 
and that later steps in the secretory pathway control the levels of active Kir2.1 at the plasma 
membrane.  To examine whether these phenomena were evident in higher cell types, I examined 
the quality control of Kir2.1 in HeLa cells.  Cycloheximide chase analysis may suggest that 
Kir2.1 was degraded by the 26S proteasome in HeLa cells, as it was in yeast, although to a much 
less extent (Figure 15A, B).  Similar results were observed regardless of whether the cells were 
pretreated with MG132 (data not shown). 
Since the majority of wild type Kir2.1 appeared to be degraded in a proteasome 
independent mechanism, the Welling lab examined whether Kir2.1 was degraded in the 
lysosome.  Consistent with a role for lysosomal degradation in controlling Kir2.1 levels, 
leupeptin increased Kir2.1 steady state levels as reported (Jansen et al., 2008; Nalos et al., 2011) 
(Figure 15C, D).  Further, leupeptin addition led to increased colocalization with the late 
endosomal/lysosomal marker CD63 (Figure 15E). 
 To determine if ESCRT was required for the lysosome dependent degradation of Kir2.1, 
the ESCRT components Tsg101 (ESCRT-I) and Hrs (ESCRT-0) were depleted.  Treatments with 
targeted siRNAs led to the nearly complete absence of Tsg101 and an ~50% decrease in the 
amount of Hrs (Figure 15F, G).  In parallel, there was a corresponding increase in Kir2.1 (Figure 
15H).  Addition of leupeptin did not lead to a further increase in Kir2.1 when the ESCRT 
components were knocked down, consistent with the delivery to and degradation of the channel 
in the lysosome (Figure 15I).  Together, the collective data from the yeast and human cell models 
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demonstrate that ESCRT-dependent targeting of Kir2.1 to the vacuole/lysosome regulates the 
levels of functional Kir2.1. 
 
Figure 15: Kir2.1 is degradation is primarily lysosomal dependent and requires ESCRT 
A) Kir2.1 stability was analyzed by a cycloheximide chase in HeLa cells.  HeLa cells transfected 
with pcDNA3.1-HA-Kir2.1 were treated with 15µM MG132 () or DMSO () for the indicated 
time points and were harvested, lysed, and analyzed by SDS-PAGE.  Kir2.1 was detected with 
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an anti-HA antibody.  Actin levels served as a loading control. Data represent the means 4-5 
experiments ± SD.  A representative blot is shown in B. C) The amount of Kir2.1 was assessed 
by western blot analysis of  HeLa cells transfected with pcDNA3.1- HA-Kir2.1 for 24 h followed 
by an 18 h treatment of 100 µM leupeptin where indicated.  D) The means ± SE from 3 trials 
from C treated with () or without leupeptin () were quantified.  E) Confocal microscopy was 
performed in HeLa cells transfected with pcDNA3.1-HA- Kir2.1.  Cells were treated with 100 
µM leupeptin as described in materials and methods and were mounted in media containing 
DAPI.  Colocalization of Kir2.1 (green) and CD63, a marker of endosomes/ lysosomes is shown 
in the Merge (yellow). HeLa cells were co-transfected with the indicated siRNA and pcDNA3.1-
HA-Kir2.1 and after 72h cells were harvested and the levels of Kir2.1, VPS23 VPS27, and 
tubulin were measured. Where indicated, 100 µM leupeptin was added to cells for 18 h.  Tubulin 
served as a loading control. H) The levels of Kir2.1 when VPS23 or VPS27 were knocked down 
(lane 3 from F and G) were normalized to the scramble control (lane 1 from F and G) to 
determine the effect of siRNA on Kir2.1 abundance.  The data represent the means ± SE of 6-8 
trials. I) The levels of Kir2.1 when leupeptin was added when VPS23, VPS27, (lane 4 from F 
and G) or scramble (lane 2 from F and G) () siRNAs were transfected and were normalized to 
Kir2.1 levels when leupeptin was absent (lanes 1 and 3) () to determine the magnitude of the 
leupeptin response.  The data represent the means ± SE of 6-8 trials.  The data represent the 
means ± SE of 6-8 *p<0.05, **p<0.01, ***p<0.001 
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2.4 DISCUSSION 
The data presented in this thesis demonstrate that Kir2.1 is subject to protein quality control at 
multiple levels in both yeast and human cells.  An initial characterization of Kir2.1 in yeast 
demonstrated that a majority of the channel is ER localized and that a majority of the protein is 
targeted for ERAD.  In contrast, our screen revealed that components required for vacuolar 
targeting regulate the levels of active Kir2.1.  These data suggest that a larger, permanently 
misfolded population of Kir2.1 is targeted by ERAD and may be unable to mature.  However, 
Kir2.1 that migrates beyond the ER appears to be in a folding competent state.  At this point, 
ESCRT and associated factors (see below) select Kir2.1 species that may still be unfolded, but 
not to the extent for selection by the ERAD pathway, or they may transiently adopt misfolded 
conformations.  The idea of an unstable population of maturing and even functional ion 
transporters is not new (Apaja et al., 2010; Helliwell et al., 2001; Hill and Cooper, 2000; Lu et 
al., 2007), but our data represent the first hint of the relative strengths of unique quality control 
mechanisms that act on a single protein in the secretory pathway. 
To a significant extent our studies in HeLa cells validated the use of yeast as a model to 
identify the relative contributions of quality control pathways that impact Kir2.1 biogenesis.  I 
show that Kir2.1 is regulated by both ERAD and by ESCRT-mediated lysosomal degradation, as 
in yeast, but the relative contribution of each is inverted.  In yeast, the majority of Kir2.1 was 
degraded by ERAD with a minor population of Kir2.1 being targeted to the vacuole.  In contrast, 
in HeLa cells Kir2.1 is primarily degraded in the lysosome, whereas a smaller population of 
Kir2.1 is targeted for ERAD.  One explanation for this phenomenon may be the unique lipid 
 88 
compositions in the ER in yeast and human cells.  Of note, lipids such as cholesterol and 
phosphatidylinositol 4,5-bisphosphate are known to alter Kir2.1 function and may influence its 
stability (Huang et al., 1998; Romanenko et al., 2004).  Alternatively, yeast may lack assembly 
or trafficking factors required for efficient transport of functional Kir2.1.  For example, the rat 
monocarboxylate transporter, MCT1, does not efficiently traffic to the plasma membrane in yeast 
unless the cell surface glycoprotein, CD147, which has been shown to bind tightly to MCT1, is 
also expressed (Makuc et al., 2004).  While yeast may not be a perfect model for studying 
protein quality control of mammalin proteins, the identification of ESCRT points to the utility of 
using such model systems. 
In addition to ESCRT, we identified other factors in our yeast screen that mediate Golgi 
trafficking and vacuolar function.  For example, Vps38, a member of the phosphatidylinositol 3-
kinase complex II (PI3KII), was the strongest hit in our screen for proteins that affect Kir2.1 
function.  PI3K is a member of two complexes, PI3KI and PI3KII, that synthesize 
phosphatidylinositol 3-phosphate for a variety of functions (Kihara et al., 2001).  PI3KI localizes 
primarily to the vacuole and is involved in autophagy, whereas PI3KII localizes to the Golgi and 
endosome and regulates protein trafficking from the endosome to the Golgi (Burda et al., 2002; 
Obara et al., 2006).  Deletion of the genes encoding Vps38 and another component of both PI3K 
complexes, Vps30, leads to decreased retromer function (Burda et al., 2002).   Retromer 
functions in the recovery of proteins from the endosome to the Golgi (Seaman et al., 1998), and 
interestingly all five members of the retromer complex (Vps5, 17, 26, 29, 35) are represented 
within the 20 strongest hits in the screen.  Although the mechanism is undefined, deletion of 
retromer also leads to increased plasma membrane residence of other select membrane proteins 
in yeast, flies, and worms, (Dang et al., 2011; Kim et al., 2007; Korolchuk et al., 2007), which is 
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consistent with our findings.  More recently the receptor activator of NF-κB, which is involved 
in osteoclast formation, was shown to be inhibited by retromer-mediated transport from the 
endsome to the Golgi (Xia et al., 2013).  Inhibition of retromer may cause a factor that would 
normally antagonize Kir2.1 plasma membrane residence, such as a Golgi retention factor, to be 
degraded, or retromer may function in the retrieval of a Kir2.1 population that traffics through an 
endosomal intermediate en route to the plasma membrane.   
Besides PI3KII and retromer, additional proteins that regulate trafficking/localization of 
proteins at the Golgi and endosome were identified as weaker hits in the screen.  These include 
several Golgi-associated GTPases (Arl1, Arl3, Ypt6) that regulate Golgi-endosomal trafficking 
(Behnia et al., 2004; Li and Warner, 1996; Luo and Chang, 1997).  For example, Ypt6, interacts 
with Vps52 in the Golgi-Associated Retrograde Protein (GARP) complex, which retrieves 
proteins from the endosome to the Golgi, and two GARP components were among the hits (i.e., 
Vps52 and Vps53) (Conibear and Stevens, 2000; Siniossoglou and Pelham, 2002).  Other protein 
complexes involved in trafficking within the Golgi such as the TRAPP complex (Tca17, Trs85) 
(Montpetit and Conibear, 2009; Sacher et al., 2000) and the Conserved Oligomeric Golgi (COG) 
complex (Cog5, Cog6, Cog7, Cog8) (Ram et al., 2002; Ungar et al., 2002) were amongst the 18 
weakest hits, but whether these play a direct or indirect role in Kir2.1 trafficking is unclear.   
Nevertheless, the regulation of Kir2.1 trafficking at the Golgi is consistent with Golgi 
accumulation of the Andersen-Tawil Kir2.1 mutant, which becomes trapped in this compartment 
due to its inability to be selected for anterograde transport (Ma et al., 2011).   
Vacuole targeting of proteins via ESCRT requires ubiquitination by Rsp5 or Tul1 (Dupre 
et al., 2004; Helliwell et al., 2001; Hicke and Dunn, 2003; Katzmann et al., 2004; Pizzirusso and 
Chang, 2004; Wang et al., 2011).  Rsp5 is an essential protein so it would have been absent from 
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our screen, but the Rsp5 adaptor proteins Bsd2 and Tre1, which regulate the trafficking and 
stability of plasma membrane and Golgi proteins, were identified (Hettema et al., 2004; Portnoy 
et al., 2000; Stimpson et al., 2006).    
 Importantly, the rescue of a trk1Δ trk2Δ strain on low potassium when each of these 
genes were deleted was mediated by Kir2.1 function and is not simply a result of the deleted 
gene making the yeast more tolerant to potassium-poor media. For each hit, I showed that the 
introduction of a vector control was unable to improve growth to the same level as a strain 
expressing Kir2.1.  However, a screen for genes that when deleted increased sensitivity to 
cationic drugs identified Arl1, the COG complex, the GARP complex and retromer (Barreto et 
al., 2011), suggesting that some of the hits from our screen may alter the localization of other 
potassium channels, in addition to Kir2.1.   These and many of our hits also lead to increased 
CPY secretion (Bonangelino et al., 2002), suggesting that there is general increased trafficking in 
strains deleted for these genes.   However the strains that increase CPY secretion do not 
completely overlap with the hits identified in our screen, suggesting that Kir2.1 localization is 
regulated differently than this soluble vacuolar resident protein (see Appendix A).  In fact, there 
is more overlap of our screen with the genes identified in a screen for genes that rescue the 
localization of a mutant form of the plasma membrane ATPase, Pma1, that is targeted directly 
from the Golgi to the vacuole (e.g. Vps38, Vps36, Vps29, Vps13, Vps35, Vps27, and Bsd2) 
(Luo and Chang, 1997).  This result suggests the existence of an overlapping protein quality 
control mechanism for these two unstable plasma membrane proteins. 
 My data contribute to a growing number of substrates that are regulated by protein 
quality control at the Golgi and plasma membrane in yeast (Chang and Fink, 1995; Coughlan et 
al., 2004; Haynes et al., 2002; Hong et al., 1996; Jenness et al., 1997; Spear and Ng, 2003; Wang 
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and Ng, 2010) and mammals (Apaja et al., 2010; Armstrong et al., 1990; Ashok and Hegde, 
2009; Okiyoneda et al., 2010).  However, how substrates like Kir2.1 are recognized as misfolded 
in later compartments is not readily apparent, possibly because our screen only monitors the 
functional population.  In contrast, Dr. Needham found that a core collection of Hsp70 and 
Hsp40s aid in the recognition of Kir2.1 as an ERAD substrate in the ER.  Interestingly, studies in 
mammalian cells have identified Hsc70, Hsp90, and Hsp40s as important for the recognition of 
mutant CFTR that is rescued to the plasma membrane (Okiyoneda et al., 2010).   Future work 
will uncover whether these and other chaperones operate at multiple quality control networks for 
Kir2.1 and perhaps other ion transporters. 
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3.0  DISCUSSION 
Kir2.1 is a transmembrane protein that traffics through the secretory pathway, and each cellular 
compartment that it encounters on its way to the plasma membrane where it functions may 
monitor Kir2.1.  A collaboration with Dr. Needham revealed that a significant portion of Kir2.1 
is regulated by ERAD in yeast.  However, deletion of these genes had little effect on functional 
levels at the plasma membrane, suggesting an alternative quality control step beyond the ER 
(Figure 10).  In support of an additional protein quality control mechanism, the screen I 
performed to identify regulators of Kir2.1 plasma membrane residence primarily revealed 
endosomal/Golgi proteins (Figure 11, Table 4 Appendix A).  The fact that ERAD genes were not 
identified suggests a division of labor for Kir2.1 regulation in which ERAD monitors the 
nonfunctional protein while factors later in the secretory pathway monitor the protein that may 
still function. 
   Kir2.1 is an ERAD substrate in both yeast and mammals (Figures 7 and 15), but it 
requires a set of factors that are not solely represented by ERAD-L, ERAD-C, or ERAD-M (see 
Section 1.4).  Specifically, its degradation is dependent on Hrd1, but not Kar2/BiP, which 
represents the ERAD-L/M pathways.  In addition, Doa10 and Ssa1 of the ERAD-C pathway are 
required for the degradation of Kir2.1. The degradation dependence on multiple ERAD pathways 
seems to be a developing theme among multimeric ion channels.  For example, ENaC, another 
multimeric channel with similar topology to Kir2.1, also shows dependence on both the Hrd1 
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and Doa10 E3 ubiquitin ligases (see Appendix B).   Both of these ion channels are 
transmembrane proteins with a cytosolic loop, and could have misfolded lesions that can be 
recognized by both Hrd1 and Doa10.  This hints at multiple lesions within Kir2.1 that are 
recognized by the ERAD machinery.  
These lesions may result in part from the channel monomer’s inefficient assembly into a 
tetrameric channel.  Kir2.1 requires contacts within the membrane and the ER lumen that appear 
to be important for its oligomerization (Tinker et al., 1996) and the exposure of these contacts in 
the absence of assembly may reveal ERAD recognition sites.  Alternatively, assembly may be 
required to expose its ER export signal and/or mask an unidentified ER retention signal, 
similarly to what has been observed with other Kir channel localization signals (Ma et al., 2011; 
Yuan et al., 2003).  A poorer assembly efficiency in yeast may also explain why there is more 
Kir2.1 ERAD than in mammalian cells.   
Even though Kir2.1 is primarily an ERAD substrate in yeast, the screen I performed 
identified primarily Golgi/endosomal-associated proteins (Appendix A), suggesting a post ER 
regulation of Kir2.1, which is consistent with the Andersen-Tawil mutant accumulating in the 
Golgi in mammalian cells.  In addition, the identification of ESCRT indicates that Kir2.1 is 
targeted to the vacuole.  However, it is also possible that ESCRT is indirectly affecting Kir2.1 
stability by targeting another factor that alters channel activity.  Studies in human cells confirm 
that Kir2.1 is stabilized when the lysosome is degraded suggesting lysomal degradation of Kir2.1 
(Jansen et al., 2008).  However, it is not clear whether the cellular decision to degrade Kir2.1 is 
being made at the plasma membrane or in an intracellular compartment.   
The large number of Golgi/endosomal proteins identified would suggest that the decision 
to degrade Kir2.1 is made at an intracellular compartment.  The identification of retrieval 
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complexes such as retromer and GARP (Table 4, Appendix A) is consistent with a decision 
being made at the endosome.  However, studies in collaboration with the Welling lab 
demonstrated that a reduction of retromer did not alter total Kir2.1 protein levels (data not 
shown), suggesting that if retromer also functions to regulate Kir2.1 in human cells it does so by 
redistributing Kir2.1 from a plasma membrane directed pool to an intracellular resident pool.  
One possibility is that GARP and retromer retrieve a population of Kir2.1 in endosomes that 
would otherwise traffic to the plasma membrane.  If this is the case, then an examination of 
Kir2.1 plasma membrane levels by biotinylation in HeLa cells could reveal that there is more 
Kir2.1 at the plasma membrane when retromer is inhibited.  Moreover, if deletion of retromer 
components simply alters the distribution of Kir2.1 and disruption of ESCRT prevents Kir2.1 
degradation, then deletion of both ESCRT and retromer components in the context of trk1Δ 
trk2Δ should produce synergistic growth on low potassium in yeast. 
Although I have identified factors that regulate Kir2.1 and there are hints as to where they 
act, it is not clear if the decision to degrade Kir2.1 is made before or after delivery to the plasma 
membrane.  Retromer may be targeting a pool of Kir2.1 being delivered to the plasma 
membrane, or it may be targeting a recycling population following internalization.  To determine 
if factors such as retromer recognize Kir2.1 before or after delivery to plasma membrane, a 
mutant Kir2.1 construct in which a tyrosine based motif important for endocytosis is impaired 
could be used (Tong et al., 2001; Wischmeyer et al., 1998).  This mutant should increase plasma 
membrane residence of Kir2.1 and should increase growth on low potassium in a trk1Δ trk2Δ 
strain due to Kir2.1 being trapped at the plasma membrane.  If this mutant is combined with the 
deletion of a gene product that acts prior to endocytosis (e.g., retromer), then there should be 
increased growth, whereas if it acts after endocytosis there should be no further increased 
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growth.  Alternatively, deletion of END3 inhibits endocytosis (Benedetti et al., 1994) and if 
combined with deletion of a gene that alters Kir2.1 plasma membrane residence there should be a 
similar result as found in experiments with the tyrosine mutant.  While using an end3 mutant 
strain would provide less specificity to Kir2.1, it would also inhibit the growth rate of the yeast 
strain, thus, allowing for an increased signal of Kir2.1 mediated rescue of trk1Δ trk2Δ upon 
deletion of a regulatory factor that functions prior to endocytosis.   
  Although the functional rescue of the trk1Δ trk2Δ strain by Kir2.1 indicates that it is 
functioning at the plasma membrane, the only endocytic factors that were identified were the 
Rsp5 adaptors, Tre1 and Bsd2, suggesting that Kir2.1 is ubiquitinated by Rsp5.  An Rsp5 
temperature sensitive mutant that is catalytically inactive provides a tool to determine whether 
either of these adaptors do in fact lead to the Rsp5 dependent ubiquitination of Kir2.1 (Wang et 
al., 1999).  However, Rsp5 also functions at the Golgi and ER (Haynes et al., 2002; Shcherbik et 
al., 2003; Wang et al., 2011), and the large number of hits associated with the Golgi may suggest 
that these genes act there.  While studies of how Tre1 and Bsd2 regulate Kir2.1 may reveal a 
mechanism for targeting Kir2.1 for degradation in yeast, translating these findings to human 
cellular biology is currently infeasible because both of these genes lack clear mammalian 
homologs. 
Kir2.1 is degraded in the yeast vacuole, but genes that control vacuolar function such as 
the vacuolar protease, Pep4, were not identified.  One possibility is that the vacuole represents a 
terminal site of protein trafficking and that once delivered to the vacuole a protein becomes 
trapped; thus, Kir2.1 would not be able to traffic back to the plasma membrane where it 
functions.  In this model, Kir2.1 would accumulate in the vacuole when genes important for 
vacuolar function are deleted.  However, this is difficult to test in yeast because the majority of 
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Kir2.1 is ER localized.  Nevertheless, I did attempt to see if Kir2.1 accumulates in the vacuole in 
a pep4Δ strain by immunofluorescence.  Unfortunately due to low signal, I saw inconclusive 
weak accumulation of Kir2.1 in the vacuole (data not shown). 
In fact it takes very few active channels to rescue growth of the potassium transporter 
deficient strain.  While Trk1 is estimated to be ~8 fold more abundant than Trk1, both proteins 
are ranked in the bottom 5% of expressed proteins in S. cerevisiae (Wang et al., 2012).  
Therefore, it is not suurprinsing that it does not take much Kir2.1 to rescue growth on low 
potassium.  For example, if it is assumed that a yeast cell has a volume of 100 fL, a membrane 
potential of -75 mV and requires 100 mM internal concentration of potassium to survive, that 
Kir2.1 has a single channel conductance of 30 ps and an open probability of 0.7, and that the 
membrane potential is not altered by the expression of Kir2.1, then it would take ~10 min for one 
channel to restore the intracellular potassium concentration from 1 mM to 100 mM on 10 mM 
potassium (Welling, PA., 2013 personal correspondence).  If so few channels are required to see 
a phenotype, then localization studies to determine organellar distribution in yeast are infeasible. 
The small amount of Kir2.1 needed to produce the growth phenotype in trk1Δ trk2Δ yeast 
limits the ability to perform biochemical studies.  For example, indirect immunofluorescence of 
Kir2.1 an overwhelming ER signal masks the signal at the plasma membrane even when ESCRT 
is deleted.  Even when Kir2.1 was expressed from the highly expressing GPD promoter, sucrose 
gradient centrifugation suggested that less than 5% of Kir2.1 resided at the plasma membrane 
(Figure 6), and monitoring changes in such a small population is difficult and makes such studies 
in yeast infeasible. Therefore, the need arises for alternate systems to elucidate the factors that 
regulate Kir2.1 biogenesis. 
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Evaluating the hits from the screen in mammalian expression systems such as HeLa cells 
provides a more physiologically relevant system to study human potassium channels and was 
used to confirm ESCRT’s role in regulating Kir2.1 plasma membrane residence.  However, to 
evaluate proteins identified in yeast the identity of the human homolog must be known.  As 
discussed yeast offer numerous advantages (see Section 1.1), and a yeast expression system that 
increases Kir2.1 plasma membrane residence would be a valuable tool to study post-ER quality 
control of Kir2.1.  In one established system, Kir2.1 was expressed from the inducible, high 
expressing GAL promoter.  The increased plasma membrane residence observed in this system 
may be a result of the inducible system.  Kir2.1 may take time to accumulate to the point that it is 
recognized by ERAD and acute expression of the protein may prevent such accumulation.  
Alternatively, high expression of Kir.21 may saturate ERAD, similar to what is observed when 
the ERAD substrate, CPY*, is overexpressed, and is instead targeted to the vacuole (Haynes et 
al., 2002).  This presents an added challenge because if protein quality control becomes 
saturated, then it becomes unclear if the amount of degraded protein increases from the “normal” 
protein quality control pathways or if cellular morphology has been altered.  If native levels of 
protein quality control are still occurring, inducible yeast systems like the one that utilizes the 
GAL promoter may be better suited for characterizing gene that act after ERAD.  While this 
system may lead to more plasma membrane residence and provide a way to biochemically 
characterize hits from the screen, inducible expression systems were unsuccessful in performing 
screens of Kir3.2 due to the low signal to noise (Haass, 2007).   
Several uncharacterized and poorly characterized genes were identified in the yeast 
screen I performed that would be more easily studied in alternative expression systems that 
increase Kir2.1 plasma membrane residence.  One protein of particular interest is Vps13 
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(Appendix A).  Vps13 has been identified in other screens to identify factors that regulate the 
trafficking of secretory proteins (Brickner and Fuller, 1997; Chang and Fink, 1995; Redding et 
al., 1996; Robinson et al., 1988; Rothman et al., 1989).  Vps13 is a Golgi localized protein, 
whose human ortholog has been linked to acanthocytosis and Cohen syndrome disease 
(Kolehmainen et al., 2003; Rampoldi et al., 2001).  In yeast, deletion leads to the accumulation 
of intralumenal vesicles and decreased phosphoinositides at the prospore, leading to decreased 
sporulation efficiency (Park and Neiman, 2012).  Decreased sporulation efficiency is also shared 
with ESCRT members, such as Vps27 (Deutschbauer et al., 2002).  
Like Vps13, the function of ECM30 (Appendix A) is unknown but data suggest it may 
alter Gap1 sorting and show cell wall defects, possibly due to the mislocalization of one of 
biosynthetic components (Costanzo et al., 2010; Lussier et al., 1997).  In addition, the open 
reading frame YJL163C which shows homology to folate transporter, and YJL132W, which 
shows homology to the glycosylphosphatidylinositol phospholipase D1 gene were identified. 
Besides understanding how genes are involved in trafficking, the genetic screen I 
performed provides a model for understanding protein quality control mechanisms of other 
potassium channels.  There are four other members of the Kir2 subfamily and six other Kir 
families that could be potentially used in the screen I developed.  Although these proteins are 
closely related, they differ in function, cellular localization, and protein interactions, suggesting 
that they may be regulated differently (Hibino et al., 2010).  For example, Kir1.1 (ROMK) is 
primarily ER localized in human cells and thus may be more dependent on ERAD (Yoo et al., 
2005).  However, ROMK is unable to rescue growth of the potassium transporter deficient strain 
on low potassium unless a point mutation is made in the pH sensing domain (Paynter et al., 
2010), suggesting that such screens may not be as straight forward.   
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In addition to Kir proteins, there are numerous potassium channels of physiological 
relevance that can be screened.  Besides potassium channels, the selectivity filter of sodium 
channels can be mutated to allow them to be more potassium permissive, and I have attempted to 
perform the screen with the epithelial sodium channel (see Appendix B).  Although I was 
unsuccessful, mutations in the selectivity filter of Kir3.2 to make it sodium permissive suggest 
that such a strategy may be successful.  In conclusion, the screen I performed establishes a model 
to probe the protein quality control of ion channels, and may lead to a better understanding of 
how the cell monitors proteins as they progress through the secretory pathway.  The efforts may 
also ultimately lead to a way to treat the many channelopathies that exist. 
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APPENDIX A 
SCREEN HITS 
Table 5: Expanded list of genes identified in a screen for increased Kir2.1 funciton 
  Gene Name SGD Description 
a Summaries b Reference Mammalian Ortholog 
Growth 
Score c 
CPY 
Secretion 
d 
1 VPS38 
Part of a Vps34p 
phosphatidylinositol 3-
kinase complex that 
functions in 
carboxypeptidase Y 
(CPY) sorting; binds 
Vps30p and Vps34p to 
promote production of 
phosphatidylinositol 3-
phosphate (PtdIns3P) 
which stimulates kinase 
activity 
Identified in VPL 
screen that mislocalizes 
vacuolar proteins to the 
cell surface  
(Rothman et 
al., 1989) 
UVRAG 
(Itakura et al., 
2008) 
1 0.97 
Involved in targeting 
carboxypeptidase Y 
(CPY) and mutant 
Pma1 to the vacuole 
(Luo and 
Chang, 1997) 
Mediates interaction 
between Vps30 and 
Vps34-Vps14 - PI3K 
complex II 
(Kihara et al., 
2001) 
Involved in targeting 
CPY and not Pma1 or 
CPS, Vps5 and Vps17 
(retromer) bind PI3P 
via PX domain 
(Burda et al., 
2002) 
2 VPS36 
Component of the 
ESCRT-II complex; 
contains the GLUE 
(GRAM Like Ubiquitin 
binding in EAP45) 
domain which is 
involved in interactions 
with ESCRT-I and 
ubiquitin-dependent 
sorting of proteins into 
Identified in VPL 
screen that mislocalizes 
vacuolar proteins to the 
cell surface, forms class 
E compartment,  
(Rothman et 
al., 1989) 
EAP45/VPS36 
(Kamura et al., 
2001) 
0.86 0.58 Identified in screen that 
led to increased alkaline 
phosphatase (ALP) in 
the vacuole, increased 
CPY secretion,  
(Nothwehr et 
al., 1996) 
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the endosome Forms a complex with 
Vps36 and Vps22 by 
gel filtration, associates 
with endosomes by 
fluorescent microscopy, 
release from 
membranes is Vps4 
dependent, functions 
downstream of ESCRTI 
and binds to ESCRTIII  
(Babst et al., 
2002b) 
Crystal structure of 
quaternary ESCRT II 
complex shows 
stoichiometry of 2:1:1 
of Vps25:Vps22:Vps36, 
hydrophobic patch of 
Y441, L97, I100, L141 
important for binding to 
Vps22, disruption of 
complex leads to class 
E phenotype, D548 
forms a salt bridge with 
R83 of Vps25,  
(Hierro et al., 
2004) 
Crystal structure of 
quaternary ESCRT II 
complex shows 
stoichiometry of 2:1:1 
of Vps25:Vps22:Vps36, 
four salt links with 
Vps22, ESCRTII 
interacts with Vps20 
(ESCRTIII) which 
increases binding of 
ESCRTIII to 
membranes in vitro 
(Teo et al., 
2004) 
Identified as a 
suppressor of cdc1-1, 
suppression due to 
accumulation of Smf1, 
conferred sensitivity to 
Li+ and Ca2+ 
(Eguez et al., 
2004) 
The N-terminal GLUE 
domain interact with the 
C-terminus of Vps28 by 
gel filtration and co-
immunoprecipitation, 
ESCRTII complex 
binds to Folch lipid 
vesicles mediated by 
the GLUE domain 
which contains a PH 
domain, GLUE domain 
localizes ESCRTII to 
endosomes, Vps36 NZF 
domain binds ubiquitin 
(Teo et al., 
2006) 
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3 DID2 
Class E protein of the 
vacuolar protein-
sorting (Vps) pathway; 
binds Vps4p and 
directs it to dissociate 
ESCRT-III complexes; 
forms a functional and 
physical complex with 
Ist1p; human ortholog 
may be altered in breast 
tumors 
Class A (wild-type) 
vacuoles in vacuole 
morphology study 
(Raymond et 
al., 1992) 
CHMP1 
(Howard et al., 
2001)- 
CHMP1A 
CHMP1B 
(Tsang et al., 
2006) 
0.46 0.07 
Identified as a 
suppressor of doa4 
mutant, characterized 
similar to Vps46, 
localizes to class E 
compartment when 
Vps4/Did6 ATPase is 
defective 
(Amerik et 
al., 2000) 
Did2 coordinates Vps4-
mediated dissociation of 
ESCRT-III from 
endosomes 
(Nickerson et 
al., 2006) 
Ist1, Did2, Vta1, and 
Vps60 Function 
Together to Positively 
Modulate Cargo 
Sorting, Did2 recruits 
Ist1 to endosomes 
(Rue et al., 
2008) 
4 GIM4 
Subunit of the 
heterohexameric 
cochaperone prefoldin 
complex which binds 
specifically to cytosolic 
chaperonin and 
transfers target proteins 
to it 
Synthetically lethal with 
TUB4, deletion is 
osmotically sensitive 
(Geissler et 
al., 1998) 
PFD2 (Vainberg 
et al., 1998) 0.45 0.04 
Part of prefoldin 
complex that binds 
chaperonin 
(Vainberg et 
al., 1998) 
Synthetically lethal with 
STU1 
(Brew and 
Huffaker, 
2002) 
5 VPS22 
Component of the 
ESCRT-II complex, 
which is involved in 
ubiquitin-dependent 
sorting of proteins into 
the endosome; appears 
to be functionally 
related to SNF7; 
involved in glucose 
derepression 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-invertase fusion 
protein,  
(Robinson et 
al., 1988) 
EAP30 (Schmidt 
et al., 1999) 0.40 0.54 
Identified in VPL 
screen that mislocalizes 
vacuolar proteins to the 
cell surface 
(Rothman et 
al., 1989) 
Identified in 
mutagenesis screen for 
inability to grow on 
raffinose  
(Vallier and 
Carlson, 
1991) 
Forms a complex with 
Vps36 and Vps22 by 
gel filtration, associates 
with endosomes by 
fluorescent microscopy, 
release from 
membranes is vps4 
dependent, functions 
downstream of ESCRTI 
and binds to ESCRTIII  
(Babst et al., 
2002b) 
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Crystal structure of 
quaternary ESCRTII 
complex shows 
stoichiometry of 2:1:1 
of Vps25:Vps22:Vps36, 
coiled coil with 2 
winged helix domains, 
binds to hydrophobic 
patch of Vps36 (Y441, 
L97, I100, L141) 
(Hierro et al., 
2004) 
Crystal structure of 
quaternary ESCRTII 
complex shows 
stoichiometry of 2:1:1 
of Vps25:Vps22:Vps36, 
four salt links with 
Vps36, D214 form a 
salt bridge with vps25 
R83, ESCRTII interacts 
with vps20 (ESCRTIII) 
which increases binding 
of ESCRTIII to 
membranes in vitro 
(Teo et al., 
2004) 
Identified as a 
suppressor of cdc1-1, 
suppression due to 
accumulation of Smf1, 
conferred sensitivity to 
Li+ and Ca2+ 
(Eguez et al., 
2004) 
6 VPS2 
Class E Vps protein of 
the ESCRT-III 
complex, required for 
sorting of integral 
membrane proteins into 
lumenal vesicles of 
multivesicular bodies, 
and for delivery of 
newly synthesized 
vacuolar enzymes to 
the vacuole, involved in 
endocytosis 
Identified in a screen 
for increased CPY 
secretion 
(Rothman 
and Stevens, 
1986) 
CHMP2a (Fujita 
et al., 2004) 0.36 0.37 
Identified in screen for 
defective endocytosis of 
STE3 
(Davis et al., 
1993) 
Identified in screen that 
led to increased ALP in 
the vacuole, increased 
CPY secretion,  
(Nothwehr et 
al., 1996) 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-inveratase fusion 
protein,  
(Robinson et 
al., 1988) 
Identified as a 
suppressor of doa4 
mutant, characterized 
similar to vps46, 
localizes to class E 
compartment when 
vps4/Did6 ATPase is 
defective 
(Amerik et 
al., 2000) 
Forms ESCRTIII 
complex with Vps20, 
vVs24 and snf7 by 
(Babst et al., 
2002a) 
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fractionation and 
colocalization, forms a 
subcomplex with vps24 
7 LDB16 
Protein of unknown 
function; null mutants 
have decreased net 
negative cell surface 
charge; GFP-fusion 
protein expression is 
induced in response to 
the DNA-damaging 
agent MMS; native 
protein is detected in 
purified mitochondria 
Screen of ldb phenotype 
that is associated with 
reduced incorporation 
of mannosyl phosphate 
groups into the 
mannoprotein-linked 
oligosaccharides 
(Corbacho et 
al., 2005) 
none 0.35 0 Mitochondria proteomics 
(Reinders et 
al., 2006) 
Microarray reveals at 
least three fold increase 
in response to DNA 
damage (MMS) 
(Lee et al., 
2007) 
Removal of promoter 
produces weak Opi 
phenotype 
(Hancock et 
al., 2006) 
8 VPS23 
Component of the 
ESCRT-I complex, 
which is involved in 
ubiquitin-dependent 
sorting of proteins into 
the endosome; 
homologous to the 
mouse and human 
Tsg101 tumor 
susceptibility gene; 
mutants exhibit a Class 
E Vps phenotype 
Identified in VPL 
screen that mislocalizes 
vacuolar proteins to the 
cell surface, normal 
vacuole 
(Rothman et 
al., 1989) 
Tsg101 (Li et 
al., 1999) 0.31 0.67 
Deletion rescues mating 
defect of stp2 mutant, 
localizes to class E 
compartment 
(Li et al., 
1999) 
Cloned by 
complementation, 
interacts with vps28, 
CPS misprocessing 
suggests endosomal 
function 
(Babst et al., 
2000) 
Characterization of 
ESCRT1 
(Vps23,28,37), binds 
ubiquitinated cargo 
(Katzmann et 
al., 2001) 
9 VPS35 
Endosomal subunit of 
membrane-associated 
retromer complex 
required for retrograde 
transport; receptor that 
recognizes retrieval 
signals on cargo 
proteins, forms 
subcomplex with 
Vps26p and Vps29p 
that selects cargo 
proteins for retrieval; 
interacts with Ypt7p 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-invertase fusion 
protein 
(Bankaitis et 
al., 1986; 
Robinson et 
al., 1988) 
Vps35 (Zhang, 
2000) 0.29 0.99 
Identified in screen that 
led to increased ALP in 
the vacuole, increased 
CPY secretion 
(Nothwehr et 
al., 1996) 
Dominant negative is 
rescued by 
overexpression of 
Vps29, fractionates 
with Vps29, required 
for assembly of the 
complex, forms a 
subcomplex with Vps26 
(Seaman et 
al., 1998) 
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and Vps29, primarily 
membrane bound, 
deletion causes 
disruption of Vps29 
membrane association, 
crosslinking experiment 
pulls down rest of 
retromer 
Crosslinks with A-ALP, 
used to examine 
retromer sorting signal 
(Nothwehr et 
al., 2000) 
10 VPS5 
Nexin-1 homolog 
required for localizing 
membrane proteins 
from a prevacuolar/late 
endosomal 
compartment back to 
the late Golgi 
apparatus; structural 
component of the 
retromer membrane 
coat complex; forms a 
retromer subcomplex 
with Vps17p; required 
for recruiting the 
retromer complex to 
the endosome 
membranes 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-inveratase fusion 
protein,  
(Bankaitis et 
al., 1986; 
Robinson et 
al., 1988) 
SNX1 
(Nothwehr, 
1997), Snx2 
(Schwarz, 2002) 
(Wassmer, 
2009) 
0.20 0.97 
Deletion exhibits class 
B vacuolar morphology 
(Raymond et 
al., 1992) 
Identified in screen that 
led to increased ALP in 
the vacuole, increased 
CPY secretion, mutant 
has growth defect at 
37°C 
(Nothwehr et 
al., 1996) 
Crosslinking 
experiment pulls down 
rest of retromer, is able 
to self assemble, 
(Seaman et 
al., 1998) 
11 GOS1 
v-SNARE protein 
involved in Golgi 
transport, homolog of 
the mammalian protein 
GOS-28/GS28 
Gos1 identified as a 
SNARE in silico 
(McNew et 
al., 1997) 
GOS-28/GS28 
(McNew et al., 
1998) 
0.20 0.53 
A snare that directly 
associates with Sed5, 
deletion disrupts ER-
Golgi or intra-Golgi 
transport of CPY 
(McNew et 
al., 1998) 
12 VPS29 
Endosomal protein that 
is a subunit of the 
membrane-associated 
retromer complex 
essential for endosome-
to-Golgi retrograde 
transport; forms a 
subcomplex with 
Vps35p and Vps26p 
that selects cargo 
proteins for endosome-
to-Golgi retrieval 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-inveratase fusion 
protein 
(Bankaitis et 
al., 1986; 
Robinson et 
al., 1988) 
Vps29 (Haft et 
al., 2000) 0.17 1 
Rescues a dominant 
negative Vps35 
suggesting an 
interaction, fractionates 
with Vps35, membrane 
localization is 
dependent on Vps35, 
crosslinking experiment 
pulls down rest of 
retromer, required for 
assembly of the 
complex, forms a 
subcomplex with Vps26 
and Vps35 
(Seaman et 
al., 1998) 
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13 APS1 
Small subunit of the 
clathrin-associated 
adaptor complex AP-1, 
which is involved in 
protein sorting at the 
trans-Golgi network; 
homolog of the sigma 
subunit of the 
mammalian clathrin 
AP-1 complex 
Identified in yeast by 
degenerate PCR, 
deletion with CHC1 
caused growth defect, 
Aps1 associates with a 
biochemically distinct 
complex from Aps2 
(Phan et al., 
1994) 
AP19/AP1S1, 
AP17/AP1S2 
(Kirchhausen et 
al., 1991), 
AP1S3 
0.16 0.01 
14 VAM10 
Protein involved in 
vacuole 
morphogenesis; acts at 
an early step of 
homotypic vacuole 
fusion that is required 
for vacuole tethering 
Deletion prevents 
vacuolar fusion under 
osmotic conditions, 
displays Vam3 
dependent vacuolar 
fusion in vitro, Opposite 
of VPS5 strand 
(Kato and 
Wickner, 
2003) 
none 0.15 0.94 
15 SCS7 
Sphingolipid alpha-
hydroxylase, functions 
in the alpha-
hydroxylation of 
sphingolipid-associated 
very long chain fatty 
acids, has both 
cytochrome b5-like and 
hydroxylase/desaturase 
domains, not essential 
for growth 
Identified as being 
similar to 
cytochromeb5, required 
for α-HO 26:0 
(Mitchell and 
Martin, 
1997) 
FA2H (Alderson 
et al., 2004) 0.15 0.02 
16 VAB2 
Protein with a potential 
role in vacuolar 
function, as suggested 
by its ability to bind 
Vac8p; likely member 
of BLOC complex 
involved in endosomal 
cargo sorting; Vab2p-
GFP-fusion localizes to 
cytoplasm in punctate 
pattern 
Interacts with Vac8 by 
yeast two hybrid, Vac8 
and Nvj1 mediate 
nucleus-vacuole 
junctions 
(Pan et al., 
2000) 
none 0.14 0.02 Localizes to cytoplasm in punctate pattern 
(Huh et al., 
2003) 
Vab2 interacts with 
members of the BLOC-
1 complex (sorts cargo 
to lysosome related 
organelles) 
reviewed in 
(Hayes et al., 
2011) 
17 PKR1 
V-ATPase assembly 
factor; functions with 
other V-ATPase 
assembly factors in the 
ER to efficiently 
assemble the V-ATPase 
membrane sector (V0); 
protein abundance 
increases in response to 
DNA replication stress 
Deletion causes growth 
defect on low iron 
media due to Fet3 (iron 
transporter) activity at 
the plasma membrane, 
vacuole ATPase 
decreased in deletion 
preventing vacuole 
acidification, ER 
localized 
(Davis-
Kaplan et al., 
2006) 
none 0.14 0.47 
18 VPS26 
Vacuolar protein 
component of the 
retromer; forms part of 
the multimeric 
membrane-associated 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-inveratase fusion 
protein 
(Bankaitis et 
al., 1986; 
Robinson et 
al., 1988) 
VPS26A, 
VPS26B (Kerr 
et al., 2005) 
0.14 1 
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retromer complex 
involved in vacuolar 
protein sorting along 
with Vps35p, Vps29p, 
Vps17p, and Vps5p; 
essential for endosome-
to-Golgi retrograde 
protein transport; 
interacts with Ypt7p; 
protein abundance 
increases in response to 
DNA replication stress 
Identified in screen that 
led to increased ALP in 
the vacuole, increased 
CPY secretion,  
(Nothwehr et 
al., 1996) 
Crosslinking 
experiment pulls down 
rest of retromer, 
mislocalizes Vps10 
similar to other 
retromer components, 
forms a subcomplex 
with Vps29 and Vps35 
(Seaman et 
al., 1998) 
19 BSD2 
Heavy metal ion 
homeostasis protein, 
facilitates trafficking of 
Smf1p and Smf2p 
metal transporters to 
the vacuole where they 
are degraded, controls 
metal ion transport, 
prevents metal 
hyperaccumulation, 
functions in copper 
detoxification 
Mutant has increased 
sensitivity to copper 
and cadmium, 
Liu, 1994 
none 0.13 0.03 
Localizes to the ER, 
mutants are 
hypersensitive to 
cadmium and copper 
due to loss of regulation 
of Smf1,  
(Liu et al., 
1997) 
Regulates Smf2 similar 
to Smf1 
(Portnoy et 
al., 2000) 
20 VPS37 
Component of the 
ESCRT-I complex, 
which is involved in 
ubiquitin-dependent 
sorting of proteins into 
the endosome; 
suppressor of rna1-1 
mutation; may be 
involved in RNA 
export from nucleus 
Identified in VPL 
screen that mislocalizes 
vacuolar proteins to the 
cell surface 
(Rothman et 
al., 1989) 
VPS37A, 
VPS37B, 
VPS37C, 
VPS37D 
(Seaman, 2008) 
0.13 0.83 characterization of ESCRT1 
(Vps23,28,37), binds 
ubiquitinated cargo 
(Katzmann et 
al., 2001) 
21 RAV1 
Subunit of the RAVE 
complex (Rav1p, 
Rav2p, Skp1p), which 
promotes assembly of 
the V-ATPase 
holoenzyme; required 
for transport between 
the early and late 
endosome/PVC and for 
localization of TGN 
membrane proteins; 
potential Cdc28p 
substrate 
Identified in screen that 
rescued mating 
competency of Kex2 
mutant (Soi3), mutants 
displayed normal 
vacuolar morphology, 
interferes with Kex2 
retention 
(Redding et 
al., 1996) 
DMXL1 
(Kraemer et al., 
2000) 
0.13 0.24 
Associated with Skp1 
and Rav2, associates 
with members of the 
Vacuolar ATPase, 
mutants are deficient in 
V-ATPase function, 
deletion prevents 
assembly of v1 domain,  
(Seol et al., 
2001) 
Mutants accumulate 
early endosomes and 
have decreased 
endocytosis of FM4-64,  
mutant leads to slowed 
degradation but not 
(Sipos et al., 
2004) 
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internalization of Ste3, 
membrane associated 
protein by 
sedimentation assay,  
functions upstream of 
class E compartment, 
22 YJL163C Putative protein of unknown function 
  SLC46A1 
(folate 
transporter) 
0.11 0.02 
23 Vps52 
Component of the 
GARP (Golgi-
associated retrograde 
protein) complex, 
Vps51p-Vps52p-
Vps53p-Vps54p, which 
is required for the 
recycling of proteins 
from endosomes to the 
late Golgi; involved in 
localization of actin 
and chitin 
Identified in transposon 
mutagenesis screen for 
CPY secretors, vps10 
and other late Golgi 
proteins were 
destabilized in deletion,  
requires other complex 
members for stability, 
forms 1:1:1 complex 
(Conibear 
and Stevens, 
2000) 
VPS52 (Liewen 
et al., 2005) 0.11 0.75 
Binds ypt6 (Siniossoglou 
and Pelham, 
2002) 
24 VPS17 
Subunit of the 
membrane-associated 
retromer complex 
essential for endosome-
to-Golgi retrograde 
protein transport; 
peripheral membrane 
protein that assembles 
onto the membrane 
with Vps5p to promote 
vesicle formation; 
required for recruiting 
the retromer complex 
to the endosome 
membranes 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-invertase fusion 
protein,  
(Bankaitis et 
al., 1986; 
Robinson et 
al., 1988) 
Snx5, Snx6 
(Wassmer et al., 
2009) 
0.093 1 
Crosslinking 
experiment pulls down 
rest of retromer, forms a 
subcomplex with Vps5 
(Seaman et 
al., 1998) 
25 GYP7 
GTPase-activating 
protein for yeast Rab 
family members 
including: Ypt7p (most 
effective), Ypt1p, 
Ypt31p, and Ypt32p (in 
vitro); involved in 
vesicle mediated 
protein trafficking 
Identified as a GAP for 
Ypt7 in vitro, Ypt7 
defects not observed 
when Gyp7 altered 
(deleted or 
overexpressed) in vivo 
(Vollmer et 
al., 1999) 
TBC1D15 
(Zhang et al., 
2005), 
TBC1D17 
0.083 0.01 The GTP bound state of 
YPT7 promotes 
vacuolar fusion, Gyp7 
inhibits vacuolar fusion, 
stimulates HOPS 
release 
(Eitzen et al., 
2000) 
26 ECM30 
Putative protein of 
unknown function; may 
play a role in cell wall 
biosynthesis, mutants 
have abnormal relative 
levels of mannose and 
glucose and have 
Transposon 
mutagenesis screen on 
calcaphlor white 
decreased 
mannose/glucose levels 
(Lussier et 
al., 1997) 
none 0.083 0.01 
Localizes to the 
cytoplasm 
(Huh et al., 
2003) 
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Gap1p sorting and 
transport defects; 
(GFP)-fusion protein 
localizes to the 
cytoplasm 
Forms a complex with 
Ubp15 that regulates 
Gap1 plasma membrane 
localization 
(Costanzo et 
al., 2010) 
27 ARL1 
Soluble GTPase with a 
role in regulation of 
membrane traffic; 
regulates potassium 
influx; G protein of the 
Ras superfamily, 
similar to ADP-
ribosylation factor 
Identified using 
degenerate PCR, mutant 
and overexpression 
have growth defects, is 
a myristolated protein 
that localize to Golgi 
membranes, 
(Lee et al., 
1997) 
ARL1 (Lee et 
al., 1997) 0.081 0.81 
Deletion is temperature-
sensitive and unable to 
grow on sucrose 
suppressed by YPT1, 
increased CPY 
secretion 
(Rosenwald 
et al., 2002) 
Deletion is sensitive to 
hygromyocin which is 
suppressed by the 
downstream effectors, 
Hal4, Hal5, and 
Sap155,  deletion does 
not alter Trk1 
(Munson et 
al., 2004) 
28 YPT6 
Rab family GTPase, 
Ras-like GTP binding 
protein involved in the 
secretory pathway, 
required for fusion of 
endosome-derived 
vesicles with the late 
Golgi, maturation of 
the vacuolar 
carboxypeptidase Y; 
has similarity to the 
human GTPase, Rab6 
Ts mutant leads to 
decreased transcription 
of ribosomal genes, 
deletion is lethal at 
37°C, invertase 
secretion and CPY 
glycosylation are 
inhibited in mutants, 
glycosylation pattern of 
invertase suggests role 
in ER-Golgi trafficking, 
(Li and 
Warner, 
1996) 
RAB6 (Li and 
Warner, 1996) 0.078 0.52 
Mutants showed defects 
in Golgi associated 
glycosylation of CPY, 
ALP, and invertase; N-
linked glycosylation 
enzymes are not 
properly localized in 
mutants but O-linked 
and ER glycosylation 
are, synthetic lethal 
with sec35 mutant, 
involved in 
Golgi/endosomal 
trafficking 
(Luo and 
Gallwitz, 
2003) 
29 MVB12 
ESCRT-I subunit 
required to stabilize 
oligomers of the 
ESCRT-I core complex 
(Stp22p, Vps28p, 
Srn2p), which is 
Colocalizes with 
ESCRTI by 
fluorescence and gel 
filtration, stabilizes 
interaction of coiled-
coil domain of Vps23,  
(Chu et al., 
2006) MVB12A, 
MVB12B 
(Seaman, 2008) 
0.077 0.14 
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involved in ubiquitin-
dependent sorting of 
proteins into the 
endosome; deletion 
mutant is sensitive to 
rapamycin and nystatin 
GFP tagged localizes to 
endosomes, deletion of 
ESCRTI components 
destabilized MVB12, 
Coimmunoprecipitates 
with vps23, deletion led 
to native size shift of 
vps23 and vps37, 
deletion produces a 
class E compartment,  
(Curtiss et 
al., 2007) 
30 MAK10 
Non-catalytic subunit 
of N-terminal 
acetyltransferase of the 
NatC type, required for 
replication of dsRNA 
virus; expression is 
glucose-repressible 
Deletion inhibits 
acetlyation of NatC 
substrates,  
(Polevoda 
and Sherman, 
2001) 
MAK10/NAA35 0.067 0.65 
31 ARL3 
GTPase of the Ras 
superfamily required to 
recruit Arl1p to the 
Golgi; similar to ADP-
ribosylation factor 
Deletion is cold-
sensitive, arl3 mutants 
were defective in 
endocytosis of Lucifer 
Yellow, cytosolicly 
localized by IF and 
gradient analysis,  
(Huang et al., 
1999) 
ARL3 0.065 0.85 
Acetylated by the NatC 
complex and recruits 
arl1 to the Golgi,  
(Behnia et 
al., 2004) 
32 RAV2 
Subunit of RAVE 
(Rav1p, Rav2p, 
Skp1p), a complex that 
associates with the V1 
domain of the vacuolar 
membrane (H+)-
ATPase (V-ATPase) 
and promotes assembly 
and reassembly of the 
holoenzyme 
Associated with Skp1 
and Rav1, associates 
with members of the 
Vacuolar ATPase, 
mutants are deficient in 
V-ATPase function, 
(Seol et al., 
2001) 
none 0.064 0.13 
33 VPS13 
Protein of unknown 
function; 
heterooligomeric or 
homooligomeric 
complex; peripherally 
associated with 
membranes; involved 
in sporulation, vacuolar 
protein sorting, 
prospore membrane 
formation and protein-
Golgi retention; 
homologous to human 
CHAC and COH1 
which are involved in 
chorea acanthocytosis 
and Cohen syndrome, 
respectively 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-inveratase fusion 
protein, weak secretion 
phenotype 
(Robinson et 
al., 1988) 
VPS13A, 
VPS13B, 
VPS13C, 
VPS13D 
(Velayos-Baeza 
et al., 2004) 
0.061 0.92 
Identified in screen that 
rescued mating 
competency of Kex2 
mutant, mutants 
displayed normal 
vacuolar morphology, 
interferes with Kex2 
retention 
(Redding et 
al., 1996) 
Soi1 encodes a 358kD 
protein that has 
homology to a C. 
elegans protein, 
immunofluorescence 
(Brickner and 
Fuller, 1997) 
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shows altered Kex2 
localization in deletion 
Relocalizes to the 
prospore and is required 
for cytokinesis, deletion 
leads to decreased 
phosphatidylinositides 
at the prospore and 
increased intralumenal 
vesicles 
(Park and 
Neiman, 
2012) 
34 TRE1 
Plasma membrane 
protein that binds to 
Bsd2p and regulates 
ubiquitylation and 
vacuolar degradation of 
the metal transporter 
Smf1p; function is 
redundant with that of 
Tre2p; has similarity to 
transferrin receptors 
Similar to transferrin 
receptor, contains PY 
motifs, deletion with 
tre2 results in increased 
Smf1, overexpression 
restores growth on 
cadmium of bsd2Δ, PY 
motif binds Rsp5 but is 
not required for 
ubiquitination, 
ubiquitination depends 
on Bsd2 
(Stimpson et 
al., 2006) 
none 0.050 0.01 
35 COG8 
Component of the 
conserved oligomeric 
Golgi complex (Cog1p 
through Cog8p), a 
cytosolic tethering 
complex that functions 
in protein trafficking to 
mediate fusion of 
transport vesicles to 
Golgi compartments 
Deletion causes growth 
defect in combination 
with sec35-1, mobility 
shift when deleted 
suggests in a complex 
with sec34 and sec35 
(Ram et al., 
2002) 
COG8 (Miller 
and Ungar, 
2012) 
0.048 0.49 Homologous to 
mammalian COG 
complex 
(Ungar et al., 
2002) 
in vitro translation 
studies  incorporation is 
dependent on Cog 5, 
Cog7, and Cog6  
(Loh and 
Hong, 2004) 
36 VPS30 
Subunit of 
phosphatidylinositol 
(PtdIns) 3-kinase 
complexes I and II; 
Complex I is essential 
in autophagy and 
Complex II is required 
for vacuolar protein 
sorting; ortholog of the 
higher eukaryotic gene 
Beclin 1 
Identified in a 
morphological screen 
for autophagic bodies 
(Tsukada and 
Ohsumi, 
1993) 
BECN1/Beclin-
1 (Aita et al., 
1999) 
0.047 1 
Deletion secretes CPY 
and PrA, peripherally 
associates with the 
membrane, deletion 
causes mislocalization 
of Vps10 by gradient 
analysis,  
(Seaman et 
al., 1997) 
Identified in VPT 
screen which led to 
increased secretion of 
CPY-inveratase fusion 
protein, weak secretion 
phenotype 
(Robinson et 
al., 1988) 
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Immunoprecipitation 
shows interaction with 
vps38 and vps34, 
deletion secretes CPY 
and prevents transport 
of API, autophagy 
inhibited in deletion, 
Vps30 binds to Vps368 
which then allows 
binding to Apg14 and 
Apg15, associates with 
membranes,  
(Kihara et al., 
2001) 
Deletion secretes CPY, 
deletion mislocalizes 
Kex2 and Vps10, 
deletion depletes PI3P, 
which inhibits Vps5 and 
Vps17 from binding 
membranes through PX 
domain 
(Burda et al., 
2002) 
Identified in a 
mutagenesis screen for 
increased A1PiZ, UPR 
is constitutively active, 
A1PiZ is targeted to the 
vacuole in vps30, 
vps38, vps10 dependent 
manner for degradation 
(Kruse et al., 
2006) 
37 GTR2 
Putative GTP binding 
protein that negatively 
regulates Ran/Tc4 
GTPase cycle; activates 
transcription; subunit of 
EGO and GSE 
complexes; required for 
sorting of Gap1p; 
localizes to cytoplasm 
and to chromatin; 
homolog of human 
RagC and RagD 
homologous to GTR1, 
rescues cold sensitivity 
of gtr1-11 strain, GST 
pulldown shows 
interaction with GTR1 
that is necessary for 
interaction with itself, 
suppresses prp20-1 
(Nakashima 
et al., 1999) 
RAGC, RAGD 
(Sekiguchi et al., 
2001) 
0.038 0 
Identified in screen for 
the inability to resume 
growth following 
rapamyocin treatment, 
localized to the 
vacuolar membrane, 
involved in 
microautphagy 
(Dubouloz et 
al., 2005) 
Interacts with GTR1 by 
yeast two hybrid, 
deletion decreases Gap1 
activity, colocalizes 
with other GSE 
complex members on 
endosomal membranes, 
GDP bound state has 
higher Gap1 activity, 
interaction with Gap1 
necessary for 
internalization 
(Gao and 
Kaiser, 2006) 
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38 CCR4 
Component of the 
CCR4-NOT 
transcriptional 
complex, which is 
involved in regulation 
of gene expression; 
component of the major 
cytoplasmic 
deadenylase, which is 
involved in mRNA 
poly(A) tail shortening 
Identified in a screen 
for regulators of ADHII 
activity,  
(Denis, 1984) 
CCR4/CNOT6 
(Dupressoir et 
al., 2001) 
0.033 0 
39 YJL132W 
Putative protein of 
unknown function; 
localizes to the 
membrane fraction; 
possible Zap1p-
regulated target gene 
induced by zinc 
deficiency; YJL132W 
is a non-essential gene 
    
GPLD1 0.033 0.01 
40 TCA17 
Subunit of TRAPPII, a 
multimeric GEF 
involved in intra-Golgi 
and endosome-to-Golgi 
transport; promotes 
association of 
TRAPPII-specific 
subunits with the core 
complex; sedlin related; 
human Sedlin 
mutations cause SEDT, 
a skeletal disorder 
Identified in a screen 
for increased plasma 
membrane residence of 
GFP-Snc1-Suc reporter 
gene, Mass spec 
following affinity 
purification identified 
other Trapp complex 
members, Trs33 and 
Trs65 are necessary for 
interaction with Trs20, 
gel filtration shows 
association with 
TRAPPII, Involved in 
stability of TRS65 and 
Bet5 with TRAPPII, 
Necessary for proper 
localization to the Golgi 
(Montpetit 
and 
Conibear, 
2009) 
TrappC2L 
(Scrivens et al., 
2009) 
0.033 0.01 
Interacts with the N-
terminus of Trs130 by 
yeast two hybrid, loss 
of TCA17 reduces 
amount of Trs31 in 
TrappII complexes and 
overall reduction in 
TRS130 
(Choi et al., 
2011) 
41 COG6 
Component of the 
conserved oligomeric 
Golgi complex (Cog1p 
through Cog8p), a 
cytosolic tethering 
complex that functions 
in protein trafficking to 
mediate fusion of 
transport vesicles to 
Golgi compartments 
Coimmunoprecipitates 
with Sec35, interacts 
with Sec35 and Sec36 
by yeast two hybrid, 
deletion causes growth 
defect similar to Sec34 
and Sec35 mutants, 
mobility shift when 
deleted suggests in a 
complex with Sec34 
(Ram et al., 
2002) 
COG6 ((Miller 
and Ungar, 
2012) 
0.033 0.6 
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and Sec35 
Homologous to 
mammalian COG 
complex 
(Ungar et al., 
2002) 
in vitro translation 
studies  incorporation is 
dependent on Cog 5 and 
Cog7 which is then 
required for 
incorporation of Cog8, 
(Loh and 
Hong, 2004) 
42 COG5 
Component of the 
conserved oligomeric 
Golgi complex (Cog1p 
through Cog8p), a 
cytosolic tethering 
complex that functions 
in protein trafficking to 
mediate fusion of 
transport vesicles to 
Golgi compartments 
Deletion causes growth 
defect in combination 
with sec35-1, mobility 
shift when deleted 
suggests in a complex 
with Sec34 and Sec35 
(Ram et al., 
2002) 
COG5 (Miller 
and Ungar, 
2012) 
0.031 0.35 
Homologous to 
mammalian COG 
complex 
(Ungar et al., 
2002) 
in vitro translation 
studies show direct 
interaction with Cog4 
and Cog7, interaction 
with Cog7 is required 
for incorporation of 
Cog6 which is then 
required for 
incorporation of Cog8 
(Loh and 
Hong, 2004) 
43 VTA1 
Multivesicular body 
(MVB) protein 
involved in endosomal 
protein sorting; 
regulates Vps4p 
activity by promoting 
its oligomerization; has 
an N-terminal Vps60- 
and Did2- binding 
domain, a linker region, 
and a C-terminal Vps4p 
binding domain 
Interaction with Vps4 
by yeast two hybrid and 
GST pulldown, delays 
post internalized 
degradation but not 
internalization of alpha 
factor, deletion 
increases CPY secretion 
and Ste3 accumulation, 
deletion forms class E 
compartment  
(Yeo et al., 
2003) 
SBP1(Azmi et 
al., 2006)VTA1 
(STRING) 
0.027 0.12 Identified in a screen 
for aberrant vacuolar 
morphology, fluid 
phase endocytosis 
delayed, CPS-GFP is 
mislocalized to the class 
E compartment in 
deletion, Ste3 is more 
stable in deletion, 
deletion sensitive to 
calcafluor white, 
colocalizes with Pep12, 
(Shiflett et 
al., 2004) 
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copreciptated with 
Vps60 
Decreased membrane 
association in vps4Δ, 
forms a dimer, 
promotes vps4 
oligomerization and 
activation of Vps4 
ATPase activity through 
the VSL region in the 
C-terminus 
(Azmi et al., 
2006) 
44 OPI8 
Dubious open reading 
frame unlikely to 
encode a protein, based 
on available 
experimental and 
comparative sequence 
data; partially overlaps 
verified gene 
DID2/YKR035W-A 
Weak Opi- phenotype, 
overlaps DID2 
(Hancock et 
al., 2006) 
none 0.021 0.07 
45 TRS85 
Subunit of TRAPPIII 
(transport protein 
particle), a multimeric 
guanine nucleotide-
exchange factor for 
Ypt1p, required for 
membrane expansion 
during autophagy and 
the CVT pathway; 
directs Ypt1p to the 
PAS; late post-
replication meiotic role 
Pulled down by Bet3-
PrA with TRAPP 
complex, 
overexpression 
suppresses bet3-1 
(Sacher et al., 
2000) 
none 0.019 0.41 
Identified in a screen 
for nitrogen starvation 
sensitivity, deletion 
leads to reduced 
autophagy and 
pexophagy, involved in 
CVT vesicle formation 
(Meiling-
Wesse et al., 
2005) 
Not a part of TRAPPII 
but is a part of TRAPPI 
(Choi et al., 
2011) 
46 SAP155 
Protein required for 
function of the Sit4p 
protein phosphatase; 
forms a complex with 
Sit4p; member of a 
family of similar 
proteins including 
Sap4p, Sap185p, and 
Sap190p; protein 
abundance increases in 
response to DNA 
replication stress 
Coimmunoprecipitates 
with Sit4-HA and 
Sit4:PY,overexpression 
suppresses temperature 
sensitivity of sit4-102, 
deletion causes slowed 
growth on YPD, 
function of Sit4 requires 
Saps 
(Luke et al., 
1996) 
PP6R1, PP6R2, 
PP6R3 
(Stefansson and 
Brautigan, 2006) 
0.015 0.01 
47 COG7 
Component of the 
conserved oligomeric 
Golgi complex (Cog1p 
through Cog8p), a 
cytosolic tethering 
Deletion causes growth 
defect in combination 
with sec35-1, mobility 
shift when deleted 
suggests in a complex 
(Ram et al., 
2002) COG7 (Miller 
and Ungar, 
2012) 
0.014 0.38 
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complex that functions 
in protein trafficking to 
mediate fusion of 
transport vesicles to 
Golgi compartments 
with Sec34 and Sec35 
Homologous to 
mammalian COG 
complex 
(Ungar et al., 
2002) 
in vitro translation 
studies show direct 
interaction with Cog4 
and Cog5, interaction 
with Cog5 is required 
for incorporation of 
Cog6 which is then 
required for 
incorporation of Cog8 
(Loh and 
Hong, 2004) 
48 GDH3 
NADP(+)-dependent 
glutamate 
dehydrogenase; 
synthesizes glutamate 
from ammonia and 
alpha-ketoglutarate; 
rate of alpha-
ketoglutarate utilization 
differs from Gdh1p; 
expression regulated by 
nitrogen and carbon 
sources; GDH3 has a 
paralog, GDH1, that 
arose from the whole 
genome duplication 
    
GLUD1, 
GLUD2 
(STRING) 
0.013 0 
49 YJL118W 
Putative protein of 
unknown function; may 
interact with 
ribosomes, based on 
co-purification 
experiments; YJL18W 
is a non-essential gene; 
deletion enhances the 
toxicity of 
heterologously 
expressed human 
alpha-synuclein 
    
None 0.0097 0 
50 VPS53 
Component of the 
GARP (Golgi-
associated retrograde 
protein) complex, 
Vps51p-Vps52p-
Vps53p-Vps54p, which 
is required for the 
recycling of proteins 
from endosomes to the 
late Golgi; required for 
vacuolar protein sorting 
Identified in transposon 
mutagenesis screen for 
CPY secretors, vps10 
and other late Golgi 
proteins were 
destabilized in deletion,  
requires other complex 
members for stability, 
forms 1:1:1 complex 
(Conibear 
and Stevens, 
2000) 
Vps53 (Liewen 
et al., 2005) 0.0095 0.01 
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51 IRS4 
EH domain-containing 
protein involved in 
regulating 
phosphatidylinositol 
4,5-bisphosphate levels 
and autophagy; Irs4p 
and Tax4p bind and 
activate the PtdIns 
phosphatase Inp51p; 
Irs4p and Tax4p are 
involved in localizing 
Atg17p to the PAS 
    
TRIOBP 
(STRING) 0.0079 0.52 
52 RGD2 
GTPase-activating 
protein (RhoGAP) for 
Cdc42p and Rho5p 
GAP identified in silico, 
binding confirmed by 
yeast 2 hybird, activity 
measured by  the 
MESG/phosphorylase 
in vitro assay  
(Roumanie et 
al., 2001) 
none 0.0074 0.02 
53 BGL2 
Endo-beta-1,3-
glucanase, major 
protein of the cell wall, 
involved in cell wall 
maintenance 
Purified protein used to 
identify gene, cloned 
gene had homology to 
beta1,3 exoglucanase, 
disruption did not affect 
transformation, growth, 
osmotic stability, 
mating, and sporulation 
(Klebl and 
Tanner, 
1989) 
none 0.0045 0.03 
Beta1,3 endoglucanse 
not exoglucanse, 
enzyme characterized, 
overproduction causes 
slow growth phenotype 
(Mrsa et al., 
1993) 
Hypoosmotic screen 
revealed overproduciton 
of BGL2, phenotype 
complemented by 
PKC1 
(Shimizu et 
al., 1994) 
Factor of c. albicans 
virulence 
(Sarthy et al., 
1997) 
Deletion of homolog in 
Aspergillus fumigatus 
showed no phenotype 
(Mouyna et 
al., 1998) 
  WT       0 0 
a Descriptions from the Saccharomyces Genome Database  
b Summaries from the literature of select genes involved in trafficking, localization, and stability  
c Growth Score calculated from doubling times (see Materials and Methods) 
d CPY secretion score (Bonangelino et al., 2002) 
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APPENDIX B 
PROTEIN QUALITY CONTROL OF THE EPITHELIAL SODIUM CHANNEL 
(Sections of this Appendix were previously published in Buck, T.M., A.R. Kolb, C.R. Boyd, 
T.R. Kleyman, and J.L. Brodsky. 2010. The endoplasmic reticulum-associated degradation of the 
epithelial sodium channel requires a unique complement of molecular chaperones. Mol Biol Cell. 
21:1047-58.) 
B.1 INTRODUCTION 
ENaC represents another ion channel that can be used in yeast studies to reveal protein quality 
control mechanisms.  ENaC is a sodium channel composed of three homologous subunits (α, β, 
γ) localized to the kidney, airway, and colon epithelia that functions to maintain sodium and 
volume homeostasis (Snyder, 2005; Soundararajan et al., 2010).  Misregulation of ENaC surface 
expression leads to diseases that alter blood pressure such as Liddle’s syndrome and 
Pseudohypoaldosteronism (Snyder et al., 2002; Su and Menon, 2001).  ENaC has also been 
shown to interact with the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) 
(Berdiev et al., 2009) and has been implicated in Cystic Fibrosis phenotypes (Gentzsch et al., 
2010; Huber et al., 2010; Rauh et al., 2010).  Thus, ENaC levels and function must be tightly 
regulated throughout the secretory pathway.   It is somewhat surprising that studies have focused 
 119 
almost exclusively on the later steps of regulation even though less than 20% of the protein 
ultimately resides in the membrane (Hanwell et al., 2002; Rotin et al., 2001; Valentijn et al., 
1998). 
 In this appendix, I describe my work aimed at understanding how ENaC is subject to 
protein quality control in the ER.  I first characterize the ubiquitination requirements of the 
ENaC subunits during ERAD in yeast.  I then describe my attempts to establish the conditions 
for a screen of ENaC plasma membrane regulators.  
B.2 UBIQUITINATION OF ENAC 
The ENaC subunits are ERAD substrates, and Dr. Buck demonstrated that ENaC ERAD 
is dependent on both Hrd1 and Doa10 in yeast.  Since these ligases are typically involved in 
recognizing different types of lesions, Hrd1 and Doa10 may be performing an additional function 
besides ubiquitination of the substrate, such as retrotranslocation of the substrate (Carvalho et al., 
2010; Zhong and Fang, 2012).  In addition, the lumenal Hsp40’s, Scj1 and Jem1 are required for 
ENaC degradation, but unlike other ERAD substrates, the Hsp70, Kar2 was not required.  Thus, 
ENaC likely requires a unique set of protein quality control factors.  However, because these 
chaperones appear to be acting in a unique way, it is not clear at what step during ERAD they are 
required.  To address these questions, I examined the ubiquitination of ENaC using an in vitro 
and an in vivo assay. 
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B.2.1 Materials and Methods - Ubiquitination Assays 
The in vitro ubiquitination assay (Nakatsukasa et al., 2008) was adapted to measure the 
extent of ubiquitinated ENaC in ER-derived microsomes prepared from wild-type and mutant 
yeast strains expressing the indicated HA-tagged ENaC subunit. Microsomes and cytosol from 
transformed strains grown in selective medium were prepared as described (McCracken and 
Brodsky, 1996), and 20 µl ubiquitination reactions contained ~20 µg of microsomes, an ATP-
regenerating system, and 2 mg/ml cytosol in B88 (20 mM HEPES, pH 6.8, 150 mM KOAc, 250 
mM sorbitol, 5 mM MgOAc, and a protease inhibitor cocktail [2 µg/ml leupeptin, 2 µg/ml 
aprotinin, 10 µg/ml trypsin inhibitor, 1 µg/ml E64, 10 µg/ml TPCK, 1 mM PMSF, 0.1 µg/ml 
pepstatin A]). Reactions were assembled on ice with protease inhibitor cocktail and were then 
prewarmed to 23°C for 10 min before 2 µl of 125 I-labeled ubiquitin was added (~200,000 
cpm/µl). At the indicated time point, the reaction was quenched with 1.25% SDS containing a 
protease inhibitor cocktail and 10 mM N-ethylmaleimide (NEM). ENaC subunits were 
immunoprecipitated with anti-HA conjugated resin (Roche) with protease inhibitors. The 
precipitated samples were split and half of the material was used for a Western blot analysis to 
detect the precipitated ENaC subunit and the other half was used for phosphorimager analysis. 
Data were analyzed and quantified using Image Gauge Software (v3.45; Fuji Film Science Lab). 
The detection of ubiquitinated ENaC in yeast was performed essentially as described 
(Ahner et al., 2007). In brief, cells expressing the indicated HA-tagged ENaC subunit were 
grown to log phase in 30 ml of selective medium. Next, the cells were disrupted with glass beads 
in lysis buffer (150 mM NaCl, 50 mM Tris, pH7.5, 0.1% NP40, 10 mM NEM, and a protease 
inhibitor cocktail) by agitation on a Vortex mixer 10 times for 30 s with 30 s incubations on ice 
between each cycle. Cell debris was removed by centrifugation, and the protein concentration 
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was estimated by measuring the absorbance at 280 nm. ENaC was immunoprecipitated from 
equal amounts of lysate with anti-HA–conjugated resin (Roche), and the precipitated proteins 
were resolved by SDS-PAGE. Half of each sample was used to detect ENaC, and the other half 
was used to detect polyubiquitinated ENaC. ENaC was detected with anti-HA antibody (Roche), 
and ubiquitinated ENaC was detected with anti-ubiquitin antiserum (obtained from the 
laboratory of C. Pickart, Johns Hopkins University School of Medicine [deceased]) after boiling 
the nitrocellulose membrane for 30 min in water. Data were obtained and quantified as described 
above. 
B.2.2 Results – Ubiquitination Assays 
Dr. Buck in the Brodsky lab demonstrated that ENaC degradation is dependent on both Hrd1 and 
Doa10.  When either of these is deleted there is significant stabilization of the ENaC subunits, 
and when both are deleted, there is synergistic stabilization.  To assay whether the extent of 
stabilization correlated with the degree of ubiquitination—and thus that the effect of deleting the 
ligases was direct—I examined α- and β-subunit ubiquitination in vivo. To this end, the α- and β-
subunits were immunoprecipitated from wild type and from hrd1Δ and hrd1Δdoa10Δ mutant 
yeast, and an anti-ubiquitin antibody was used in a subsequent Western blot analysis. The results 
presented in Figure 16A and B, indicate that subunit ubiquitination was significantly decreased 
in yeast lacking Hrd1 or both Hrd1 and Doa10. These data are consistent with a requirement for 
these ligases during ERAD, as observed (Buck et al., 2010), and indicate that the effects of 
deleting the ligases are direct. 
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 Figure 16: Ubiquitination of ENaC 
ENaC ubiquitination is impaired in yeast strains lacking the E3 ubiquitin ligases Hrd1 
and Doa10. A) Wild type (WT) or the indicated mutant yeast strains expressing either the α- () 
or β- () ENaC subunit were processed as described and the level of ubiquitination was 
assessed.  The bar graph represents the means of 5–7 determinations, ±SEM, and the data in the 
mutant strains were standardized to the amount in the wild-type cells. A typical experimental 
result is shown in B. C) Microsomes from wild type (HRD1/DOA10) or the hrd1Δ  doa10Δ 
mutant strain expressing either α- or β-ENaC were prepared and subjected to the in vitro 
ubiquitination assay. The bar graphs represent the means of three (β) or eight (α) determinations, 
±SEM.  D) Microsomes from wild type (JEM1/SCJ1) or the jem1Δ scj1Δ mutant strain 
expressing either α- or β-ENaC were prepared and subjected to the in vitro ubiquitination assay 
as described. The bar graphs represent the means of six determinations, ±SEM. A typical result is 
shown in E. 
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To confirm these data, I next developed an assay in which the degree of ENaC subunit 
ubiquitination could be assessed in vitro. This assay was based on a system in which the 
conjugation of 125I-ubiquitin onto membrane-integrated ERAD substrates could be monitored 
after their expression in yeast (Nakatsukasa et al., 2008). I therefore prepared ER-derived 
microsomes from α-ENaC-expressing yeast and delineated the time, temperature, and cytosol 
dependence on ENaC subunit ubiquitination in vitro (Figure 17).  I found that the optimal ENaC 
ubiquitination was observed when the reactions were allowed to proceed for 40 min. with 1-
2mg/mL of cytosol.  
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 Figure 17: Optimization of the in vitro ubiquitination assay for α-ENaC. 
Microsomes were prepared from yeast expressing α-ENaC and the in vitro ubiquitination 
assay was performed as described under the indicated conditions. In A reactions contained 2 
mg/mL of cytosol and were performed at 23°C, in B reactions were performed at 23°C for 40 
min, and in C reactions contained 2 mg/mL cytosol and were performed for 40 min. 
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I next prepared microsomes from either wild-type yeast or hrd1Δdoa10Δ cells that 
expressed the α- or β-subunit and used the optimized conditions to assess subunit ubiquitination 
in vitro. I again found that subunit ubiquitination decreased in the ligase mutant strain (Figure 
16C). These results suggest that Hrd1 and Doa10 ubiquitinate ENaC directly. 
Further, Dr Buck identified the Hsp40s, Scj1 and Jem1, as another set of factors that 
participate in the ERAD of ENaC.  ENaC degradation was stabilized when SCJ1 and JEM1 were 
deleted.  The inefficient degradation of the ENaC subunits in the scj1Δ jem1Δ strain might either 
result from an inability of the protein to be delivered or recognized by E3 ligases or result from 
an inability to transfer the ubiquitinated species to the proteasome. To differentiate between these 
scenarios, I assessed subunit ubiquitination in vitro, as described above, in a wild-type strain and 
in cells lacking Scj1 and Jem1 (Figure 16D, E). The relative percentage of ubiquitinated protein 
decreased significantly for both the α- and β-subunit, consistent with the Hsp40s playing a role 
before ubiquitination in the ERAD process. 
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B.3 A YEAST SCREEN TO IDENTIFY EFFECTORS OF ENAC PLASMA 
MEMBRANE RESIDENCE 
ENaC is an ERAD substrate that functions at the plasma membrane and like Kir2.1 it must 
assemble into a multimeric channel, although in the case of ENaC it is a trimer (Stewart et al., 
2011; Stockand et al., 2008).  The most active channel consists of α, β, and γ subunits.  
Elimination of either β or γ ENaC reduces current to 10% of the full channel activity, and α alone 
produces only ~1% of the activity (Canessa et al., 1994b).  Although ENaC is normally highly 
selective for sodium over potassium (1000 Na+:1 K+), a mutation can be made within the α-
ENaC selectivity filter to make it more permissive to potassium over sodium (4K+: 1Na+) (Sheng 
et al., 2000).  While this mutation favors potassium, it still is not as selective as a natural 
potassium channel, such as Kir2.1, a potassium channel expressed in skeletal muscle, heart, 
brain, lung, and kidney (Kubo et al., 1993; Tang et al., 1995a).  I attempted to establish a screen 
for α-ENaC similar to that described in Chapter 2.  To this end I attempted to find conditions in 
which when the potassium permissive ENaC mutant was expressed in a trk1Δ trk2Δ strain it 
would rescue growth on low potassium.   
 
B.3.1 Attempts to optimize a screen for alpha ENaC 
To find the optimal conditions to use for the screen, I made a series of wild type and mutant 
ENaC expression plasmids to test on various media. The mutant ENaC constructs include the 
 127 
selectivity filter mutant 587GYG589, and the GYG mutant with a 26 amino acid fragment cleaved 
that has been shown to increase channel open probability (GYGΔ) (Carattino et al., 2007; Sheng 
et al., 2000).    To regulate ENaC expression, I placed these constructs under the control of 
different promoters: GPD (highest constitutive expression), TEF (high constitutive expression), 
MET25 (methionine repressible), and GAL (galactose inducible).  Dr Buck previously made the 
GPD plasmids.  To construct the remaining plasmids, I used the backbone of PRS4x6 vectors 
(Mumberg et al., 1995) and inserted the ENaC construct into the polylinker by cutting the 
construct from the GPD vectors with EcoR1 and Xho1.  All plasmids were made and confirmed 
by sequencing.  The plasmids were transformed into yeast lacking Trk1 and Trk2 and tested for 
rescue of growth under media conditions that varied for potassium concentration (100, 50, 30, 
0mM K+ added), pH (3, 4, 6), and amino acid supplement (SC, SD). For these efforts I was 
assisted by Cary Boyd, who was a postdoctoral PSTP researcher. 
Expression of Kir2.1 always worked as a positive control, however sometimes the vector 
control would appear to rescue, most likely due to the presence of suppressors.  The potassium 
selective mutant also gave inconsistent results (Figure 18).  This inconsistency was seen 
regardless of the plasmid or media conditions and may be due to suppressors (Liang et al., 1998; 
Vidal et al., 1990; Wright et al., 1996) or differences in plasmid copy number.  Even if the 
results were averaged a condition and ENaC construct combination could not be found that 
produced a signal detectable over background.  Although there were times when the ENaC 
mutants rescued as predicted, there was not enough consistency to do a reliable screen.  
Nevertheless some trends could be seen.  All ENaC constructs, regardless of promoter, grew at 
pH 6 even at the lowest potassium concentration, while growth became more selective at lower 
pH.  In addition growth was slower on SD media and at lower pH.  There also did not appear to 
 128 
be a difference between the GYG and the GYGΔ construct.  Thus, the GYGΔ was not considered 
for future studies. 
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A) 
 
B) 
 
Figure 18: Growth assays of trk1Δ trk2Δ yeast expressing ENaC mutants 
A) Summary of all experiments done with either the PRS416 TEF vectors or the GPD 
426 vectors.  Each experiment was scored as a 1 for growth or 0 for no growth and the total was 
divided by the number of experiments.  B)  trk1Δ trk2Δ strains containing PRS416 TEF plasmids 
with either Kir2.1, α-ENaC (WT), α-ENaC with 587GYG589 mutation (GYG), or 587GYG589 
mutation with the inhibitory peptide deleted (GYGΔ) were streaked onto –URA plates 
supplemented with 50, 30 or 0 mM K+ at a pH of 4.  Shown are three separate experiments 
indicating the inconsistency of the results.   
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To overcome issues with plasmid copy number and provide a more consistent context for the 
screen, I integrated the TEF, MET25, and GAL constructs into the TRK1 locus of a yeast strain 
already deleted for TRK2 with the NAT resistance gene.  I designed primers to an area in the 
backbone common to all the plasmids used that flanked the URA gene and ENaC.  This ~5.5kb 
region was PCR amplified and transformed into yeast and allowed to integrate by homologous 
recombination.  Integration was confirmed by PCR using one internal primer to the PCR 
amplified region and one external primer to the TRK1 locus.  The resulting integrants were then 
tested in similar conditions as above.  I confirmed and tested all of the MET25 constructs. 
None of the MET25 constructs rescued growth on low potassium, including the positive 
control, Kir2.1.  One possibility for failed rescue may be due to insufficient protein expression 
levels.  To confirm this, a time course performed by Cary Boyd showed that expression of ENaC 
ceased 20hrs after the removal of methionine in liquid culture.  As a way to further increase 
channel activity, and thus its ability to augment growth on low potassium, I expressed α-ENaC 
with either β- or γ-ENaC.  However, this caused the strain to grow so slowly that a growth screen 
was infeasible.  
As an alternative approach I attempted to perform a sodium sensitivity screen with wild 
type ENaC.  To this end I engineered a yeast strain that lacked the ENA genes that encode the 
primary sodium efflux system (Garciadeblas et al., 1993; Haro et al., 1991).  Yeast encode up to 
4 copies of this gene, depending on the strain.  I deleted ENA by homologous recombination and 
the resulting strain was sensitive to sodium.  However, ENaC could not be expressed in this 
strain, and I could not identify conditions that would allow for a screen for ENaC protein quality 
control factors.  Instead, I performed the Kir2.1 screen described in chapter 2. 
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B.3.2 Does ENaC function at the plasma membrane in yeast 
One possibility why a screen using ENaC was not successful is that there was not enough 
functional channel at the plasma membrane.  Like mammalian cells the majority of ENaC 
localizes to the ER in yeast (Buck et al., 2010).  Only a small population (less than 5%) traffics 
to the plasma membrane (Figure 19 lanes 17-19) and this may not be enough to produce a 
noticeable phenotype.   A plasma membrane population of ENaC would be consistent with 
previous results that showed that expression of ENaC made cells sensitive to high concentrations 
of sodium (Gupta and Canessa, 2000).  However, it is not clear whether the observed toxicity is 
due only to excessive sodium entering the cell through the channel or whether overexpressing a 
heterologous protein also contributed to the increased sensitivity of the yeast.  In fact, yeast 
expressing ENaC grow more slowly and my analysis of the unfolded protein response using a β- 
galactosidase reporter showed that ENaC expression highly induces the UPR, suggesting that it 
is the expression and not the function of ENaC that mediates toxicity (Table 5).  Thus, ENaC 
may not be suited for a screen that depends on it functioning at the plasma membrane.   
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 Figure 19: Sucrose gradient analysis of ENaC 
The ENaC subunits were individually expressed in yeast and subjected to sucrose 
gradient analysis as described in chapter 2. Cell lysates prepared from yeast expressing the ENaC 
subunits were centrifuged on a 20-70% sucrose gradient containing either EDTA or Mg2+.  
Gradients were performed in the absence of Mg2+ (+EDTA) to separate plasma membrane from 
Golgi and ER and in the presence of Mg2+ to separate Golgi from PM and ER.  Fractions were 
taken, TCA precipitated and immunoblotted for HA (ENaC), Sec61 (ER marker), Anp1 (Golgi 
marker), and Pma1 (plasma membrane marker). 
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Table 6: The UPR is induced in yeast strains expressing ENaC. 
Strain/Protein WT/pRS326 WT/α-ENaC WT/β-ENaC ire1Δ/pRS326 
UPR (-DTT) 600 4000 2700 5.0 
(+DTT) 1500 3700 3100 7.8 
 
The UPR (in β-galactosidase units) in the indicated strains was measured from cells that 
were grown in the presence or absence of 5 mM DTT for 1 h as described (Kabani et al., 2003).  
PRS326 is a vector control that lacks an insert. 
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